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ABSTRACT
Oxidative folding is one of the key challenges hampering the development of peptide-
based compounds as therapeutics. While disulfide-rich peptides are often thought to be
more appealing drug lead compounds because of their stable, highly-crosslinked structure,
their oxidative folding to the correct disulfide connectivity is often difficult, and is optimized
in a peptide-specific way. This work advanced knowledge of chemical and biological means
to improve oxidative folding of conotoxins. Herein I present a generalized folding protocol
suitable for folding diverse disulfide-rich peptides. I also show that the incorporation of
selenocysteines to replace a disulfide bridge with a diselenide effectively adds an intramolec-
ular oxidative folding catalyst, where this bridge had previously been assumed to be static,
with any folding improvements being a consequence of conformational effects. These are
followed by a discussion of oxidative folding mechanisms in vivo, relating energy expenditure
to directing disulfide isomerization to the desired connectivity, as well as a novel analysis
tool to consider the codon conservation of the cysteine residues that comprise the disulfide
scaffold. This work represents significant improvements to chemical strategies to efficiently
produce disulfide-rich peptides and genetic analyses towards a better understanding of the
role oxidative folding plays in the evolution of disulfide scaffolds of cysteine-rich peptides.
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1.1 Overview of Chapter 1
Oxidative folding is critical to the chemical and biological syntheses of disulfide-rich
peptides, and is the focus of this thesis. The following sections of this chapter will
provide a general overview of oxidative folding. Challenges inherent to conformation-driven
thiol-disulfide exchange and traditional methods of oxidative folding are also discussed.
Conotoxins are a useful model system to study oxidative folding, and the value of this
model system—both to chemical methodologies and pharmaceutical development—are the
topic of the ensuing sections. The concluding section of this chapter outlines the scope of
this dissertation.
1.2 Oxidative Folding
Oxidative folding, or the concomitant formation of disulfide bridges and three-
dimensional structure in peptides and proteins, is usually mediated by various enzymes in
vivo, or an excess of disulfide transfer reagents in vitro. In both cases, the ultimate source of
the oxidizing equivalents for the formation of disulfide bridges is molecular oxygen; however,
the direct transfer of electrons between thiols and molecular oxygen is spin-forbidden.
Consequently, intermediaries are used to facilitate the oxidation of thiols to disulfides. These
intermediaries can vary significantly based on context, and include enzymatic machinery
with flavin adenine dinucleotide (“FAD”) cofactors [1], several transition metals (copper and
iron are particularly effective) [2, 3, 4], and diselenides [5]. However, these intermediaries
are most commonly used to form the disulfide transfer reagents, which themselves serve as
a second layer of intermediary. Glutathione is one particularly common disulfide transfer
reagent, and is used both in vivo and in vitro [6, 7, 8, 9, 10].
The proper formation of disulfide bridges is critical to the function of many proteins and
peptides because disulfides stabilize active conformations; this was first shown by Anfinsen’s
group in 1957 by reduction of the disulfides of ribonuclease A [11], and further confirmed
2with the reactivation of reduced ribonuclease A in subsequent work [12]. This work gave
the first hints that in disulfide-containing peptides and proteins, the formation of disulfide
bridges could provide insight into folding mechanisms and intermediates. The prototypical
example of the ability to use disulfides to trap folding intermediates, whereby allowing the
determination of the folding pathway, is bovine pancreatic trypsin inhibitor (BPTI), by
work done in the laboratory of Thomas Creighton [13]; intermediates with native disulfides
were shown to dominate the folding pathway of BPTI several years later [14].
Where proteins usually have enough sequence-encoded folding information to form the
native disulfide bridges with high efficiency (first shown by Anfinsen, [12]), the same is
not generally true of peptides due to their dramatically shorter sequence, particularly
for disulfide-rich peptides, in which cysteine can comprise over 30% of the sequence (for
instance µ-KIIIA, which is 37.5% cysteine [15]). While the shorter sequence of peptides
may consequently seem burdensome, it also offers advantages because short peptides can
be easily synthesized using solid phase synthesis methods [16, 17], allowing facile access
to sequence modifications and incorporation of unnatural amino acids. Consequently, the
efficient formation of native disulfide bridges in short, cysteine-rich peptides is the challenge
addressed herein.
1.2.1 The Challenge of Oxidative Folding
As is intuitively obvious, the formation of the desired disulfide bridging pattern becomes
more difficult with increasing numbers of disulfide bridges, as well as with decreasing
sequence length (such that the cysteines comprise a larger fraction of the total peptide
sequence). If all disulfide isomers are equally accessible and equally favored (which is rarely
the case), then the total number of maximally oxidized disulfide isomers, p, is given by
p = n!! =
n!




where n is the number of cysteine residues (the double factorial is used to indicate the
product of all odd numbers between 1 and n). My derivation of this formula is presented as
Appendix A. For a more empirical view of the relationship between the number of cysteines
and the possible disulfide isomers, see Table 1.1. It is worth noting that while exponential
growth is usually considered the “holy grail” of growth rates, factorial growth is considerably
faster. In biology, exponential growth is the fastest rate at which organisms can replicate,
and factorial growth only applies to increases in complexity. Exponential and factorial
growth are compared in Figure 1.1, using bacterial growth (given by 2n, since each cell
division cycle doubles the number of cells) and the number of disulfide isomers possible.
3Table 1.1. Empirical view of the number of possible disulfide isomers. The left column
shows the number of cysteines in a peptide, and the right column shows the number of
disulfide isomers that are possible with the specified number of cysteines. The table includes
values up to 16 cysteines because genes for peptides containing up to 16 cysteines have been
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Figure 1.1. Comparison of factorial and exponential growth. The number of possible
disulfide isomers is shown in blue, and increases according to Eq. 1.1 (factorial growth).
Bacterial growth is used as a model for exponential growth, as each cell division cycle
doubles the number of bacterial cells (modeled with 2n). For the number of disulfide isomers,
the horizontal axis gives the number of cysteines, and the vertical axis gives the number
of disulfide isomers (excluding topological isomers); in the case of bacterial growth, the
horizontal axis gives the number of cell division cycles, and the vertical axis gives the
total number of bacterial cells. With these two examples, factorial growth first surpasses
exponential growth with the addition of the ninth cysteine residue.
5It is worth noting that not all of these disulfide isomers are necessarily going to be
accessible to every peptide. Peptide bonds do offer some general structure, and only certain
φ and ψ torsion angles are allowed (the ω torsion angle is virtually always planar, as
a consequence of resonance structures of the peptide bond), due to spatial limitations
imposed by the side chains of each residue, as well as structural limitations by the backbone
bonds themselves. As an example, vicinal disulfide bonds (a disulfide between two adjacent
cysteines) are usually highly disfavored. While this does impose some limitations to the
number of disulfide isomers that can be accessed, it does not eliminate disulfide isomers in
any predictable way. For instance, PIIIA has recently been shown to fold to three disulfide
isomers which have activity, one of which includes two vicinal disulfides [18].
Additionally, a single disulfide isomer can have more than one three-dimensional form,
such that bonds must be broken and reformed to convert between topological isomers.
These have classically been referred to as ‘knots’ [19], despite not necessarily being knots in
the formal mathematical sense (although they can be). Examples of ‘knotting isomers’ are
shown in Figure 1.2, which shows both an ‘effective’ (top) and a ‘real’ (bottom) topological
isomer of a single disulfide scaffold. The unknotted isomer is also shown (center). Conversion
between the ‘effective’ topological isomers (the top two isomers in Figure 1.2) does not
necessarily require breaking bonds, although the pathways available to short, disulfide-
rich peptides (based on excluded volume, conformational limitations and loop lengths)
would require breaking and reforming at least one disulfide. Conversion between the ‘real’
topological isomers requires breaking and reforming at least one disulfide.
Consequently, the oxidative folding of peptides remains an interesting challenge, and
offers an excellent venue for the development of novel folding techniques and chemical
approaches, many of which will be discussed further in the coming pages.
1.2.2 In Vitro Oxidative Folding Reactions
Oxidative folding of peptides and proteins has classically been done in solution, and
requires very dilute peptide (20-50 µM) in order to avoid oligomerization [20]. There are
two general approaches to in vitro oxidative folding: conformation-driven thiol-disulfide
exchange, and stepwise disulfide bridge formation. These two methods are substantively
distinct; while the former allows for single folding and purification steps, the folding yield
can vary substantially, from below 5% to above 95% [21, 22], the latter theoretically only
yields a single disulfide bridging pattern, but is limited by the number of orthogonal cysteine
protecting groups and requires multiple purification steps. Because the challenges facing
stepwise bridge formation are essentially limited to efficient purification of a single product,
6C1 C2 C3 C4 C5 C6
C1 C2 C3 C4 C5 C6
C1 C2 C3 C4 C5 C6
Figure 1.2. Topological isomers for a three-disulfide containing peptide. The top two
isomers shown are ‘effective’ topological isomers, in that conversion between the two does
not necessarily require breaking and reforming disulfides, although in a peptide containing
less than 40 total residues, this type of conversion would only be accomplished by breaking
and reforming one or more disulfide(s) due to conformational constraints. Such a conversion
(top to middle) can be accomplished without breaking bonds by threading C1 through the
C2-C4 disulfide (back to front), and threading C6 through the C3-C5 disulfide (front to
back); the conversion is completed by ‘lifting’ the C1-C6 disulfide up from between the
C2-C4 disulfide and the C3-C5 disulfide. The bottom isomer is a ‘real’ topological isomer
of the upper two isomers, as any conversion between the upper two and the bottom isomer
would require breaking and reforming disulfides.
7I will focus primarily on conformation-driven thiol-disulfide exchange.
Numerous oxidants are employed to form disulfide bridges from free thiols, each with
its own advantages and disadvantages. The most common oxidants for in vitro oxidative
folding of peptides are disulfide transfer reagents, such as a mixture of oxidized and reduced
glutathione, shown in Figure 1.3. Since its discovery in the endoplasmic reticulum [7],
glutathione has become the prototypical disulfide transfer reagent because it is believed to
better mimic oxidative folding in vivo. Other broadly-employed oxidative reagents include
dimethyl sulfoxide (DMSO), iodine and transition metals, in particular iron and copper. The
mechanism of DMSO-oxidation was reported in 1975, and established that the rate-limiting
step was the formation of a sulfoxide-thiol adduct [23], although DMSO-based oxidation can
also result in sulfoxide formation at methionine [24]. Iodine is a potent oxidant, which forms
a sulfenyl iodide intermediate with thiols, which then further reacts with another equivalent
of thiol to form a disulfide and two equivalents of hydrogen iodide [25]. However, disulfide
formation by iodine can promote oxidation of other residues, including sulfoxide formation
at methionine and oxidation of tryptophan to oxindole-tryptophan [26, 27]. The mechanism
of copper-catalyzed disulfide formation is also known [3]; this mechanism is complex, and
shows biphasic kinetics. Metal-catalyzed oxidation is often referred to as “air oxidation”
because it usually employs trace metals already in the solution, rather than explicit addition
of metals that are known to be redox-active.
1.3 Conus Venom Peptides as a Model
System for Oxidative Folding
Conotoxins are a particularly appealing system to study oxidative folding of small,
cysteine-rich peptides because they are therapeutically relevant and extremely diverse.
Conotoxins exhibit a broad range of oxidative folding yields, hydrophobicities, number
of disulfides, and disulfide scaffolds, making them an excellent sampling with which to lay
groundwork for oxidative folding that can then be extended to virtually any cysteine-rich
peptide.
Additionally, there are numerous sequences of conotoxins for which only genetic infor-
mation is known, which has led to several studies on the specific effects posttranslational
modifications can have on oxidative folding [28, 29]. The rate at which new sequences can
be discovered by genetic means significantly exceeds the rate at which new peptides can be
characterized from venom, and consequently the generation of cDNA libraries has become






























Figure 1.3. Glutathione, a typical disulfide transfer reagent used for the formation of
disulfide bridges in vitro. To transfer the disulfide equivalent to a peptide, the peptide
thiolate attacks the disulfide of oxidized glutathione (right), and the resulting mixed
disulfide is subsequently attacked by another peptide thiolate; reduced glutathione (left)
is added to increase the rate of disulfide isomerization. Note that the thiol hydrogen (as
shown on reduced glutathione) is removed to generate the thiolate, which is what acts as
the nucleophile to drive the reaction.
9as the signal sequence and mature toxin are encoded in distinct exons [30, 31, 32], the correct
classification of a genomic sequence into a family of conotoxins (usually accomplished by
comparison of disulfide scaffolds as well as signal sequence homology) is made much more
difficult with genomic DNA. Nonetheless, the peptide sequences of the mature toxins can
be fairly easily identified, emphasizing the need for high-throughput synthesis and oxidative
folding techniques.
Conus shows a great diversity of disulfide scaffolds (see Figure 1.4), which allows
conotoxins to function as a model system for virtually any known peptide that is also short
and disulfide rich (with respect to oxidative folding). Furthermore, because conotoxins are
used pharmacologically by the snail to incapacitate prey, it is reasonable to expect that
almost every conotoxin will show activity if presented with the correct receptor. While a
typical conotoxin only has one active disulfide isomer, a peptide that has no biologically
active isomers would consume energy without conferring any benefit to the snail, and so
would be an evolutionary disadvantage to the snail, and selective pressures would drive its
removal from the genome.
1.4 Conus as a Rich Source of
Pharmaceutical Leads
As I have alluded to previously, conotoxins have broad therapeutic potential. Prialt
was FDA approved in 2004 for the treatment of chronic pain [33], and remains the only
conotoxin to have gained FDA approval to date. Nonetheless, several other conotoxins have
entered clinical trials, including CVID, MrIA, Conantokin-G, Contulakin-G, and Vc1.1 [34].
While the majority have undergone clinical trials to treat intractable or neuropathic pain,
Conantokin-G was being developed to treat epilepsy. Of these, only Prialt and CVID have
three disulfide bridges, whereas MrIA and Vc1.1 have two disulfides and Conantokin-G and
Contulakin-G have no disulfides. The bias towards peptides with fewer disulfides emphasizes
the challenge that is presented by oxidative folding, and the relevance of that challenge to
pharmaceutical development.
Peptide-based therapeutics have classically been less prevalent in the clinic than tra-
ditional small-molecule therapeutics because of their zwitterionic character (making them
less likely to diffuse through a membrane to intracellular targets), as well as their high
production cost. Conotoxins largely target extracellular receptors, whereby overcoming
many of the traditional concerns about peptide-based therapeutics; however, effective
delivery to the site of action remains a challenge–which was addressed by the use of
10
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Figure 1.4. Disulfide Scaffolds in Conus. Only known disulfide scaffolds with three or fewer
disulfide bridges are shown. Since there is only one possible scaffold for a peptide containing
one disulfide bridge, only one is shown. There are several disulfide scaffolds in Conus which
bear two disulfide bridges. The focus of my work has been conotoxins bearing three disulfide
scaffolds, which are much more numerous. Only those with published examples are shown,
although other connectivities and cysteine placements are possible. Intercysteine loops are
shown as being of variable, nonzero length. There are also many known cysteine patterns
with more than three disulfide bridges; however, in many cases the connectivity of the
disulfide bonds remains unknown, and those peptides are beyond the scope of this work.
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an intrathecal pump in the case of Prialt. The high production cost of peptide-based
therapeutics derives partly from the cost of materials, which will be driven down as these
become more prevalent; a large portion of the high production cost also comes from oxidative
folding, which introduces additional steps with varying yields, further compounding the high
cost of the base materials.
Despite the inherent challenges, disulfide-rich peptides are very promising drug leads;
cross-linking has shown efficacy in increasing the metabolic half-life of peptides [35, 36],
which likely functions by tightly packing the peptide structure, as well as ‘locking-in’
specific, active conformations, effectively making the backbone peptide bonds less accessible
to proteases. When disulfide-rich peptides are eventually degraded, their component amino
acids can simply be recycled by the patient’s body, alleviating many concerns with undesired
effects of drug metabolites. Additionally, the increased surface area of interaction with the
target that accompanies a peptide’s larger size (relative to a small-molecule therapeutic)
often provides greater specificity, thereby reducing off-target effects. This last aspect has
also been critical to the development of conotoxins as research tools [37, 38], largely due to
their extraordinary subtype selectivity.
Oral bioavailability is one of the key challenges facing the development of peptide
based drugs, although this can reportedly be overcome by backbone cyclization [39]. The
advantages and disadvantages of peptide based therapeutics have been extensively reviewed,
both generally [40, 41] and specific to conotoxins [33, 34].
1.5 Scope of the Thesis
While oxidative folding is often challenging, many of the inherent challenges can be
overcome, as I show in the following chapters. Working with conotoxins allows the
development of novel techniques to improve oxidative folding efficiency in vitro, as well
as enhancing our understanding of the biological mechanisms involved in directing folding
to the desired conformation. Furthermore, as several conotoxins are undergoing preclinical
and clinical development [33, 34, 42], the tools discussed herein are directly relevant to the
improvement of human health.
As much of the work with oxidative folding has been done in vitro, I begin with the
improvements to in vitro oxidative folding. Chapter 2 presents a generalized oxidative
folding protocol, which was a critical step in being able to assay the multitudinous sequences
of unknown activity because the same methods could be used to fold multiple peptides in
parallel, with reasonable yields. Chapter 3 outlines the discovery of diselenide catalysis of
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oxidative folding, which allows further improvements to the throughput of in vitro folding,
as well as allowing future work to bypass a purification step in initial screens for activity.
The discussion of evolutionary pressures involved in folding (Chapters 4 & 5) is presented
in a fairly narrow scope; however, the work discussed therein has implications that reach to
virtually every biological system. While it has been known for some time that the amino
acid sequence of a protein encodes the necessary information to form its three-dimensional
structure [43], it is all too often underappreciated that this information must also drive
the evolution of the gene that encodes the protein because the correct formation of its
three-dimensional structure is as indispensable as the protein itself.
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CHAPTER 2
TOWARDS AN OPTIMIZED AND
GENERALIZED METHOD FOR
OXIDATIVE FOLDING
The majority of this chapter is a paper that was published in 2010;1 I will provide a
brief background for this work, as well as some additional concluding remarks, in light of
discoveries that have happened since this paper was published.
2.1 Introduction
When I started working with conotoxins, there was no generalized protocol that could
be used to efficiently fold a broad array of disulfide-rich peptides containing three or more
disulfides. Rather, the oxidative folding had to be optimized for each peptide, from an
original set of starting parameters. Occasionally, those starting parameters were sufficient
to generate testable quantities of peptide, and this effect was only moderately predictable.
The starting parameters for oxidative folding of cysteine-rich peptides included (final
concentrations) 0.1 M Tris, pH 7.5 with 1 mM EDTA, 1 mM oxidized glutathione and 1
mM reduced glutathione. The reduced, or “linear,” peptide is added to this mixture such
that the final peptide concentration is 20 µM. As discussed in Chapter 1, as well as in the
Scope and Comments section of the following paper, the peptide concentration had to be
kept dilute in order to promote intramolecularity of disulfide bond formation (effectively
avoiding disulfide-linked aggregates).
The usual course of the optimization is to first do a folding timecourse using the
starting parameters. These parameters can then be altered in response to the effects seen
in the timecourse. For example, to promote disulfide isomerization, additional reduced
glutathione can be added. If aggregation proves to be a significant issue (usually a
1Steiner, A., Bulaj, G. Optimization of Oxidative Folding Methods for Cysteine-rich Peptides: A Study
of Conotoxins Containing Three Disulfide Bridges. J. Pep. Sci. 2010; 17(1): 1-7. doi: 10.1002/psc.1283.
Reproduction is licensed from John Wiley and Sons under license number 3038911040462.
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result of hydrophobicity of the peptide or appended groups, like a palmitoyl group on
the -amine of lysine), then varying amounts of detergents or cosolvents can be added.
The optimization continues until an acceptable oxidative folding yield is achieved (what
constitutes “acceptable” can vary dramatically, from enough to generate testable material
to fully-optimized for large-scale production). Other tangential directions can also be tested,
for instance using dimethyl sulfoxide as the oxidant (in lieu of glutathione); these are also
discussed in Section 2.2.
In the following paper, I created an oxidative folding method that was fairly general-
izable, as well as being amenable to high-throughput oxidative folding in ways that were
beyond the grasp of peptide-specific optimizations. This was accomplished by employing
ClearOx, a reagent that was developed by George Barany’s group [1, 2], and had been
tested with conotoxins [3], but had never undergone extensive optimization or generaliza-
tion. This was combined with diselenide-bridges within the peptide substrate, which were
believed at the time to function by conformationally restricting the peptide, as well as
reducing the number of possible outcomes (due to the favoring of the diselenide over mixed
sulfur-selenium bonds, as demonstrated in [4]).
Additionally, one of the critical aspects of this paper was the introduction of “Apparent
Folding Yield,” as a term to describe the total amount of correctly folded peptide that
results from a folding reaction, relative to the amount of peptide that was added to the
reaction (effectively a mass/mass yield measurement on a scale too small to accurately
measure mass). Because the high peptide concentrations used for ClearOx folding (3 mM)
risked aggregation, as well as covalent linkage to the immobilized oxidation medium, the
Apparent Folding Yield is distinct from the “Relative Folding Yield,” which is the fraction
of the recovered peptide that corresponds to the correctly folded form. Most work to date
had employed Relative Folding Yield, referring to this as the yield of the folding reaction.
The General Optimized Procedure, Section 2.2.1.1, presents an abbreviated form of
the full protocol outlined in this paper, which is detailed in Section 2.2.3.2. To expand
on this abbreviation slightly, only linear peptide was used in the folding reactions. The
acidification with formic acid resulted in a final pH of approximately 1.74. The number
of molar equivalents of ClearOx was determined based on [2], and the resin was prepared
by swelling in dichloromethane, followed by serial washes in dimethylformamide, methanol,
50% acetonitrile in water and finally 50% acetonitrile in 0.1 M MOPS, pH 7. The method
of preparing the resin and subsequently dividing it into the reaction vessels likely does not
merit the number of significant figures that is presented in the text, which was maintained
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from [2].
The dimethyl sulfoxide concentrations used ranged from 0.7-1.4 M (approximately a
11,700 - 23,400-fold excess over the disulfides in the peptide); this overwhelming excess may
be the cause of the slightly more random distribution of folding isomers that is seen with
dimethyl sulfoxide-mediated folding. Despite the overwhelming excess, folding by dimethyl
sulfoxide is very slow compared to folding with glutathione or ClearOx.
Additionally, some care should be taken with the terminology used in this paper. While
glutathione is discussed as an oxidant, this is not entirely true; glutathione disulfide (or
oxidized glutathione) is a disulfide transfer reagent, whereas reduced glutathione drives
disulfide isomerization, but is not an oxidant in any capacity. Also, while Prialt is the only
FDA-approved conotoxin, five other venom-derived peptides have also been approved by
the FDA: Capoten, Integrilin, Aggrastat, Angiomax and Byetta [5].
For each of the folding reactions, as well as the yield determinations, the absorbance
was monitored at 220 nm. This wavelength was chosen because it maintains a consistent
baseline (allowing more meaningful integration of peaks), as well as detecting the peptide
bonds with reasonable efficiency. This is also why the same peptide is used to determine the
’Apparent Folding Yield’–the number of peptide bonds must be the same, and preferably
in a similar overall conformation.
The observed differences between the ‘Apparent Folding Yield’ (AFY) and the ‘Relative
Folding Yield’ (RFY) could result from a number of factors. For the glutathione-containing
reactions with SIIIA, the AFY is systematically higher than the RFY, suggesting that the
total integral (in absorbance·minutes) of the folding chromatogram may be artificially high
due to folding intermediates with glutathione-peptide disulfides, effectively increasing the
number of peptide bonds detected. For the diselenide-containing peptides, the AFY is
systematically lower than the RFY, suggesting that the diselenide may absorb 220 nm light
differently than a disulfide in a comparable chemical environment (since the disulfide-only
form was used as the reference to determine the AFY). Conformation-based effects on the
absorbance were assumed to be negligible, although this may not be entirely true; any
conformation-based deviations in absorbance would only affect the RFY. However, it is
evident from the values of the AFY and RFY for ClearOx that the AFY does correct
for disulfide adducts to the resin, as well as potential aggregation. Thus, provided that
the correct peptide is used as the reference material, the AFY is likely to be the superior
measure.
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2.2 Optimization of Oxidative Folding Methods for
Cysteine-rich Peptides: A Study of Conotoxins
Containing Three Disulfide Bridges
Steiner, A., Bulaj, G. Optimization of oxidative folding methods for cysteine-rich
peptides: A Study of conotoxins containing three disulfide bridges. J. Pep. Sci. 2010;
17(1): 1-7. doi:10.1002/psc.1283.
2.2.1 Abstract
The oxidative folding of small, cysteine-rich peptides to selectively achieve the native
disulfide bond connectivities is critical for discovery and structure-function studies of many
bioactive peptides. Because the propensity to acquire the native conformation greatly
depends on the peptide sequence, numerous empirical oxidation methods are employed.
The context-dependent optimization of these methods has thus far precluded a generalized
oxidative folding protocol, in particular for peptides containing more than two disulfides.
Herein we compare the efficacy of optimized solution-phase and polymer-supported ox-
idation methods using three-disulfide bridged conotoxins, namely µ-SIIIA, µ-KIIIA and
ω-GVIA. The use of diselenide bridges as proxies for disulfide bridges is also evaluated. We
propose the ClearOx-assisted oxidation of selenopeptides as a fairly generalized oxidative
folding protocol. The generalized reaction scheme for µ-SIIIA is shown in Figure 2.1
2.2.1.1 General Optimized Procedure(s)
2.2.1.1.1 Glutathione: Ten-fold concentrated solutions were used to prepare a folding
reaction with 1 mM oxidized glutathione, 1 mM reduced glutathione, 0.1 M Tris, pH 7.5, 0.1
mM EDTA, 20 µM µ-Conotoxin SIIIA. The reaction was allowed to proceed for 16 hours,
















Figure 2.1. Generalized reaction scheme, shown with µ-SIIIA. Z denotes pyroglutamate,
and # denotes amidation at the C-terminus.
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2.2.1.1.2 Dimethyl Sulfoxide: To a dilute solution of dimethyl sulfoxide (11.63%)
were added 10-fold concentrated solutions to a final concentration of 0.1 M Tris, pH 7.5,
0.1 mM EDTA and 20 µM µ-Conotoxin SIIIA, making the final DMSO concentration 10%.
The reaction proceeded for 16 hours, and was quenched by acidification with formic acid to
a final concentration of 8%.
2.2.1.1.3 ClearOx: To 12 molar equivalents of swelled and washed resin was added a
solution of 3 mM µ-Conotoxin SIIIA in 50% acetonitrile, 50% 0.1 M MOPS, pH 7. The
reaction proceeded for 1 hour, and was quenched by 100-fold dilution with 0.1% TFA in
water.
2.2.2 Scope and Comments
Disulfide bonds conformationally restrict a peptide, which is crucial to their biological
activity. However, achieving specificity in the topology of disulfide formation during
chemical synthesis is difficult, in particular for peptides containing more than two disulfide
bridges (for two disulfide bridged peptides, the orthogonal side chain protection of pairs of
cysteines and regioselective folding is the method of choice [6]). The challenge in chemical
synthesis of disulfide-rich peptides is reflected in their oxidative folding yields, ranging from
prohibitively low to quantitative [7]. Coincidently, a majority of cysteine-rich bioactive
peptides contain three or more disulfide bridges, including plant-derived protease inhibitors,
defensins from both vertebrates and invertebrates, and neurotoxins from spiders, scorpions
and mollusks. Despite the fact that these peptides comprise a pool of millions of bioactive
compounds, many of which have already become research tools and even therapeutics, their
discovery and structure-function studies have progressed at a relatively slow pace. Due
to their small size, chemical synthesis has been the method of choice over recombinant
expression, but efficient oxidative folding methods remain the bottleneck in exploring the
full potential of cysteine-rich peptides [8, 9, 10].
Herein we compare oxidation methodologies in the context of conotoxins, a large class
of cysteine-rich peptides that includes one of the only venom-derived, FDA-approved
biopharmaceuticals to date [11, 12, 13, 14]. These peptides are very short (10-40 residues),
usually with 2-4 disulfide bonds, and exhibit a wide range of folding yields (see Table 2.1).
Conus peptides are an excellent model system for the study of disulfide bond formation
because they are natural product peptides that are sufficiently complex and diverse to
address the myriad variables of oxidative folding.
There are several methods used to oxidize cysteine-rich peptides to their folded products;
these methods fall into three broad categories: solution phase, polymer-bound oxidants
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Table 2.1. * indicates that these values are approximated from the graph provided in the
publication. † indicates that this is thermally optimized, but without folding additives, and
folding additives improve folding yield. ‡ indicates that Tween-40 was used as a folding
additive. ♣ indicates that Methanol was used as a folding additive. ♠ indicates that a
special preparation of a ternary matrix (miniGroEL/DsbA/PPI/Agarose) was used to fold
the peptide. ♦ indicates that the peptide is present in humans, but was originally discovered
in teleost fish.
Comparing Oxidative Folding Yield for Various Cysteine-Rich Peptides
Peptide Origin Folding Method Yield Ref.
µ-SIIIA C. striatus Solution 18%* ± 5%* [15]
µ-GIIIA C. geographus Solution 49.3% ± 3%* [16]
ω-MVIIC C. magus Solution† 8%* ± 1%* [16]
ω-MVIIC C. magus ClearOx† 13%* ± 2%* [16]
δ-PVIA C. purpurascens Solution† 2.1% ± 0.5%* [17]
δ-PVIA C. purpurascens Solution‡ 6.4% ± 0.8%* [17]
α-ImI C. imperialis Solution♣ 73% ± 4% [18]
α-GI C. geographus Solution 68% [3]
α-GI C. geographus Hydrocarbon resin 34% [3]
α-GI C. geographus ClearOx 80%-88% [3]
µ-PIIIA C. purpurascens Solution 20% ± 1%* [3]
µ-PIIIA C. purpurascens Hydrocarbon resin 15% ± 1%* [3]
µ-PIIIA C. purpurascens ClearOx 32.5% ± 2.5%* [3]
Cn5 Scorpion Resin-bound Media♠ 87% [19]
α-AahI Scorpion Solution 0.3%-2% [20]
β-CssII Scorpion Solution 34.1% [21]
AAI A. hypocondriacus Solution > 95% [22]
Urotensin II Human♦ ClearOx 54% [2]
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and on-resin oxidation. To form the disulfide, deprotonation of the thiol is required to
make the reactive nucleophilic thiolate [23, 24]; consequently, the pH must be buffered
(near neutral) to control the thiol/thiolate equilibrium (see Table 2.S1 for pH dependence).
The protonation/deprotonation of cysteine residues is sequence dependent [25], and this
property could be used to modulate reactivity of individual cysteines. The other variables
in the folding reaction, such as peptide concentration, temperature, and folding time should
be optimized. Further optimization of peptide folding can be accomplished using folding
additives. These factors can often be predicted based on the sequence of the peptide. Salt
can suppress electrostatic interactions [26], and organic solvents that are miscible with
water, detergents, or 1-ethyl-3-methylimidazolium acetate can significantly increase the
relative folding yield of hydrophobic peptides [18, 27, 28].
Solution phase oxidation is the most commonly employed method to form intramolecular
disulfide bonds in peptides [18, 26, 27, 29, 30]. Solution-phase oxidation requires very dilute
peptide (20-50 µM), in order to ensure that the disulfide bonds form intramolecularly. At
higher peptide concentrations, the effective concentration of the intramolecular thiols is
surpassed by the concentration of intermolecular thiols, leading to oligomers and resulting
in lower folding yields [6]. Because solution-phase oxidation has been thoroughly explored,
there are numerous possible oxidants (glutathione, selenoglutathione, cysteine, cystamine,
DMSO, (+/-)-trans-1,2-bis(2-mercaptoacetamido)cyclohexane (BMC) [31], and molecular
oxygen are common examples), with context-dependent variations in the folding efficiency.
While selenoglutathione can oxidize peptides at mildly acidic pH (∼ 5), to our knowledge,
it has not been used to fold peptides with three or more disulfides [32]. Glutathione-based
redox buffers are common, as they are believed to better reflect oxidation pathways in
vivo [33, 34]. The folding efficiency and extent of oxidation are also influenced by the
ratio of oxidized to reduced glutathione (see Figure 2.2). Dilute dimethyl sulfoxide (final
concentration 5-10%) is another common oxidant. The product ratios from glutathione and
DMSO methods are often very similar, although dimethyl sulfoxide oxidation can give a
slightly more random distribution of folding isomers (see Figure 2.3), and often requires
longer folding times (see Table 2.S4). Molecular oxygen is also used to oxidize thiols to
disulfides. Drawing oxygen from either air or oxygen atmosphere, this method relies on
low-levels of oxygen dissolved in solution; consequently, these methods are relatively slow
(usually requiring several days) [6].
Folding at high dilution presents problems with both scaled-up and higher throughput

















































































































































































































Figure 2.2. Apparent folding yield of SIIIA oxidation under various oxidation conditions.
Error bars show standard deviation from 3 analytical HPLC separations. Unless otherwise
stated, “Glutathione” indicates 1 mM oxidized (GSSG) and 1 mM reduced (GSH) glu-
tathione. All reactions with glutathione or DMSO proceeded for 16 hours. ClearOx folding
reactions were carried out with 12 equivalents of ClearOx resin, and proceeded for 1 hour.
HPLC separations were monitored by measuring UV absorbance at 220 nm.
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Figure 2.3. Representative HPLC traces of glutathione- and DMSO-assisted folding of
SIIIA. Both folding reactions were carried out at pH 7.5 for 16 hours at room temperature.
Also, both HPLC separations were done with the same gradient, from 4.5% to 31.5%
acetonitrile, with 0.9% change per minute, and maintaining 0.1% TFA throughout.
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type of oxidation, the oxidant is bound to a solid support at low loading levels, exploiting
the pseudodilution effect to fold peptides at significantly higher concentrations; nonetheless,
intramolecular disulfide bonding remains preferred. The low loading levels ensure that each
molecule of the peptide is isolated, and intramolecular disulfide bonds are favored. With
respect to polymer-bound folding methods, we evaluated the use of ClearOx resin. Solution-
phase oxidants to fold peptides isolated on a hydrocarbon-based resin has been previously
explored [3]; however, the (relative) folding yields did not justify further consideration
of these methods (see Table 2.1). On more complicated or difficult folding substrates,
agarose-bound folding media that includes folding chaperones and oxidant has also been
employed [19].
With peptides containing one or two disulfides, oxidative folding before cleavage from
the resin has been reported [10, 35, 36]. While on-resin folding methods are quite effective
for folding one or two disulfide bonds, successful folding of three or more disulfide bonds
with resin-bound peptide has not been reported to our knowledge.
µ-Conotoxin SIIIA (shown in Figure 2.1) has three disulfide bridges and has been the
subject of several folding studies [15, 29, 30]. Noteworthy, µ-SIIIA is a potent blocker of
neuronal subtypes of sodium channels, and exhibits analgesic activity in animal models
of pain [37]. Also, SIIIA has a known three-dimensional structure [38]; it is used here as
the model peptide to compare various oxidation methods. The wider applicability of these
folding methods is demonstrated with additional Conus peptides, µ-KIIIA and ω-GVIA,
and these results are presented in the Supplemental Information.
To describe efficiency of the folding methods, we employed two terms: ‘relative folding
yield’ (accumulation of the native species, relative to all folding species, determined from
HPLC separations of the quenched folding mixtures) and ‘apparent folding yield’ (recovery
of the native species, relative to the amount of linear form used in the folding reaction). As
illustrated in Figure 2.4, relative folding yield is taken to mean the fraction of the integrated
HPLC peak corresponding to the natively folded species, relative to the total integrated
HPLC area corresponding to all folding species in a given HPLC chromatogram. This is
the canonical measurement of refolding efficiency on the analytical scale. Apparent folding
yield is the fraction of correctly folded peptide to peptide in the reaction, accomplished
by comparison of the HPLC peak corresponding to the natively folded species in the
reaction with the integral of the same peak of a known quantity of very pure (≥95%
by analytical HPLC) reference folded peptide. In selenocysteine-containing peptides, the

















































Figure 2.4. Methods for determining folding yields used in this study. A) Sample
analytical HPLC separation of a quenched SIIIA folding reaction. Relative folding yield
is calculated by taking the peak area of the natively folded peak (blue), and dividing by the
total area (sum of blue and purple). To calculate apparent folding yield, the peak area of a
folded and purified sample (with the same total amount of peptide as the folding reaction)
is used as a reference, representing 100% yield. The apparent folding yield is then the area
of the peak in the folding reaction (blue) divided by the average area of reference peaks
(mean of 3 runs). B) A comparison between relative folding yield and apparent folding
yield of selected conditions for oxidation of SIIIA.
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these are quite distinct measurements of folding efficiency (Figure 2.4).
Both relative folding yield and apparent folding yield are useful measurements of folding
efficiency; their difference lies in what is used as the theoretical value for 100% conversion.
The canonical measurement (relative folding yield) takes this value as the integral of the
entire folding area, hence assuming that all oxidation products are represented in the HPLC
chromatogram (e.g., there is no aggregation). Conversely, apparent folding yield uses
a separate HPLC chromatogram of the same peptide that has been folded, purified and
quantified (for example, by spectrophotometry), hence comparing with an amount of the
folded species that would represent 100% conversion. While neither is equivalent to the gold
standard of a mass-to-mass calculation of yield, we use apparent folding yield throughout
in order to meaningfully compare between oxidation methods with different propensities for
aggregation. Also of note, the proposed intermediate for the polymer-supported oxidation
method that we employ is resin-bound, and hence is not present in the HPLC separation.
Canonical folding yield data is available in the Supplemental Information.
2.2.3 Experimental Procedures
2.2.3.1 Reduced Peptides
Peptides were synthesized on a single-channel automated peptide synthesizer using Rink
Amide resin and standard Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry. All cysteine
residues were trityl protected. Selenocysteine residues were 4-methoxybenzyl protected.
Peptides without selenocysteine residues were cleaved from resin with Reagent K (trifluo-
roacetic acid (TFA) : phenol : water : thioanisole : 1,2-ethanedithiol; 33 : 2 : 2 : 2 : 1 by
volume). Selenocysteine-containing peptides were cleaved from resin with enriched Reagent
K† (TFA : phenol : water : thioanisole : 2,2’-dithiobis(5-nitropyridine); 178 : 14 : 5 : 1.6 :
1 by volume). DTNP is included in order to remove the p-methoxybenzyl protecting group
from selenocysteine, which produces an adduct of selenocysteine with 2-thio-5-nitro-pyridine
[39, 40]. Cleaved peptides were filtered and precipitated with methyl tert-butyl ether.
Selenocysteine-containing peptides were then treated with 50 mM DTT (in 0.1 M Tris, pH
7.5 with 0.1 mM EDTA) for 2 hours, in order to remove the 2-thio-5-nitro-pyridine adduct.
The diselenide-containing peptide is recovered following HPLC purification [41]. Peptides
without selenocysteine were also purified by HPLC on a Waters 600 chromatograph with
a dual-wavelength absorbance detector using Vydac C18 semipreparative and preparative
columns. All SIIIA HPLCs (linear and folded) were run with a linear gradient from 4.5%
to 31.5% acetonitrile, with 0.9% change per minute, maintaining 0.1% TFA throughout.




2.2.3.2.1 Glutathione based oxidation. Oxidative folding with glutathione-
based redox buffers was accomplished with varying ratios of oxidized and reduced glu-
tathione. Typical reaction conditions were 0.1 M Tris, 0.1 mM EDTA, 0.5-2 mM oxidized
glutathione (GSSG), 0-2 mM reduced glutathione (GSH) and 20 µM µ-SIIIA (final concen-
tration), pH 7.5. The pH dependence was investigated using MOPS in lieu of Tris/EDTA
as the buffer (see Supplemental Information). The buffered glutathione redox system was
first established, and the peptide was added as the final component. Reactions were set up
in triplicate on an analytical scale (14 nmol of peptide), and were allowed to proceed for 16
hours. The temperature dependence of solution-phase folding was evaluated at 4◦ C, 22◦
C and 37◦ C using a mixture of 1 mM GSSG, 1 mM GSH. In order to manipulate product
ratios in a solution-phase oxidation reaction, folding temperature and time are commonly
optimized in parallel. The effect of pH was tested using three buffer systems. Folding at
acidic pH was assayed with 0.1 M sodium acetate/acetic acid buffer (pH 4); mid-range pH’s
were considered with 0.1 M MOPS (pH 6-8); 0.1 M sodium carbonate/bicarbonate buffer
(pH 10) was used to assess folding under basic conditions. Quenching by acidification was
accomplished by addition of formic acid to a final concentration of 8% (final pH ≈ 1.78).
2.2.3.2.2 Dimethyl sulfoxide mediated oxidation. Folding reactions contained
0.1 M Tris, pH 7.5, 0.1 mM EDTA, 5-10% dimethyl sulfoxide and 20 µM µ-SIIIA (final
concentrations). Because the reaction begins when the peptide contacts DMSO, the
buffered, dilute DMSO was prepared, and the peptide was added as the final component.
Reactions were set up in triplicate on an analytical scale (14 nmol of peptide). After 16
hours, formic acid was added to a final concentration of 8% to quench the folding reaction
(final pH ≈ 1.83). A final concentration of 10% dimethyl sulfoxide was found to be most
effective to fold µ-SIIIA.
A summary of various folding conditions investigated and the resulting apparent folding
yields is shown in Figure 2.2, with representative HPLC chromatograms of the folding
reactions are shown in Figure 2.3.
2.2.3.3 Polymer-Supported Oxidation
ClearOx is a commercially available resin that has been preloaded with Ellman’s reagent
(5,5’-dithiobis-(2-nitrobenzoic acid), DTNB), immobilizing the peptide by reaction of the
peptide thiolate with the on-resin disulfide, producing a peptide-resin disulfide intermediate
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[2]. Because ClearOx is preloaded, the low-loading conditions are preestablished to favor
intramolecular disulfide bonding at millimolar peptide concentrations (indicated by the
apparent folding yield, shown in Figure 2.2).
2.2.3.3.3 ClearOx based folding. Twelve molar-equivalents of resin per disulfide
(1 equivalent = 2.768 µg resin/nmol peptide/disulfide to be oxidized) were swelled in
dichloromethane for 30 minutes. For folding 30 nmoles of SIIIA, 2.93 mg of ClearOx
was employed. Twenty to thirty milligrams of ClearOx was prepared in a single vessel,
using 300-700 µl of each of the swelling and washing solvents. To begin washing, excess
dichloromethane was pipetted off, and replaced with dimethylformamide. The same process
was repeated with centrifugation to wash the resin with methanol, then 50% acetonitrile in
water and finally 50% acetonitrile, 0.05 M MOPS, pH 7. To ensure that the resin will remain
swelled, the solution is never entirely removed, enforcing the low-loading conditions that
allow efficient folding while the solution is changed from dichloromethane to one that is more
amenable to oxidative folding of peptides. The swelled and washed resin was then divided
into separate vessels for each folding reaction. Fifty percent acetonitrile, 0.05 M MOPS,
pH 7.0 was used to redissolve µ-SIIIA to 3 mM. To minimize folding and aggregation due
to air-mediated oxidation, the peptides were resuspended as shortly before use as possible.
Following resin preparation, all excess wash solution was pipetted off and replaced with
solution containing 3 mM µ-SIIIA. Reactions were done in triplicate on an analytical (30
nmol) scale. Folding reactions proceeded for 1 hour in 50% acetonitrile in 0.1 M MOPS, pH
7.0. Reactions were quenched by acidification, accomplished by 100-fold dilution with 0.1%
TFA in water (final pH ≈ 2.17). Air oxidation and disulfide shuﬄing are possible unless
the reaction is acidified; for preparative work, this can also be done by addition of formic
acid in order to maintain a small reaction volume. The peptide solution was then removed
from the polymer-bound oxidant following centrifugation.
The amount of cosolvent present during ClearOx-based oxidative folding may affect both
the relative folding yield and apparent folding yield; while this effect tends to vary based on
the oxidation substrate, 50% acetonitrile is sufficiently generalizable to be a starting point
for subsequent optimization. Optimization remains necessary, although the variables to be
optimized are rather limited to the amounts of cosolvent and ClearOx resin in the folding
reaction (see Supplemental Information on folding of ω-conotoxin GVIA). Noteworthy,
further optimization of ClearOx-assisted folding may involve changing to more acidic pH,
as described previously [2, 9].
Folding efficiency with ClearOx was found to be optimal at room temperature, although
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the folding time varies substantially among peptides (see Supplemental Information, Tables
2.S3, 2.S4, 2.S5). Due to generally shorter folding times and higher peptide concentrations
(which provides for preferable acidification conditions), ClearOx has significant potential
for higher throughput peptide folding.
2.2.3.4 Selenocysteine
Selenocysteine residues have recently been shown to simplify oxidative folding and
facilitate disulfide mapping in peptides [10, 15, 41, 42, 43, 44, 45]. The replacement of both
cysteines of a single disulfide bridge with selenocysteines allows one bridge to be formed
directly after deprotection and treatment with DTT [41]. The strong reduction potential of
selenium prevails over encoded sequence information [43], and consequently the preformed
bridge reduces the number of possible disulfide isomers. The preformed bridge serves as
both a combinatorial constraint with respect to the number of possible folding isomers as
well as an entropic constraint in the oxidative folding process, both of which benefit the
folding efficiency. The combinatorial effect remains constant; however, the entropic effect
depends on the location of the diselenide bridge [15, 41]. The use of diselenide bridges has
been shown to complement solution-phase oxidative folding [15, 41, 42]. Since replacement
of the first disulfide of µ-SIIIA with a diselenide gave the largest increase in relative folding
yield [15], this substrate, namely [C3U;C13U] SIIIA (Sec-SIIIA) was used in the folding
experiments.
2.2.3.4.4 Folding of selenocysteine-containing peptides. In solution, seleno-
cysteine-containing peptides were folded under the same conditions as the same peptide
without the diselenide. Briefly, folding reactions contained 0.1 M Tris, pH 7.5, 0.1 mM
EDTA, 20 µM peptide, and either 1 mM each of GSSG and GSH or 5-10% DMSO.
With ClearOx, the resin preparation was identical; however, the amount of resin used
was decreased in order to maintain 12 equivalents of resin per disulfide bond to be closed
in the folding reaction. Apparent folding yield calculations of selenocysteine-containing
peptides were accomplished by normalizing to a known quantity of the folded form of the
same peptide without the diselenide proxy. Figure 2.5 shows the effect of the diselenide,
with analytical HPLC traces of parallel-foldings of SIIIA with Sec-SIIIA, both at 3 mM
peptide concentration using ClearOx resin as the oxidant. The effect on folding efficiency
is summarized in Figures 2.2 and 2.S1. When combined with a similar observation that the
ClearOx-assisted oxidation of a selenopeptide analogue of GVIA (Table 2.S5 and Figure
2.S5) also produced relatively high folding yields, these results suggest that the above
strategy could be considered as a more generalized folding protocol.
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Figure 2.5. Analytical HPLC traces of SIIIA (top) and Sec-SIIIA (bottom) foldings with
ClearOx. Arrows indicate the native species. Both reactions were carried out at 3 mM
peptide using 12 eq. of ClearOx in 50% acetonitrile in 0.1 M MOPS, pH 7.0 for 1 hour, and
were quenched by 100-fold dilution with 0.1% TFA.
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2.2.4 Summary and Limitations
Optimized solution phase folding often produces the highest reaction yields; however,
there are intrinsic costs to oxidative folding in the solution phase. The requirement for
high dilution conditions presents problems for large-scale and high-throughput applications.
However, with relatively minor costs, these problems may largely be overcome using resin-
bound oxidants, such as ClearOx. For example, to oxidize 1 gram of µ-SIIIA using solution
phase methods would require a reaction volume of 22.7 liters. However, to oxidize 1 gram of
µ-SIIIA using ClearOx would require a reaction volume of only 151 ml. The optimization
of folding time with ClearOx is significantly more reliable when separate reactions for each
timepoint are carried out because swelled ClearOx resin is not readily pipetted.
Selenocysteine proxies for disulfides can significantly increase the relative folding yield,
and simplify the HPLC folding pattern, allowing for easier purification. While the apparent
folding yield for some peptides is not necessarily significantly increased with a diselenide
proxy (Figures 2.2 and 2.S1), the benefit to apparent folding yield for other selenopeptides
can be quite substantial (see Supplemental Information, Figure 2.S5, Table 2.S5). We
suggest that ClearOx-assisted oxidation of selenopeptides (Figure 2.2 and 2.S5) should be
considered for higher throughput folding of cysteine-rich peptides.
Given the unprecedented molecular diversity of cysteine-rich peptides with respect to
both disulfide scaffolds and primary amino acid sequences, a word of caution about the
generality of the recommended folding methods should be made. The selection of oxidation
method and extent of optimization of the reaction conditions will depend on the peptides’
structure, quantities required for subsequent studies, as well as on the purpose of studying
the peptides. When smaller quantities (less than 1-2 mg) of a peptide are needed, it
is recommended to start with optimization of the solution phase folding methods. For
folding larger quantities of a peptide, the resin-bound oxidants should be considered. For
folding difficult peptides, or for higher throughput oxidative folding of multiple peptides
or combinatorial libraries, the use of selenopeptide analogues and resin-bound oxidants is
suggested.
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2.3 Supplemental Information
2.3.1 Scope of Supplement
This supplemental information describes additional folding experiments, addressed only
tangentially in the body of the paper. To expand optimization of the folding methods for
µ-SIIIA, the effects of both temperature and pH in solution phase folding reactions were
evaluated. For the µ-SIIIA folding reactions with ClearOx, effects of temperature, cosolvent
and peptide concentrations were also studied.
To generalize the folding methods described here, we carried out comparable oxidation
experiments using two additional conotoxins containing three disulfide bridges, namely µ-
KIIIA and ω-GVIA. µ-Conotoxin KIIIA shares the same cysteine framework as SIIIA,
whereas GVIA is an ω-conotoxin from C. geographus that differs in the cysteine framework
from that of SIIIA and KIIIA. Lastly, we present results on ClearOx-assisted oxidation of
a selenopeptide analogue of GVIA, confirming the effectiveness of this strategy to produce
the folded species with relatively high efficiency.
2.3.2 SIIIA
Figure 2.S1 shows the relative (canonical) folding yields for SIIIA under identical
conditions to those shown in Figure 2.2 in the main paper. Although the values for
relative folding yields (Figure 2.S1) and apparent folding yields (Figure 2.2) differ from
each other, the trends within a single oxidation system (glutathione, DMSO, ClearOx) are
consistent enough to be used for optimization (of that oxidation system). Error bars show
standard deviation from 3 analytical HPLC runs, based on calculation of the integral of the
absorbance at 220 nm. Unless otherwise stated, “Glutathione” indicates 1 mM oxidized
(GSSG) and 1 mM reduced (GSH) glutathione. All reactions with glutathione or DMSO
proceeded for 16 hours. ClearOx folding reactions were done with 12 equivalents of ClearOx
resin, and proceeded for 1 hour.
The pH dependence of SIIIA folding using solution-phase methods is shown in Table
2.S1. All reactions in Table 2.S1 were carried out with 20 µM peptide concentration, in
the presence of 1 mM of each of oxidized and reduced glutathione, and were allowed to
fold for 16 hours before the oxidation was quenched by addition of formic acid. To sample
a sufficiently large range of pH’s, it was necessary to use more than one buffer system.
The reactions at pH 6-8 were buffered with 0.1 M MOPS. While the typical solution-phase
oxidation conditions buffer with 0.1 M Tris, pH 7.5, MOPS was selected instead because
MOPS buffers effectively in more acidic solution. A sodium acetate/acetic acid buffer system







































































































































































Figure 2.S1. Relative (canonical) folding yield (fraction of integral due to natively folded
species)
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Table 2.S1.  The “relative folding yield” is expressed as the mean value of 3 experiments,
taking the fraction of the total integral that is attributable to the native foldamer. ℘ The
standard deviation of the relative folding yield, based on 3 experiments. ∇ The “apparent
folding yield” is expressed as the mean value of 3 experiments, taking the integral of the
region of the folding chromatogram attributable to the native foldamer, and normalizing
with a known quantity of very pure folded peptide (see Figure 2.4 in text). ~ The standard
deviation of the apparent folding yield, based on 3 experiments.
Table S1:
Role of Buffer pH in SIIIA Folding Yield
pH Rel. Yield σY ℘ App. Yield∇ σA~
4.0 0.78% 0.01% 0.94% 0.02%
6.0 52.34% 0.28% 67.59% 0.89%
7.0 58.52% 4.50% 66.27% 2.41%
8.0 52.25% 0.31% 65.43% 2.08%
10.0 19.34% 1.70% 25.11% 0.19%
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employed for folding at pH 10. It is apparent that the folding efficiency is highest when the
peptide is folded in the pH range 6-8.
Temperature dependence of folding in solution phase oxidation is shown in Table 2.S2.
All reactions in Table 2.S2 were carried out at 20 µM peptide concentration. Reactions
were buffered with 0.1 M Tris, 0.1 mM EDTA, pH 7.5, using 1 mM GSSG and 1 mM
GSH, and were quenched by addition of formic acid to a final concentration of 8%. No
major changes in the folding yields were observed when the reactions were carried out at
4◦ C and 22◦ C, whereas folding at higher temperature (37◦ C) produced less favorable
results. Noteworthy, oxidative folding at low temperatures (0-4◦ C) might be recommended
for peptides that exhibit hydrophobic character. For example, folding yields for very
hydrophobic δ-conotoxins were significantly improved when peptides were oxidized in an
ice bath [46].
The effect of temperature on the folding of SIIIA using ClearOx as the oxidant are shown
in Table 2.S3. All reactions in Table 2.S3 were carried out at 3 mM peptide concentration,
in triplicate. Mean and standard deviation are presented for both relative folding yield
and apparent folding yield. All reactions were run in 50% acetonitrile in 0.1 M MOPS,
pH 7.0. Only 1 timepoint (1 hour) was analyzed for ClearOx-based reactions. Reactions
were quenched by 100-fold dilution with 0.1% TFA in water. Interestingly, the temperature
dependence observed for ClearOx-based oxidation was much more significant than that of
solution phase oxidation.
The solvent and peptide concentrations were also found to be important for ClearOx-
assisted folding of SIIIA (Figure 2.S2). All reactions were buffered with 0.05 M MOPS, pH
7, were carried out with 12 eq. of ClearOx, and were allowed to proceed for 1 hour. The
peptide concentration and amount of acetonitrile were varied, and are shown next to the
corresponding HPLC trace. The possibility of air oxidation precluded analysis of longer
timepoints with the aqueous and dilute conditions, and a single folding time was selected
for comparison across all conditions. For dilute reactions (20 µM SIIIA), quenching was
accomplished by addition of formic acid to a final concentration of 8%. For concentrated
folding reactions, 100-fold dilution with 0.1% TFA was used to quench the folding reactions.
At high peptide concentrations (3 mM) and 50% acetonitrile, SIIIA folds quite effectively
(top trace in Figure 2.S2). However, when the folding solution was made to parallel those
used to fold with glutathione or DMSO, using dilute peptide (20 µM) in aqueous solution,
ClearOx failed to fold SIIIA (bottom trace in Figure 2.S2). Based on this finding, we suggest
that these two factors (cosolvent and peptide concentration) are very important factors to
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Table 2.S2. Temperature dependence of SIIIA folding in solution
Table S2:
Temperature Dependence of Folding of SIIIA in Solution
Temp. Time Rel. Yield σY App. Yield σA
4 ℃
30 min 58.23% 0.76% 66.63% 2.65%
60 min 56.18% 2.48% 68.98% 0.65%
180 min 54.49% 0.40% 69.89% 1.57%
16 hrs. 51.94% 0.81% 68.65% 1.29%
22 ℃
30 min 53.89% 3.43% 64.99% 0.82%
60 min 52.14% 1.56% 65.62% 0.31%
180 min 51.86% 4.27% 58.76% 0.35%
16 hrs. 48.25% 2.56% 58.26% 1.33%
37 ℃
30 min 41.43% 0.23% 51.70% 1.04%
60 min 40.97% 0.08% 50.17% 0.05%
180 min 41.24% 0.57% 48.59% 1.94%
16 hrs. 40.52% 0.42% 45.26% 0.77%
Table 2.S3. Temperature dependence of SIIIA folding with ClearOx
Table S3:
Temperature Dependence of Folding of SIIIA with ClearOx
Temp. Rel. Yield σY App. Yield σA
4 ℃ 19.67% 9.43% 6.22% 0.41%
22 ℃ 38.21% 3.29% 23.80% 1.59%
37 ℃ 26.89% 10.33% 22.20% 2.09%
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3 mM SIIIA; 50% Acetonitrile
20 µM SIIIA; 1% Acetonitrile
*
3 mM SIIIA; 1% Acetonitrile
20 µM SIIIA; 50% Acetonitrile











Figure 2.S2. Solvent System and Peptide Concentration in Folding SIIIA with ClearOx.
Arrows indicate the correctly folded species, and * indicates the linear form.
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consider for optimization of ClearOx-assisted folding.
2.3.3 KIIIA
µ-Conotoxin KIIIA has a similar structure to µ-SIIIA, and has been the subject of
several folding studies [47, 48, 49]. The reaction scheme for the folding is shown in
Figure 2.S3. Three folding conditions for KIIIA were examined: glutathione-, DMSO-
and ClearOx-assisted oxidation. Because the conditions for solution-phase folding of KIIIA
were established previously [48], these conditions were applied here for glutathione-mediated
oxidation. Table 2.S4 shows the folding yields of KIIIA folding conditions. All folding
reactions proceeded at room temperature. Mean and standard deviation are presented for
both relative folding yield and apparent folding yield (reactions were done in triplicate).
The glutathione folding reactions were done with 1 mM GSSG, 1 mM GSH. Glutathione-
and DMSO-mediated folding were performed at 20 µM µ-KIIIA, and were buffered with
0.1 M Tris, 0.1 mM EDTA, pH 7.5; solution-phase folding was quenched by addition of
formic acid to a final concentration of 8%. ClearOx folding reactions were done with 3
mM µ-KIIIA, 12 eq. ClearOx, and were buffered with 0.1 M MOPS, pH 7; quenching was
accomplished by 100-fold dilution in 0.1% TFA in water.
Folding results for KIIIA suggest that the ClearOx-based method was more effective than
the glutathione-assisted oxidation. Interestingly, this result is somewhat opposite for SIIIA,
emphasizing the importance of screening various strategies and conditions for optimization
of folding, even when working with related peptides.
2.3.4 GVIA
In order to compare solution-phase and polymer-supported folding methods using a
peptide that differs in its cysteine scaffold from SIIIA and KIIIA, we also studied the folding
of ω-conotoxin GVIA and its selenopeptide analogue (reaction scheme shown in Figure 2.S4).
Folding of GVIA has been investigated previously [41, 50, 51, 52]. The structure of GVIA
is shown in Figure 2.S4; this conotoxin is known to fold to an ICK (inhibitory-cystine-knot)
motif. Noteworthy, GVIA is a potent blocker of voltage-gated calcium channels.
The folding reactions shown in Table 2.S5 were done as follows. Glutathione and DMSO
mediated oxidation reactions were buffered with 0.1 M Tris, 0.1 mM EDTA, pH 7.5, and
contained 20 µM peptide. The oxidant was either 5% DMSO or a redox buffer of 1 mM
GSSG, 2 mM GSH, as previously established [50]. Solution phase reactions were quenched
by addition of formic acid to a final concentration of 8%. ClearOx reactions were run in















Figure 2.S3. Reaction scheme for KIIIA (# = amidated C-terminus)
Table 2.S4. Folding Yields of KIIIA; values shown are Mean ± Std. Dev.
Table S4:
Oxidative Folding of KIIIA in Various Conditions
Condition Time Rel. Yield σY App. Yield σA
Glutathione
30 min 42.04% 0.40% 36.19% 1.15%
60 min 42.22% 0.27% 35.50% 1.58%
5% DMSO
30 min 2.30% 0.14% 2.04% 0.17%
60 min 3.49% 0.16% 3.12% 0.19%
16 hrs. 44.64% 1.76% 30.84% 0.41%
12 eq. ClearOx
30 min 60.37% 8.93% 33.04% 3.06%
















Figure 2.S4. Reaction scheme for GVIA (# = amidated C-terminus, O = Hydroxyproline)
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Table 2.S5. Folding yields of GVIA; values shown are mean ± std. dev.
Table S5:
Oxidative Folding of GVIA in Various Conditions
Condition Time Rel. Yield σY App. Recov. Yield σA
Glutathione
60 min 38.88% 0.30% 40.02% 1.53%
90 min 43.92% 5.89% 40.76% 2.00%
5% DMSO
16 hrs. 25.97% 3.58% 25.48% 1.84%
24 hrs. 30.97% 3.53% 26.09% 5.24%
12 eq. ClearOx 180 min 28.24% 1.40% 21.25% 2.70%
24 eq. ClearOx 180 min 33.29% 0.89% 24.53% 0.98%
Effect of a Diselenide Proxy (Sec-GVIA)
Glutathione 90 min 68.87% 0.21% 82.40% 2.65%
24 eq. ClearOx 180 min 60.87% 2.41% 53.54% 2.44%
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of ClearOx, and were quenched by 100-fold dilution with 0.1% TFA in water. All folding
reactions proceeded at room temperature, in triplicate. Mean and standard deviation are
shown for both relative folding yield and apparent folding yield. The apparent folding yield
for both GVIA and Sec-GVIA was calculated based on the integral of the folded peak of a
known amount of very pure folded GVIA (≥95% by analytical HPLC).
Figure 2.S5 shows 3 analytical HPLC traces of GVIA folding. Arrows indicate the
correctly folded species, as determined previously [41]. The top trace shows the folding with
ClearOx, based on standard conditions with 12 eq. ClearOx per disulfide bond, folding at
3 mM GVIA in 50% acetonitrile, 0.05 M MOPS, pH 6 for 3 hours. The center trace shows
glutathione-folded GVIA, using the conditions that were established previously for folding
GVIA [50], with 1 mM oxidized glutathione, 2 mM reduced glutathione, 0.1 M Tris, pH 7.5
with 0.1 mM EDTA, 20 µM GVIA, and proceeded for 90 minutes at room temperature.
The bottom trace shows a selenocysteine-containing GVIA folding trace, where folding was
accomplished at 3 mM Sec-GVIA with 24 eq. ClearOx resin, folding in 50% acetonitrile, 0.05
M MOPS, pH 6 for 3 hours. ClearOx folding reactions were quenched by 100-fold dilution
with 0.1% TFA in water. The glutathione folding reaction was quenched by addition of
formic acid.
Consistent with the previously published results, GVIA folded with relatively high yields
using solution-phase oxidation (Table 2.S5 and Figure 2.S5). However, folding with ClearOx
proved to be ineffective, as indicated in Table 2.S5 and Figure 2.S5. Altered levels of
cosolvent did not ameliorate the folding efficiency. While increased levels of ClearOx do
not substantially benefit the folding efficiency of GVIA, it did increase the reproducability
of the folding reactions (see standard deviations, Table 2.S5). Lowering the pH of the
ClearOx-assisted folding reactions to 6 (rather than 7, as used for the other peptides) was
found to slightly improve the folding of GVIA.
To determine whether the simplification of the oxidative folding using a diselenide proxy
could ameliorate the folding efficiency, selenocysteine-containing GVIA was tested in a
folding reaction with ClearOx. All 3 selenopeptide analogues have been previously studied
with solution-phase folding [41], and [C8U;C19U] GVIA (Sec-GVIA) showed the largest
increase in relative folding yield. Therefore, [C8U;C19U] GVIA was selected for further
folding experiments. Figure 2.S5 shows an analytical HPLC trace of ClearOx-mediated
folding of Sec-GVIA, from which it is evident that the major product is the correctly folded
species. The apparent improvement of the folding yields of the selenopeptide analogue of
GVIA with ClearOx is similar to that observed for SIIIA (Figure 2.5), suggesting that this
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Figure 2.S5. Effect of a diselenide proxy on efficiency of ClearOx-mediated GVIA folding
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oxidation strategy may be of more general use for cysteine-rich peptides varying in their
disulfide scaffolds. However, more studies are needed to validate this generalized oxidative
folding method.
2.4 Conclusion
The use of the pseudodilution effect to increase the concentration of the folding reaction
dramatically aids high-throughput folding efforts, as the sheer fluid volume required to per-
form high-throughput oxidations at typical peptide concentrations (20 µM) is prohibitive.
Additionally, the use of 50% acetonitrile allows the use of a fairly high level of organic
solvent, which allows much better solvation of hydrophobic peptides, but remains miscible
with water. These serve to make the method presented much more generalizable than
anything presented previously; however, these methods should still be improved further
before being employed for high-throughput oxidation because efficient high-throughput
work requires sufficiently high Relative Folding Yields to also streamline chromatographic
purification, not merely the oxidation step.
One aspect of this work deserves further comment: the role that diselenide bridges were
playing in these reactions was likely underestimated. As detailed in the following chapter,
diselenide bridges are capable of functioning as both inter- and intramolecular catalysts for
the formation of disulfides, which was not known at the time of publication. Consequently,
the diselenide bridges likely altered the course of the oxidation, as well as allowing redox
chemistry to take place in the highly-concentrated solution phase. As a result, I cannot
necessarily ensure that all disulfide formation employed the pseudodilution effect, and this
may have led to aggregation, whereby modulating the Apparent Folding Yield. Conversely,
allowing some disulfide formation to occur in the solution phase may also have decreased
the extent of adduct formation with the immobilized Ellman’s Reagent. Nonetheless, the
method presented allows efficient formation of disulfide bridges using a generalized protocol
that is much more broadly applicable than anything employed at the time.
In order to consider the relative efficiency of each of the presented methods, Figure 2.S6
shows HPLC chromatograms of folding with glutathione, ClearOx and air-oxidation, as well
as folding of diselenide-containing SIIIA with ClearOx and air-oxidation. The absorbance
measurements were not scaled, indicating the relative efficacy of each oxidation method. It
is evident from Figure 2.S6 that the effect of incorporating a diselenide bridge provides a
universal benefit, regardless of which method is used to form the disulfide bridges.
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Figure 2.S6. HPLC Chromatograms of SIIIA folding conditions. Ready comparison can
be made between SIIIA folding with glutathione, ClearOx and air-oxidation; diselenide-con-
taining SIIIA ([C3U;C13U] SIIIA) is also shown for folding with ClearOx and air-oxidation.
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CHAPTER 3
AN UNEXPECTED FUNCTION FOR
DISELENIDE BRIDGES
The majority of this chapter is a paper that was published in Angewandte Chemie
International Edition in English in 2012.1 As with the preceding chapter, I will provide
a brief introduction and concluding remarks, with a particular emphasis on the aspects of
this work that are not discussed in the included paper.
3.1 Introduction
At its core, this work combines two bodies of literature that had been developed
independently of one another. The first body of literature used intramolecular diselenide
bonds as an alternative to a disulfide bond [1], which took advantage of the difference in
redox potentials between disulfide bonds, diselenide bonds and mixed sulfur-selenium bonds
[2]. Because the diselenide is so strongly favored over mixed sulfur-selenium bonds, it was
believed to be a static bridge that structurally constrained the peptide during the remainder
of the folding process.
The second body of literature used diselenide bridges as catalysts for the formation of
disulfides [3, 4, 5], and noted that the free selenol is never observed because the diselenide
is reformed very quickly by reacting with molecular oxygen in solution.
This work linked these two bodies of literature, and observed that intramolecular
diselenide bridges are actually potent intramolecular catalysts for the formation of the
remaining disulfide bridges in a peptide. We propose a mechanism, and present evidence
showing that diselenide bridges are thermodynamically quite stable, but are kinetically very
reactive.
1(a) A.M. Steiner, K.J. Woycechowsky, B.M. Olivera, G. Bulaj, Angew. Chem. Int. Ed. Engl. 2012, 51,
5580. doi: 10.1002/anie.201200062; (b) A.M. Steiner, K.J. Woycechowsky, B.M. Olivera, G. Bulaj, Angew.
Chem. 2012, 124, 5678-5682. doi: 10.1002/ange.201200062. Reproduction is licensed from John Wiley and
Sons under license number 3038910902595
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In doing this research, I had a few observations that were not included in the paper.
First, this reaction is quite temperature sensitive, and required extensive thermal control
to ensure reproducibility of rate constants. Second, the level of oxygen dissolved in solution
is a critical factor; while we were unable to remove enough oxygen to completely stop the
reaction, the dependence of the reaction rate on dissolved oxygen was readily visible as a
function of the amount of other solute. With more total solute (for instance, Urea or NaCl),
there is less oxygen dissolved in solution, which causes the reaction to slow. Conversely,
when the folding mixture is pipetted directly onto dried peptide, the reaction rate increases
dramatically.
Additionally, there is a short discussion regarding whether this is intramolecular or inter-
molecular catalysis. There are several lines of evidence suggesting that it is intramolecular
catalysis, but one intriguing result is that when a folding substrate with a diselenide is
combined with a folding substrate without a diselenide, the reaction rate appears to be
the average of the two, suggesting that there is crossover between the two substrates.
I believe that this occurs because the only oxidative catalyst present is the diselenide,
which can act both intramolecularly and intermolecularly; the intramolecular reaction
should predominate, but the intermolecular reaction occurs when peptide that lacks the
intramolecular catalyst is mixed with peptide bearing the intramolecular catalyst.
3.2 Reagentless Oxidative Folding of
Disulfide-Rich Peptides Catalyzed by
an Intramolecular Diselenide
(a) A.M. Steiner, K.J. Woycechowsky, B.M. Olivera, G. Bulaj, Angew. Chem. Int.
Ed. Engl. 2012, 51, 5580. doi: 10.1002/anie.201200062; (b) A.M. Steiner, K.J.
Woycechowsky, B.M. Olivera, G. Bulaj, Angew. Chem. 2012, 124, 5678-5682. doi:
10.1002/ange.201200062.
3.2.1 Abstract
In cysteine-rich peptides, diselenides can be used as a proxy for disulfide bridges as
the energetic preference for Se–Se bonds over mixed Se–S bonds simplifies folding (see
Figure 3.1). An intramolecular diselenide bond efficiently catalyzes the oxidative folding
of selenopeptide analogues of conotoxins, and serves as a reagentless method to accelerate
formation of various native disulfide bridging patterns.
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Figure 3.1. Graphical abstract
3.2.2 Main Text
Disulfide bonds are critical to stabilizing the native structure of many peptides and
proteins. These crosslinks are formed during oxidative folding, and machinery to assist
formation of the correct cysteine pairings is used by all walks of life, from prokaryotes
to humans [6, 7]. However, in the chemical synthesis of disulfide-containing biomolecules
alternative methods are employed to arrive at the native disulfide connectivity [8], and
usually involves redox buffers and requires peptide-specific optimization [9].
Selenocysteine is often referred to as nature’s 21st proteinogenic amino acid [10], and
it can be readily incorporated into chemically synthesized peptides. Since diselenide bonds
have greater thermodynamic stability than disulfide bonds, selenocysteine pairings can
prevail over sequence-encoded folding information in short, cysteine-rich peptides [11]. By
serving as a proxy for a disulfide bridge, selenocysteine incorporation into peptides may
reduce the complexity of oxidative folding [9, 11, 12, 13, 14]. Consequently, diselenide
bonds in peptides have been assumed to act as a fixed structural element during oxidative
folding as a result of their high stability.
Diselenide bridges were incorporated into only a handful of cysteine-rich peptides
including two-disulfide-containing apamin [11, 15] and α conotoxins [12, 16], as well as
three-disulfide-bridged conotoxins [1, 9, 13, 17]. Diselenides have also been useful to
facilitate disulfide mapping [1, 18]. While several groups have noted the enhanced kinetics
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of disulfide formation in selenopeptides [13, 16], to date, the rate enhancement has been
assumed to be due to conformational effects.
Diselenide additives have been found to catalyze oxidative protein folding for a wide
range of substrates [4, 5]. With these additives, catalysis stems from rapid regeneration of
the diselenide by reaction of the selenols formed in situ with atmospheric oxygen, even under
(mildly) reducing conditions [9, 13]. In contrast, thiols will not readily oxidize without a
catalyst, such as a metal ion. Here we tested a hypothesis that if a diselenide can act as an
intermolecular catalyst of cysteine oxidation, then disulfide-rich selenopeptides should be
able to catalyze their own aerobic oxidative folding.
Conotoxins, which are derived from the venom of marine gastropods, represent an
important target for improvements in oxidative folding efficiency. The venom of each species
of Conus has a large and distinct array of disulfide-rich peptides, many of which are used as
neuropharmacological tools [19]. While conotoxins have broad applicability, their oxidative
folding is often quite challenging [9, 13, 16, 20, 21], thus making conotoxins an attractive
system for studying the mechanisms of oxidative folding.
To examine whether diselenides enable the reagentless oxidative folding of cysteine-
rich peptides, we selected previously characterized selenocysteine-containing analogues of
ω-conotoxin GVIA and µ-conotoxin SIIIA (Figure 3.2) [9, 13].
Comparisons of the folding behavior for GVIA and [C8U;C19U] GVIA in Tris-buffered
water–without any oxidative reagents–are shown in Figures 3.3 a-c. Both kox (the rate of
formation of the first disulfide) and knative (the rate of appearance of the native connectivity)
show significant enhancement in the presence of a diselenide, thus indicating its role in
directing both oxidation and isomerization. To test the generality of this effect, similar
experiments were also carried out using µ-conotoxin SIIIA and [C4U;C19U] SIIIA (Figures
3.3 d-f). The significant increase in both kox (by approximately 12- to 20-fold) and knative
(by approximately 34- to 175-fold) indicated that diselenides are efficient oxidative catalysts
independent of the disulfide scaffold. Details of the kinetic analysis are presented in the
Supporting Information.
The reagent-free formation of a disulfide bond by an intramolecular diselenide likely
involves three chemical processes. First, the diselenide transfers an oxidizing equivalent to
a pair of thiols to form a disulfide. Second, the selenol(ate) acts as a nucleophile to promote
disulfide isomerization. Third, the selenol(ate)s are reoxidized by molecular oxygen in
solution.
Both copper(II) and selenocystine are known to catalyze the oxidation of thiols to






Figure 3.2. Folded products of peptides used in this study. a) Three-dimensional structure
of GVIA (PDBID: 2CCO). b) Schematic representation of GVIA, where the bridge indicated
in green was replaced with a diselenide in [C8U;C19U] GVIA. c) Three-dimensional structure
of SIIIA (BMRB #20023). d) Schematic representation of SIIIA; the bridge indicated in
green was replaced with selenocysteines in [C4U;C19U] SIIIA. Z = pyroglutamate, O =




























































































Figure 3.3. Folding kinetics of GVIA, SIIIA, and their diselenide-containing analogues.
HPLC chromatograms after 1 hour of folding for comparison of GVIA (a) and SIIIA (b)
to their respective diselenide-containing analogues. R = reduced form, F = natively folded
form. Full folding timecourses are available in Figure 3.S4 of the Supporting Information.
c,d) Kinetic traces of the disappearance of the starting material (bearing either six thiols
or four thiols and a diselenide), with insets showing the depletion of each reduced peptide
(maintaining colors) when the all-thiol and diselenide-containing peptides are folded in a
1:1 mixture. e,f) Kinetic traces of the formation of the natively bridged peptide. Equivalent
traces using a linear timescale are shown in Figures 3.S2 and 3.S3 of the Supporting
Information.
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catalysts afforded a substantial increase in the rate of oxidation (kox). Similarly, the
rate of native formation (knative) was also enhanced, albeit to a much lower extent. A
discussion of the error values for the rate of native formation (knative) is provided in the
Supporting Information. However, for diselenide-containing peptides, neither oxidative
catalyst provided a significant change in either the rate of oxidation or the rate of native
formation (Figure 3.4). Interestingly, the folding of wild-type GVIA in the presence of a
selenocystine additive remains less efficient than that of reagentless folding with [C8U;C19U]
GVIA.
The kinetic advantage of an intramolecular diselenide over added intermolecular dise-
lenide in GVIA suggests a unimolecular mechanism. However, further analysis suggests
that the reaction shows both inter- and intramolecular character. On one hand, the initial
oxidation of [C8U;C19U] GVIA appears concentration-independent across a 10-fold range
in concentrations (see the Supporting Information). However, a 1:1 mixture of diselenide-
containing peptide with its all-thiol counterpart suggests that intermolecular catalysis also
contributes (Figures 3.3 b and e, insets). This mixture of inter- and intramolecular catalysis
is particularly pronounced for SIIIA, where the initial oxidation step (kox) was slightly faster
with added selenocystine (intermolecular catalysis), but isomerizations and subsequent
oxidations leading to the native disulfide connectivity (knative) were slightly faster with an
intramolecular diselenide (see the Supporting Information). Further discussion is provided
in the Supporting Information.
To consider the role of diselenide placement within a peptide scaffold, we compared
[C4U;C19U] SIIIA with [C3U ;C13U] SIIIA and [C8U ;C20U] SIIIA, which were chosen for
this analysis because the reduced and folded forms are more readily separable by HPLC than
the comparable analogues of GVIA. This data is shown in Figure 3.4 and in the Supporting
Information, and demonstrates that the presence of a diselenide–regardless of its position
in the peptide–greatly accelerates folding. While always beneficial, the position of the dise-
lenide within the peptide does lead to some variation in the folding rate enhancement. This
variation could result from either conformation-induced orientation effects or differential
stability and activation energies conferred to intermediate conformations by the location of
the diselenide bridge.
Thus, in addition to directing oxidative folding towards the native disulfide connectivity,
intramolecular diselenide bridges also serve as catalysts for the formation of diuslfide bridges.
A diselenide bridge in a peptide is therefore able to catalyze disulfide formation using



















































































































































































Figure 3.4. Rate constant comparison. a) Rate constants for initial oxidation. b) Rate
constants for the formation of the native connectivity. On each graph are compared GVIA,
GVIA with 100 nM cupric chloride, [C8U;C19U] GVIA with 100 nM cupric chloride,
[C8U;C19U] GVIA, GVIA with equimolar selenocystine, [C8U;C19U] GVIA with equimolar
selenocystine, as well as variation resulting from the location of the diselenide within SIIIA.
GVIA and GVIA analogues (white bars) are graphed on the left axis; SIIIA and SIIIA
analogues (grey bars) are graphed on the right axis. In all cases, n = 3 and values shown
are mean ± SEM.
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tion. Using only molecular oxygen as the oxidant further simplifies the oxidative folding
of cysteine-rich peptides. We envision the use of reagentless oxidation of selenopeptides,
whether in solution or on-resin [9] will be effective, even for peptides that are difficult to
synthesize [21].
In the folding of selenopeptides, Se–S bonds are likely to be necessary intermediates for
catalysis of intramolecular electron-transfer reactions and isomerization steps. Examples
of stable Se–S bonds are rare [23]. Non-native Se–S bonds have also been shown to exist
in synthetic α-conotoxin and oxytocin analogues bearing a native pair of selenocysteines
[12, 16, 24]. The high reactivity of selenocysteine is likely the reason why nature has
selected disulfide bridges over diselenide bridges to form covalent crosslinks in polypeptides.
To this end, our findings warrant a cautious approach towards exploring selenopeptides
as drug leads. However, this does not preclude the added value of selenocysteine in the
chemical synthesis of cysteine-rich peptides, as well as in manipulating oxidative folding
pathways [25].
Our work shows that incorporation of diselenides into conotoxins may significantly
improve their folding rates because the oxidative folding of the peptide is catalyzed by
the peptide itself. In combination with previous reports, in which diselenides showed
superior effects on simplifying and improving folding yields and disulfide mapping, this
approach provides a significant advantage to chemical syntheses of cysteine-rich peptides.
Since molecular biology techniques have already revealed thousands of bioactive peptides
from plants, snails, spiders, scorpions, and vertebrate animals, selenopeptide technologies
will accelerate discoveries of novel research tools and biotherapeutics based on cysteine-rich
peptides.
3.2.3 Experimental Section
Detailed methods are provided in the Supporting Information. Briefly, peptides were
synthesized with standard Fmoc chemistry; all cysteine residues were trityl protected, and
all selenocysteine residues were 4-methoxybenzyl protected. After cleavage from the resin,
selenocysteine-containing peptides were treated with DTT. Peptides were then purified by
HPLC prior to oxidative folding.
Unless otherwise indicated, all oxidations were air-mediated, using molecular oxygen as
the only oxidant. Dried, reduced peptides were redissolved in 5% acetonitrile, 0.01% TFA.
The peptide solution was then added to the folding mixture, which contained (final) 0.1 M
Tris, pH 7.5, 0.1 mM EDTA, as well as any other folding additives for the specific condition.
Folding reactions proceeded at 20℃. Timepoints were analyzed by analytical HPLC.
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HPLC peak integration was used to quantify the extent of peptide folding for each
timepoint. DynaFit was used to derive kinetic parameters by fitting the data to a model of
consecutive irreversible first-order reactions [26]. Details of the kinetic analysis are presented
in the Supporting Information.
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3.3 Supporting Information
3.3.1 Abbreviations
TFA, trifluoroacetic acid; DTNP, 2,2’-dithiobis(5-nitropyridine); MTBE, methyl tert-
butyl ether; HPLC, high performance liquid chromatography.
3.3.2 Results and Discussion
3.3.2.1 Inter- vs. Intramolecularity
Several routes were considered to determine whether the catalysis of disulfide formation
by an intramolecular diselenide was an inter- or intramolecular effect. Interestingly,
oxidation reactions appear to show both intermolecular and intramolecular character.
kox measures the rate of formation of the first disulfide bond, as this was derived from the
depletion of the reduced peptide (bearing either six thiols or four thiols and a diselenide),
and therefore represents the first oxidation step. kox is used exclusively to determine the
inter- or intramolecularity, as knative also represents isomerization events as well as oxidation
(see Data Analysis, 3.3.3.3).
The invariance of kox over a 10-fold range in concentration suggests an intramolecular
mechanism (Figure 3.S1). However, if the reaction is exclusively intramolecular catalysis,
then a 1:1 mixture of unmodified peptide with its diselenide-containing analog would give
two distinct rates of depletion of the reduced peptide, both being unchanged from their
individual rates when folded separately. However, this was not the case, as is shown in
Figure 3.3b and e (and insets), for GVIA and SIIIA, respectively.
Thus, the catalysis of disulfide bond formation by an intramolecular diselenide demon-
strates both inter- and intramolecular character. However, the co-folding reactions (combin-



































































































Figure 3.S1. The effect of peptide concentration on folding rate and disappearance of the
“linear” form for [C8U;C19U] GVIA. Equivalent rates for GVIA (at 20 µM) are also shown
for comparison. In all cases, n = 3 and values shown are mean ± SEM.
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bias towards intermolecular catalysis, as the uncatalyzed folding of the unmodified peptides
is extremely slow. Also, intermolecular diselenide catalysis differs in rate from catalysis
with an intramolecular diselenide, despite the total diselenide and peptide concentrations
being constant across conditions (Figure 3.4a and Table 3.S1).
3.3.2.2 Numerical Values for Rate Constants
In Table 3.S1, we present the numerical values for the parameters involved in the analysis
of the oxidative folding of GVIA and SIIIA and their selenopeptide analogs.
The results in Table 3.S1 fit the data to the following equation, charting the extent of
folding with respect to time, in minutes (given in Equation 3.1).
[F ](t) = γ · (1− knative
knative − kox e
−kox·t +
kox
knative − kox e
−knative·t)
γ is the final yield, accounting for the fact that not all of the terminally oxidized peptide
achieves the native disulfide connectivity. kox provides the rate constant for the initial
oxidation step, and knative provides the rate constant for all subsequent oxidation and
isomerization steps leading towards native disulfide formation.
Unless otherwise indicated, the peptide concentration was 20 µM. γ is ‘unitless,’ and
represents the fraction of total peptide that achieves the native disulfide connectivity. The
units for kox and knative are both min
−1. Provided error ranges are standard errors.
3.3.2.3 Kinetic Traces of Folding with Linear Timescales
Kinetic traces with a linear timescale are shown in Figures 3.S2 and 3.S3; they emphasize
the rapidity of oxidative folding by autocatalysis with an intramolecular diselenide relative
to the uncatalyzed condition.
3.3.2.4 Folding Chromatograms
Figure 3.S4 shows the HPLC chromatograms of reagentless folding reactions with respect
to time for GVIA, [C8U;C19U] GVIA, SIIIA, [C3U;C13U] SIIIA, [C4U;C19U] SIIIA and
[C8U;C20U] SIIIA. In all chromatograms, * indicates the native peak, and x indicates the
reduced peptide.
3.3.2.5 Discussion of Error Values of knative
In some cases, the standard error values for the rate of native formation, knative are





























































































































































































































































































































































































































































































































































































































































































































































































Figure 3.S2. Kinetic traces of folding of GVIA and [C8U;C19U] GVIA, shown with a
linear timescale.


















Figure 3.S3. Kinetic traces of folding of SIIIA and [C4U;C19U] SIIIA, shown with a linear
timescale.
concentrations (10 µM and 20 µM) of [C8U;C19U] GVIA. In both cases, these are artifacts
of the kinetic model.
In the case of [C8U;C19U] GVIA, the large standard error of knative is an artifact of
the model with respect to the calculation of yield. As shown in Figure 3.3(c), there is a
decrease in the overall yield of natively folded peptide from 1 hour to 24 and 48 hours,
causing uncertainty in the output of the final yield. As discussed in the Data Analysis



















































































































[C4U;C19U] SIIIA [C8U;C20U] SIIIA
Figure 3.S4. Representative HPLC of folding chromatograms for each timepoint. *
indicates the natively folded form, and x indicates the linear/diselenide-only form. Peaks
were integrated and analyzed as described in the Data Analysis section.
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the yield is a function of knative and knon. Therefore, the variation in yield from 1 hour to
48 hours appears as error in the determination of knative and knon.
The decrease in the fraction of natively folded peptide at extended timepoints could
result from slow isomerization driven by a (very) small fraction of peptide thiols remaining
in solution or minor reversibility. Interestingly, both suggest that the intramolecular folding
mechanism is a higher-yield reaction pathway than intermolecular folding.
While the calculations and fitting to the kinetic model is not ideal due to the convolution
of yield with knative, it was selected in order to better assess errors due to covariability of kox
with knative. Alternatively, if all of the kinetic parameters are determined sequentially—kox
from the depletion of the reduced peptide, then knative and yield using the provided value of
kox with direct fitting to Equation (1)—the kinetic parameters are effectively deconvoluted
from the yield, resulting in dramatically decreased standard error values. For instance, with
[C8U;C19U] GVIA folded at 20 µM, this deconvolution of the kinetic parameters and the
yield decreases the standard error of knative from 0.236 ± 0.211 min−1 (89% error) to 0.285
± 0.0364 min−1 (13% error). The full set of sequentially-determined rate data is shown in
Table 3.S2.
In the case of the copper-catalyzed folding of GVIA, the kinetic model fails to capture the
complexity of the established copper-catalyzed reaction mechanism, wherein the formation
of disulfide bridges proceeds through two distinct phases, each with separate reaction rates
(20). However, the model was used in this instance in order to allow effective comparison
with catalysis by an intramolecular diselenide. Also, the addition of copper to the folding
reactions complicates the interpretation of HPLC chromatograms. Beginning at 2 hours,
there is a peak that could be either a 15-second shift in HPLC elution time of the reduced
peptide or a copper-specific folding intermediate, as it was not present in any other folding
conditions. These two outcomes are compared in Table 3.S3. In our analyses, we used the
interpretation that gave larger standard error values in order to avoid understatement of
errors.
It is also worth noting that for all of these conditions, the variability represented in the
determination of knative is largely due to the fitting to the kinetic model (and not due to
variability in the raw data). To demonstrate the consistency of the raw data, we can also
fit each of the three replicates separately to the kinetic model (allowing for covariability of
kox and knative), and then determine values for γ (yield), kox and knative for each replicate.
The traces for each replicate are shown in Figure 3.S5. Also, by determining the mean ±





















































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.S3. Comparison of two alternative interpretations of the copper-catalyzed folding
data. Note that if there is a shift in the elution time of the reduced peptide, the error
value for knative suggests a 541% error, whereas if the elution time of the reduced peptide
is assumed to not shift (indicating the existence of a copper-specific folding intermediate),
the error value for knative suggests a 147% error.
Table S3: Fitting of Copper Catalysis Data
Identity of Peak γ kox (min
−1) knative (min−1)
Elution time shift 0.169 0.0351 ± 0.00268 0.109 ± 0.590
Copper-specific intermediate 0.168 0.0359 ± 0.000903 0.0915 ± 0.135
10 µM [C8U;C19U] GVIA












20 µM [C8U;C19U] GVIA












Copper Catalyzed GVIA Folding
1. Elution Shift of Reduced












Copper Catalyzed GVIA Folding
2. Copper-Specific Intermediate
















Figure 3.S5. Kinetic traces for the individual replicates of (a) 10 µM folding of [C8U;C19U]
GVIA, (b) 20 µM folding of [C8U;C19U] GVIA, (c) copper-catalyzed folding, assuming
the shift of elution time of the reduced peak, and (d) copper-catalyzed folding, assuming
no shift of elution time for the reduced peak (and that there is a copper-specific folding
intermediate). Each trace was determined allowing for the covariability of kox with knative.
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the error shown in Tables 3.S1 and 3.S2 is due to variability in the raw data. This is shown
in Table 3.S4.
As indicated by the values in Tables 3.S1, 3.S2, 3.S3 and 3.S4, we elected to use the




Peptides were synthesized on a single-channel automated peptide synthesizer using Rink
amide resins and standard Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry. All cysteine
residues were trityl protected, and all selenocysteine residues were 4-methoxybenzyl pro-
tected. Peptides were cleaved from the resin with either Reagent K (for non-selenocysteine-
containing peptides) or Reagent K‡ (for selenocysteine containing peptides). Reagent K
contained a 33:2:2:2:1 mixture of TFA : Phenol : water : thioanisole : 1,2-ethanedithiol;
Reagent K‡ contained a 178:14:5:1.6:1 mixture of TFA : Phenol : water : thioanisole :
DTNP. All peptides were cleaved for 3 hours. Cleaved peptides were filtered and precipitated
with MTBE. Selenocysteine-containing peptides were then subjected to 2 hours of reduction
(incubation in 50mM DTT, 0.1M Tris, pH 7.5 with 0.1mM EDTA), which was quenched by
addition of formic acid to 8% (final). Peptides were then purified by HPLC on either
a Waters 600 chromatograph or a Waters 2535 Quaternary Gradient Module, using a
semi-preparative Vydac C18 column (218TP510). All peptides (reduced and oxidized) were
purified using a gradient that ran from 5% to 35% B90 (89.9% acetonitrile, 10% water, 0.1%
TFA), with the remainder being 0.1% TFA in water. The identity of the reduced peptides
was then validated by electrospray ionization mass spectrometry.
3.3.3.2 Oxidative Folding
All oxidations were air-mediated, using molecular oxygen as the only oxidant, except as
indicated.
Dried, reduced peptides were redissolved in 5% acetonitrile, 0.01% TFA (94.99% water)
to 200 or 400 µM. In most cases, the peptide was dissolved to 200 µM; however, for folding
reactions with a final peptide concentration of 100 µM, a more concentrated solution was
used in order to limit the effect of the TFA on the final buffered pH.
Folding mixtures were then prepared, containing everything except the reduced peptides.
Concentrations were chosen so that upon addition of the reduced peptides, the folding




























































































































































































































































































































































































































(the amount of EDTA was adjusted down to 1 nM for folding reactions containing 100 nM
CuCl2 as an oxidative catalyst). This mixture was allowed to thermally equilibrate for at
least 5 minutes in a block set to 20o C.
Peptide was then added to each folding reaction, and timepoints were taken as necessary.
For selenocysteine-containing peptides, timepoints were at 5, 10, 20, 40 and 60 minutes,
and 24 and 48 hours. For peptides that did not contain selenocysteine (or an oxidative
catalyst), timepoints were taken at 0.5, 1, 2, 4, 8, 24 and 48 hours. For folding reactions
with copper(II) chloride as an oxidative catalyst, timepoints were taken at 10, 20, 40 and 60
minutes, and 2, 24 and 48 hours. For reactions with selenocystine as an oxidative catalyst,
timepoints were taken at 5, 10, 20, 40, 60 minutes, 24 and 48 hours. Each timepoint
contained 2 nmol of peptide, and was added to a tube containing 15% of the volume of
the timepoint of 1 M HCl. This was then transferred to a pre-chilled HPLC vial, and 1.67
nmol was injected onto an analytical Vydac C18 column (218TP54) with a Waters e2695
Separations Module. For more concentrated folding reactions, 0.1% TFA (in water) was
added to a final volume of 120 µl for increased precision in folding analysis. Samples are
kept at 4o C until they are run on the analytical HPLC. All timepoints were analyzed by
analytical HPLC within 24 hours of the timepoint being taken.
All folding reactions were performed in 0.1 M Tris, pH 7.5. Upon quenching with HCl,
the pH is lowered to approximately 1.45. Any further dilution that occurred with 0.1%
TFA in water (only in more concentrated folding reactions) maintained the pH below 2.0.
Unless otherwise indicated, all folding reactions were performed with 20 µM peptide.
3.3.3.3 Data Analysis
The first step in data analysis was to use Empower 3 to perform HPLC peak integration.
This provided the percent of the total peptide that was present as either reduced or native
peptide at each timepoint. The elution times of native peptide are known from our previous
work (4), and the elution times of reduced peptides were shown using reduced peptides that
had been kept under acidic conditions, prohibiting disulfide formation.
Data were fit to a slightly modified kinetic model of the chemical reaction shown in
Figure 3.S6, where R denotes the reduced peptide (bearing either six thiols or four thiols
and a diselenide), I denotes any folding intermediates and F denotes folded peptide with
the native disulfide connectivity.
This assumes that every oxidation is irreversible. Disulfide isomerization following the
formation of the first disulfide bridge is not explicitly included in this model because any
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R I Fkox knative
Figure 3.S6. Reaction scheme used for kinetic analyses
species bearing one disulfide bridge is an intermediate. The classical model for product
formation in this reaction sequence is provided below, and is given in [26].
[F ](t) = (1− knative
knative − kox e
−kox·t +
kox
knative − kox e
−knative·t)
However, this had to be modified, since one of the assumptions is that all terminally
oxidized forms are equivalent, which is not the case for our material (there are numerous
folding isomers). Consequently, we also incorporated a multiplicative factor of γ, represent-
ing the fraction of the material that actually proceeds to the native disulfide connectivity
(final yield). Thus, our analyses were done with Equation 3.1, below.
[F ](t) = γ · (1− knative
knative − kox e
−kox·t +
kox
knative − kox e
−knative·t) (3.1)
DynaFit was used to solve Equation (1) for γ, kox and knative simultaneously, using both
the depletion of the reduced peptide (d[R]dt ) and the native formation (
d[F ]
dt ). The maximum
value was set to 0.95, as this was the approximate purity of the reduced peptides. The
yield of the reaction (γ) was solved for by adding another component, wherein I goes to
M (non-native or mis-folded folding products) at a rate of knon. Because both reactions





Error values provided are formal standard errors, as given by DynaFit. Because the
fitting software only used information on the depletion of the linear form (R) and the
appearance of the native fold (F), the value of knon is determined relative to the value of
knative in order to maintain a reasonable value for γ; consequently, errors were not calculated
on the derivation of γ.
Most computations were performed with DynaFit; sequential determination of kinetic
parameters (Table 3.S2) was performed with Prism 5. Graphical preparations were done
with PyMOL, ChemBioDraw and Prism 5.
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3.4 Conclusion
In addition to the paper that is included here, another paper with similar conclusions
was also presented side-by-side [25], based on our previous arrangement with the authors
of the other paper. This side-by-side publication used diselenide catalysis as well, but the
core focus of their discovery was the use of non-native diselenide bridges to drive oxidative
folding through productive folding pathways, whereby avoiding kinetic traps. To accomplish
this goal, Metanis and Hilvert used Bovine Pancreatic Trypsin Inhibitor (BPTI), which has
been extensively studied with respect to molecular dynamics [27], mechanism of action [28],
folding pathways [29, 30], enzymatically-assisted folding [31], as well as folding with an
intermolecular diselenide catalyst in vitro [3].
As a follow-up to these two papers, a commentary was published to discuss the
implications to oxidative folding, the potential importance of selenium and selenocysteine to
future biotechnological developments, and the enhancements to production–both chemical
and recombinant–that may result from this work [32].
In addition to the rate increase, the inclusion of an intramolecular folding catalyst
also has implications to the synthesis and testing of conotoxins. As was noted in both
Chapters 1 and 2, oxidative folding is classically considered the rate-limiting-step to the
synthesis and folding of conotoxins, and consequently to the exploration of the vast number
of conotoxin sequences that are known, but for which peptide has never been synthesized,
folded or tested for activity. In such cases, it may be advantageous to assay folding mixtures.
Consequently, the observation that oxidative folding will occur spontaneously and with
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CHAPTER 4
IN VIVO FOLDING: ENZYME CATALYSIS
AND EVOLUTION OF DISULFIDE
BRIDGES
The venom of cone snails is produced by specialized secretory cells in the venom duct.
Because Conus venom duct cells have never been cultured, there is very little direct evidence
for the mechanisms of production, or even the order of events in the biosynthesis of
conotoxins. For example, it is unknown whether posttranslational modifications occur
before, after or during folding. Nonetheless, it can be inferred from cDNA sequences
that conotoxins use the typical pathway for secreted proteins: mRNA synthesis, excision
of introns, binding of mRNA to a ribosome, ribosomal peptide synthesis on the rough
endoplasmic reticulum, posttranslational processing (including folding) and secretion into
the venom duct.
Given the final structure of conotoxins, this method of production is exactly what would
be expected. However, it remains unclear which enzymes facilitate the posttranslational
processing, whether there are cofactors that also play a role, what the order of steps are
(or even if this order is significant or controlled). It is also unknown whether energy is
expended to drive oxidative folding to a specific disulfide connectivity. There are other
questions regarding conotoxin evolution as well: what are the evolutionary pressures that
drive conservation of disulfide scaffolds? Is there significance to the codon choice at each site
(which is conserved in each conotoxin family [1, 2, 3, 4]), or does this choice only signify the
evolutionary relationship between these sequences? Some of these questions were addressed
in collaborations that will be discussed further below. Others are discussed in the following
chapter, although many of these questions remain open.
4.1 Enzyme-Assisted Folding
There are many critical aspects that distinguish in vivo from in vitro oxidative folding;
most critical among these is likely the involvement of enzymes such as protein disulfide
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isomerase (PDI) [5, 6] and the heat shock protein family of chaperones [7, 8, 9]. Post-
translational modifications also likely play a critical role, especially in cases where the
modification alters the folding efficiency [10, 11].
Given the broad array of in vitro folding efficiencies (see Table 2.1), it is likely that
certain conotoxins employ chaperones to assist their folding in vivo; however, it is unlikely
that every conotoxin employs such a chaperone system. Additionally, the particular
chaperones involved in conotoxin folding are likely to differ from one peptide to the next.
For instance, peptidylprolyl cis-trans isomerase (PPI) facilitates the folding of µ-conotoxin
GIIIA [12], but is unlikely to act on peptides without proline residues, or peptides whose
folding pathway does not require prolyl isomerization (meaning that PPI acts only on a
subset of peptides containing proline residues).
4.1.1 Protein Disulfide Isomerase
Because the ‘correct’ disulfides are critical to the action of any cysteine-rich peptide
[13, 14, 15], it is likely that cone snails employ PDI to fold conotoxins. While the
precise mechanisms behind the substrate specificity of PDI have remained elusive, one
common belief is that PDI identifies misfolded proteins by exposed hydrophobic surface
area [16]. However, numerous conotoxins have significant exposed hydrophobic surface area
in their correctly folded form, including µO-MrVIB (see Figure 4.1) and many δ-conotoxins,
suggesting that PDI in Conus may use a different motif for substrate recognition.
Because conotoxins are short, cysteine-rich peptides, they may not contain sufficient
sequence-encoded folding information to drive oxidative folding to the correct disulfide
isomer, and likely employ PDI to assist in forming the correct disulfide bonds. However, with
many substrates, the effect of PDI on folding efficiency is fairly modest [6, 17], with bovine
pancreatic trypsin inhibitor (BPTI) being one of the first examples to show a significant
benefit to PDI-catalyzed folding [6], suggesting that one of the primary functions of PDI is to
assist in disulfide isomerization in kinetically trapped intermediates. Some conotoxins may
also be small enough to not entirely bury their disulfides, allowing reduced glutathione to
function as the primary isomerization agent. As PDI is the β-subunit of prolyl 4-hydroxylase
[18], and many conotoxins contain hydroxylated proline residues [10], PDI may also be
serving a noncanonical role in conotoxin biosynthesis.
4.1.2 Endoplasmic-Reticulum-Resident Chaperones
In addition to disulfide isomerization and posttranslational modifications, there are many
other chaperones that are likely to be involved in the biosynthesis of conotoxins. The
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Figure 4.1. Three-dimensional structure of µO-MrVIB (PDBID: 1RMK), showing a
surface representation, with transparency to see the peptide model underneath. Grey/white
indicate hydrophobic regions, and red/blue indicate charged regions; disulfides are shown
in yellow.
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Hsp40/70 system is a canonical chaperone network that assists efficient protein folding, and
is therefore likely involved in the folding of conotoxins as well.
BiP is the only 70-kDa heat shock protein (Hsp70) known to reside in the endoplasmic
reticulum [19]; this class of chaperone has an ATPase domain, which controls the affinity
for client proteins [7]. The ATPase activity of BiP is postulated to explain the observed
ATP-dependence of oxidative folding of certain proteins [20, 21]. However, BiP does not
directly bind client proteins; instead, the unfolded client proteins bind to a 40-kDa heat
shock protein (a “J protein,” from the homology to DnaJ in E. coli), which then carry the
client protein to BiP. While there is only one ER-resident Hsp70, the J proteins are more
numerous and believed to control the substrate specificity of BiP by determining which
clients are shuttled to BiP [7].
4.1.3 Chaperone Activity in Oxidative
Folding of Conotoxins
As mentioned above, the role of PPI in conotoxin folding has been investigated [12],
and demonstrated that PPI does improve the folding of µ-GIIIA, although since many
conotoxins do not contain proline residues, the role of PPI is unlikely to be universal. PDI
has been shown to assist in the folding of tx3a and sTx3.1, showing notable enhancement
to both oxidation and isomerization relative to glutathione [22]. It is worth noting, though,
that the reports showing a role for PDI in assisting conotoxin folding have all used a Conus
PDI, which allows for the possibility that conotoxins employ a specialized PDI that is more
efficient with such small, cysteine-rich substrates.
Appendix B is a publication that discusses the role of chaperones in conotoxin folding
[23]. Using a Conus BiP, the addition of BiP and PDI (also from Conus) together showed
a greater effect than either individually. Because which J protein interacts with newly-
synthesized conotoxins to carry them to BiP is unknown, microsomes derived from rat liver
were added in order to provide an array of J proteins to fulfill this role. Together, these
indicate that there may well be a multienzyme complex that assists the folding of conotoxins
in vivo. Another interesting result of this work was the discovery of misfolded ImI in the
venom of C. imperialis, which established that the involvement of chaperones does not
necessarily direct the folding of conotoxins to a single, active disulfide connectivity.
4.2 Conservation of Disulfide Scaffolds
Disulfide scaffolds in Conus are extraordinarily conserved, with notable evidence for
conservation at the codon level [1, 2, 3, 4]. Given the hypervariability of the adjacent
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residues in the mature toxin, the reason for this extensive conservation is unclear. However,
there are several examples of changes to disulfide scaffolds in Conus. In particular, the
conkunitzins show a wide variety of disulfide scaffolds (see Figure 4.2), all of which are
variants of the classical kunitz domain [24]. Other examples of changes to disulfide scaffolds
can be found in the α- vs. αA-conotoxins (differing by one disulfide) [25], and in the
M-superfamily (changes to the length of intercysteine loops with associated changes to
disulfide connectivity) [4]. Given the wide diversity of disulfide scaffolds in Conus, these
few isolated examples are the exception rather than the rule, and the conservation of such
a great number of disulfide scaffolds (see Figure 1.4) is quite striking.
Appendix C is a publication that discusses potential reasons for the conservation of
disulfide scaffolds in conotoxins [26]. Disulfide-depleted analogs of ω-GVIA were used
to show the significance of the first disulfide, showing that it significantly impacted the
efficiency of oxidative folding, but that this disulfide does not modulate the activity of the
peptide. One of the most striking results of this paper is that using disulfide-depleted,
diselenide-containing ω-GVIA does not fold as efficiently as unmodified ω-GVIA, despite
only having one possible folding product (accounting for the strong preference for diselenide
bridges over mixed sulfur-selenium bonds, as discussed in Chapter 3), as compared to the
fifteen possible folding products for the unmodified peptide. These results are taken to
indicate that the first disulfide in ω-GVIA is conserved to preserve efficient folding, although
it is not known whether this bridge functions by conformationally constricting the peptide
as the remaining bridges form, or if it acts by driving disulfide isomerization through more
productive folding pathways.
4.3 Energetics of Venom Production
Venom is energetically expensive to produce; in one snake, the cost of venom regeneration
was estimated at 26% of the cost of digesting small prey [27], although this may be an
artificially low estimate [28]. To limit expenditure of venom, some venomous animals use
‘dry bites’ (no envenomation), which have been proposed to be due to kinematic constraints
[28]. In the case of the cone snail, the venom is critical to effective prey capture, as Conus
does not have an alternate (physical) means of prey immobilization. Consequently, in order
to conserve energy, each envenomation event by Conus uses a very small amount of venom;
C. purpurascens uses an average of 56 µl of venom for each envenomation [29].
The production of venom is very expensive at every step–and this is especially true for
disulfide-rich, peptidic venom because in vivo oxidative folding yields are not quantitative
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C C C C C CCCCCCCCC
C C C C C C C C C C C C C C C C C C
Figure 4.2. Disulfide scaffolds of conkunitzins. The traditional kunitz scaffold, bearing
three disulfide bridges, is also used in Conus venom, as is a reduced version in which
one disulfide has been deleted (top pannel). Conkunitzins can also have two–or even
three–kunitz domains in a single toxin; the disulfide scaffold of two tandem domains has a
fourth disulfide pair in the first kunitz domain (center pannel). Examples of conkunitzins
with three kunitz domains are scarce, but the available example has three disulfides in each
kunitz domain (bottom pannel).
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[23]. Table 4.1 shows the energetic cost of venom production, from DNA to secretion. It is
worth noting, though, that the per residue/vesicle values presented in Table 4.1 should only
be used as approximations; these values do not account for introns; furthermore, the cost
for secretion is expressed on a per vesicle basis, whereas the cost for synthesis is expressed
on a per molecule/residue basis. Nonetheless, it is evident that venom is extraordinarily
expensive to produce.
One critical question that is raised by the huge expense of venom production is why
there is so much functional redundancy in venom [28]. There are several possible reasons
for functional redundancy: (1) each peptide has its own metabolic half-life once injected into
prey, and functional redundancy would increase the likelihood that the desired function is
retained long enough for the snail to capture the prey; (2) by having multiple peptides
(potentially with drastically different structures), the snail has an increased ability to
adapt to changes in the target receptor; (3) in a venomic system with hypervariable
mature toxin regions (as in Conus–see Chapter 5), the oxidative folding efficiency (and
hence energetic cost of biosynthesis) for each peptide could vary wildly in each generation,
and functional redundancy in such a system would allow buffering of the volatility in the
energetic requirements to achieve the desired/necessary activity. It is worth noting that
these potential benefits to functional redundancy in the venom are not mutually exclusive.
This is discussed further in Chapter 5, although the focus of that discussion is buffering the
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CHAPTER 5
CONSERVATION OF CYSTEINE CODONS
IN CONOTOXINS
This chapter is a paper that has been submitted and its accompanying supplemental
information.
5.1 On the Importance of Oxidative Folding
in the Evolution of Conotoxins: Cysteine
Codon Preservation Through Gene
Duplication and Adaptation
Steiner, A., Bulaj, G., Puillandre, N. On the Importance of Oxidative Folding in the
Evolution of Conotoxins: Cysteine Codon Preservation Through Gene Duplication and
Adaptation. J. Mol. Biol., Submitted.
5.1.1 Abstract
Conotoxin genes are among the most rapidly evolving genes currently known; however,
despite the well-established hypervariability of the intercysteine loops, the cysteines demon-
strate significant conservation, with a site-specific codon bias for each cysteine in a family
of conotoxins. Herein we present a novel rationale behind the codon-level conservation of
the cysteines that comprise the disulfide scaffold. We analyze cysteine codon conservation
using an internal reference and phylogenetic tools; our results suggest that the established
codon conservation can be explained as the result of selective pressures linked to the
production efficiency and folding of conotoxins, which drive the conservation of cysteine
at the amino-acid level. The preservation of cysteine has resulted in maintenance of the
ancestral codon in most of the daughter lineages, despite the hypervariability of adjacent
residues. We propose that the selective pressures acting on the venom components of cone
snails involve an interplay of biosynthetic efficiency, activity at the target receptor, and the
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importance of that activity to effective prey immobilization. Functional redundancy in the
venom can thus serve as a buffer for the energy expenditure of venom production. The
graphical abstract is shown as Figure 5.1.
5.1.2 Main Text
Conotoxins are peptides from the venom of Conus, a genus of predatory marine
gastropod. When a cone snail envenomates its prey, a very small volume (6-480 µl; avg.
56.21 µl for C. purpurascens, [1]) of a highly-diverse venom is injected to paralyze the prey.
This highly-diverse venom is largely composed of disulfide-rich peptides, which primarily
target ion channels on the cell surface [2]. The extraordinary diversity of Conus venom is
genetically-encoded within the hypervariable mature toxin region [3] and arises from gene
duplication and positive selection [4], which are believed to be at constant work in Conus,
allowing the snail to compete effectively in the venom-target molecular arms race [5]. This
results in exceptionally potent and highly specific toxins, such that only a small volume
of venom is necessary to efficiently paralyze the prey. The high potency of conotoxins
minimizes the venom requirements (thus, energetic expenditure) of each envenomation
event, while also allowing some variation in targeted prey.
Conotoxins have been extensively studied with respect to function [6], oxidative folding
[7], gene structure [8, 9, 10], and their evolutionary patterns [3, 4, 11]. Conotoxin genes
consist of a signal sequence, propeptide, and a toxin region containing highly conserved
cysteine residues separated by hypervariable intercysteine loops. In this work we focused
on the δ- and ω- families of conotoxins, which bear the intercysteine knot (ICK) motif. The
ICK motif is defined by the cysteine scaffold, and is broadly employed by many organisms
outside Conus, including insects, plants, fungi and spiders [12]; previous work has also
referred to conotoxins bearing the ICK motif as ‘four-loop conotoxins’ [11, 13, 14].
Highly conserved cysteine residues are interspersed with the hypervariable intercysteine
loops, with a site-specific codon preference for each cysteine in the disulfide scaffold (Figure
5.2). While closely related conotoxin families have similar codon usage patterns for cysteine,
differences between two families are also conserved within each family (see Cysteine 6 in
Figure 5.2). The driving force behind the extensive site-specific conservation of cysteine
codons–which are flanked by hypervariable intercysteine loops–has not yet been fully
elucidated. Proposed mechanisms for the codon-level conservation of cysteine involve a
‘block substitution’ mechanism [15] and a macromolecule that binds specifically to TGC
or TGT [16, 13]; the latter has received support from frame-shifted pseudogenes which










































































































Figure 5.2. Codon usage statistics for the cysteine residues in two classes of four-loop
conotoxin genes. (a) shows the codon bias for the ω-conotoxins, and (b) shows the codon
bias for the δ-conotoxins. The lines above show the characteristic disulfide connectivity
of the cysteine residues. While both ω- and δ-conotoxins maintain the same general
cysteine scaffold, they are readily distinguished by the precursor sequences (both signal and
propeptide), length of the intercysteine loops, as well as the tendency of the δ-conotoxins
to be considerably more hydrophobic.
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out-of-frame cysteine codons are not conserved (see Supplemental Information), suggesting
that the frame-shifted psuedogenes have retained characteristic codons as a marker of their
evolutionary history, not necessarily as the result of a direct mechanism. The ‘block
substitution’ mechanism for generating hypervariability is consistent with feedback from
folding efficiency, as it promotes hypervariability of the intercysteine loops, but avoids
drastic perturbations to the overall length or cysteine scaffold of the toxin; furthermore,
since both the template and target likely share a common ancestor, the cysteine codons
(and disulfide scaffold) would remain preserved through numerous block substitution events.
However, block substitution requires a template, and therefore is not sufficient to explain
the extensive hypervariability observed in the intercysteine loops of conotoxins.
It is widely believed that the hypervariability of the intercysteine loops results from
positive selection after gene duplication [18, 19, 20], based on the activity of the conotoxin
at the target receptor [21, 18, 4, 22]; it follows that a mutation which confers a selective
advantage with respect to activity will be preferentially retained over a mutation which is
either neutral or detrimental to the activity. While activity does play a major role, the
production/folding efficiency is also a critical factor; both act to direct the evolution of
the amino acid sequences of the intercysteine loops, as well as the preservation of disulfide
scaffolds and posttranslational modifications. Occasionally, the latter two are significant
only to folding efficiency [23, 24, 25], although many changes affect both production effi-
ciency and activity. Consequently, we propose that both activity and production efficiency
be considered in models of conotoxin evolution.
In addition to holding the peptide in an active conformation [26, 27, 28], disulfides can
also be critical to folding efficiency. In ω-GVIA, removing the Cys1-Cys16 disulfide bridge
negligibly affects its activity on N-type calcium channels, but greatly reduces the peptide’s
propensity for the native connectivity [23]. Consequently, a disulfide can be conserved in
order to preserve activity, or to preserve efficient folding, or both. It remains unclear whether
a disulfide that is valuable only to folding efficiency acts by conformationally constraining
the peptide as the other bridges form, or whether that cysteine pair drives thiol/disulfide
exchange through a more productive folding pathway.
Post-translational modifications can also function to increase folding efficiency, without
any measurable change in activity of the peptide. For instance, hydroxylation of proline
in ω-MVIIC provides a twofold increase in folding rate, as well as a threefold increase in
yield, but does not change the activity (as measured by i.c.v. injection into mice) [24].
Also, the γ-carboxylation of glutamate can introduce calcium-dependent improvements to
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folding efficiency, without measurable effects on activity (also measured by i.c.v. injection
into mice) [25]. While chaperones can offer some benefit to folding efficiency in vivo, their
enhancement is largely limited to kinetics, as enzymes lower energy barriers, but do not
change equilibria, although it is possible that kinetic enhancement to productive folding
pathways could be coupled to secretion from the ER to effect a nonequilibrium folding
outcome. The recent discovery of misfolded ImI in Conus imperialis venom [29] established
that in vivo folding faces many of the same challenges to production efficiency as in vitro
folding. Thus, chaperones do not necessarily drive in vivo oxidative folding to a single,
“native” disulfide connectivity, further highlighting the importance of efficient oxidative
folding.
In order to assess the extent to which chaperones could modulate the outcome of
oxidative folding of conotoxins, we considered the ATP-dependence of chaperone-assisted
folding. There is an established role for energy expenditure in efficient oxidative folding
of proteins [30, 31, 32], which likely functions through BiP, the ER-resident 70 kDa heat
shock protein [33]; although the extent to which this applies to small substrates—such as
conotoxins—is unclear. Using microsome-assisted folding reactions to supply chaperones,
we assayed the role that ATP expenditure plays in directing conotoxin folding. The results
(Table 5.1) show a minor ATP dependence for the folding kinetics of certain conotoxins,
suggesting that the presence of chaperones and expenditure of energy do not qualitatively
change conotoxin folding. Consequently, the innate folding efficiency is likely to be the
dominant factor in the efficient biosynthesis of conotoxins.
In light of these results, we propose that folding efficiency is one of the critical factors
directing the evolution of conotoxins, due to its importance in an existing disulfide scaffold.
This would imply that the only selective pressure–combined with evolutionary diversification
from one (or a few) ancestral gene(s)–is at the amino acid level, and that the observed
codon conservation [16, 13, 15, 17] is an artifact of the combination of cysteine conservation
through selective pressure and phylogenetic conservatism.
Loss of a cysteine residue due to a mutation or frameshift could be significantly more
detrimental than mutations that result in changes to the residues in the intercysteine loops.
For instance, if one cysteine is removed, then the peptide will either create a disulfide dimer
(homo- or hetero-dimer) [34], or it will retain a free thiol, leading to inter- and intramolecular
disulfide shuﬄing in the venom duct, after secretion away from ER-based quality control
machinery. If a pair of cysteines is lost, the resulting disulfide scaffold may loose activity,










































































































































































































































































































































































































































































































































































































changes a non-cysteine residue, the probability of retaining the important chemical at-
tribute(s) is much greater. For example, if a given site must have a negatively charged amino
acid for folding/activity, then there are two possibilities, encoded by four codons (GAT,
GAC, GAA and GAG). Considering only single-base substitutions, then the probability to
retain an amino acid that is negatively charged is one in three, or 33.3%. Since cysteine is
the only residue capable of forming crosslinks, and can be encoded by two codons (TGT
and TGC), the probability of retaining this functionality through a single-base substitution
event is one in nine, or 11.1%. Hence, if a point mutation occurred, it would be much more
likely to be detrimental at a cysteine site than elsewhere in the peptide because only silent
mutations are viable, effectively selecting against non-silent mutation at cysteine sites.
To reexamine the codon conservation of cysteine in conotoxins, we sought a means to
assess codon bias at each site that did not account for the encoded amino acid, in order to
meaningfully compare codon conservation at cysteine to neighboring hypervariable residues.
By using an internal reference for codon conservation, we accounted for the homology
between sequences, allowing ready distinction between codon-level and amino-acid-level
conservation. To accomplish this, we adapted the “effective number of codons” [35] to
consider a group of related sequences site-by-site. In order to avoid assumptions regarding
amino acids that were missing or underrepresented, we took a weighted average of the
codon bias among amino acids that can be represented by the same number of codons (a
‘redundancy class’), allowing analysis of codon bias independent of the amino acid encoded
by each codon (details are in the Supplemental Information). The codon bias for each
cysteine is compared to the codon bias in the intercysteine loops for other residues that
can be encoded by two codons in Figure 5.3. Thus, when we accounted for homology
among the members of a conotoxin family, the codon bias for cysteine became rather subtle,
indicative of amino-acid-level conservation, rather than site-specific bias for a particular
cysteine codon.
Phylogenetic analyses can also be used to account for homology among members of a
conotoxin family. Under the assumption that the O1 superfamily of conotoxin genes evolved
from a single ancestral sequence, we constructed a phylogenetic tree to chart the divergence
of these genes. Figure 5.4 shows the phylogenetic tree for a representative subclade of the
δ-conotoxins; the trees for all sequences used in this study are shown in the Supplemental
Information. Mapping cysteine codon usage onto the tree results in six copies of the tree,
each marking codon usage for a particular cysteine (Figure 5.4, C1-C6). The trees for
cysteines 2 and 5, in particular (but see also Supplemental Information), clearly show that
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Figure 5.3. Codon bias for ω- (a) and δ- (b) Conotoxins. Values presented are the
weighted average of Ne values (sensu [35], Eq. 2) for codons encoding amino acids that
can be represented by two (and only two) codons. Because the number of residues in the
intercysteine loops differ between the ω- and δ-Conotoxins, sites that are specific to one
class of conotoxins are followed by the class to which they are specific (e.g., site 14(δ) only
shows data for δ-conotoxins). Yellow bars and ** indicate cysteine sites. Analysis was only
conducted on sites with at least 100 sequences in the alignment, at least 30 of which were
residues that could be encoded by two codons. A value of 1 indicates that only a single
codon is used, and a value of 2 indicates that there is no codon bias among the two possible
codons for each residue. The same data for the other redundancy classes are presented in
the Supplemental Information.
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Figure 5.4. Phylogenetic trees of a represenatitve subclade of δ-conotoxin genes used
in this study (all O1 conotoxins with signal, propeptide and mature sequence with a
C—C—CC—C—C cysteine scaffold published in GenBank), showing the codon usage
patterns for each cysteine. Tree reconstruction was performed on the Cipres Science
Gateway (http://www.phylo.org/portal2), using the RAxML-HPC2 on TG tool; robustness
of the nodes was assessed with a bootstrap analysis (1000 replicates). The evolution of the
cysteine codons was assessed with Meqsuite V2.74 [36], using the option “tracing character
history” and the parsimony ancestral reconstruction method. Each tree shows the codon
usage for a single cysteine, and is labeled accordingly. Shaded lines indicate TGT, and
hollow lines indicate TGC. Bootstrap values are also shown on the tree for Cysteine 1.
Each branch in the tree for Cysteine 1 is labeled with the GenBank accession number of
the sequence and the Conus species. Phylogenetic trees for the entire O1 superfamily are
shown in the Supplemental Information.
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mutations from one codon to the other arose independently several times; furthermore, in
several cases (e.g., Figure 5.4 C5 tree, TGC clade, in white), once a mutation occurs, it
is transmitted to the descendant sequences, suggesting that there is no counter-selection
to revert to the canonical cysteine codon at that site. Taken together, these results
are compatible with a scenario where cysteine is conserved at the amino acid level, and
where the observed, but weak, codon level conservation is the result of a phylogenetic
conservatism linked to the strength of the evolutionary pressure to preserve cysteine. In the
M-Superfamily of conotoxins, it has been proposed that the divergence into distinct branches
with distinct disulfide connectivities (and length of intercysteine loops) was concurrent with
a switch in codon-preference at each site [37], further supporting that the cysteine codons
are retained by evolutionary constraints on folding, and that the evolutionary pressure acts
to retain cysteine residues, but does not act directly on the codon level.
We propose that the evolutionary pressures acting on the venom components of cone
snails involve an interplay of production/folding efficiency, activity at the target receptor,
and the relative importance of that activity to effective prey immobilization. Mutations that
enhance or detriment folding efficiency or activity can be assessed with respect to energetic
cost per activity unit, allowing a combined analysis of the potential cost and value of a
mutation with respect to evolutionary pressures that cone snails experience. For example,
if a peptide with an indispensable activity is mutated such that it is twofold more active, but
folds one fourth as efficiently, then the snail must produce two times as much of that peptide
(costing twice the energy) to effect the same result upon envenomation. However, in reality,
the functional redundancy of Conus venom dampens this variability, effectively buffering the
energetic cost of venom production against drastic perturbations that result from changes
to the folding efficiency of individual conotoxins. Because mutations at cysteine residues
are more likely to result in decreased folding efficiency and/or activity, there is significant
pressure to retain cysteine residues, which in turn results in substantial codon bias over the
course of evolutionary diversification of conotoxin gene families associated to phylogenetic
conservatism. Using a measure that corrects for homology among conotoxin genes, we
have shown that the established codon bias speaks more to the evolutionary history of
the conotoxin genes than explicit codon-level conservation of cysteine. Thus, the site-
specific codon-level conservation of cysteine is driven by amino-acid level conservation of
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5.2 Supplemental Information
5.2.1 Out of Frame Cysteine Codons
Figure 5.S1 shows the extent of conservation of out of frame cysteine codons, as compared
to the cysteine codons that are in frame. This is shown separately for the δ- and ω-
conotoxins. Interestingly, there does appear to be a minor conservation of out of frame
cysteine codons at sites 9-11 in the ω-conotoxins; however, this constitutes a small fraction
of the total number of sequences.
5.2.2 Determination of the Effective Number of
Codons per Amino Acid by Site
5.2.2.1 Rationale
In order to consider codon-level conservation within a family of homologous sequences
(especially from a single genus, such as Conus), it is important to be able to account for the
homology that exists among this group of sequences. However, accounting for this homology
is somewhat nontrivial, as the ancestral sequence is usually unknown, and in some cases
cannot be readily determined.
While previous studies have not accounted for homology [13], and consequently resulted
in extreme site-specific codon bias (P < 1 · 10−4), we decided to reassess the level of codon
bias in a manner that accounts for homology between the sequences considered. However,
because we do not necessarily know the origins or extent of that homology, we do not want
to directly include any statements of what that homology may be in our analyses.
Herein we present a tool to assess codon bias site-by-site across a family of sequences,
normalizing out the identity of any encoded amino acid, and without incorporating any
assumptions about amino acids that are missing or underrepresented. However, in removing
assumptions about missing amino acids, we cannot readily compile the redundancy classes
(amino acids that can be encoded by the same number of codons, either 1, 2, 3, 4 or 6) into
a single numeric output, and therefore must consider each redundancy class separately.
We have based this novel tool on the ‘Effective Number of Codons,’ originally introduced
by Frank Wright [35]. In his work, the objective was to look at codon bias in a gene, in order
to assess translational efficiency; other codon bias analyses have taken the same approach
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Figure 5.S1. Comparison of in-frame and out-of-frame cysteine codons for ω- (A) and
δ- (B) Conotoxins. White bars show in-frame cysteine codons, green bars show cysteine
codons in the +1 position, and blue bars show cysteine codons in the +2 position. ‘Site in
sequence’ uses the same numeric designations as in Figure 5.3, and are similarly designated,
with sites that are specific to one class of sequence being marked with that class (e.g., 14(δ)
contains data for only the δ-conotoxins). ** indicates cysteine sites, which are also readily
identifiable by the large white bars that indicate in-frame cysteine codons.
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[38]. One concern is whether these methods can be used to analyze a relatively small
sample set; of five prominent methods, the ‘Effective Number of Codons’ was among the
least biased by short gene sequences [38], analogous to a relatively small set of sequences
when considered site-by-site.
While our method seems intuitively similar to measuring a Dn/Ds ratio because both
measure the correlative capacity of amino acid to a codon at each site, the two differ in a
few critical ways. Dn/Ds is used to determine the evolutionary pressures on a gene, and
what type of selection (purifying or adaptive) existed to result in the changes in that gene
[39]. In contrast, our method does not have this power; rather, it is a means to assess
codon bias by site. Our method should serve as a bridge between measures of evolutionary
pressures and conventional measures of codon bias; by allowing a site-specific measure of
codon variability, it can provide evolutionary hints as to which portions of a peptide sequence
are under different selective pressures.
5.2.2.2 Overview of Adaptations to Effective Number of
Codons
In the original treatment, the ‘Effective Number of Codons’ was determined by first
finding the ‘homozygosity’ of each amino acid, which was then averaged within each
redundancy class, and then the sum of the reciprocals is taken, weighted by the number of
amino acids in each redundancy class. The result is a number between 20 and 61, which
indicates the number of codons that are effectively used within that gene, accounting for
the extent of bias for each of the 20 amino acids. If an amino acid is not present or
underrepresented in a gene, then it is assumed that the codon bias for that amino acid
would be the same as for the other amino acids within that redundancy class.
In our treatment, we sought to eliminate any assumptions about amino acids that
were not present or underrepresented, as the sequence alignment for conotoxins contains
numerous cysteine-only sites. Consequently, when considering each site, we instead used
the effective number of codons for each amino acid, and then averaged these, weighting by
the prevalence of that amino acid at that site (within that redundancy class). This results
in a set of numbers for each redundancy class, at each site, allowing comparisons of codon
bias between two sites using values that are intrinsically meaningful (for instance, for Site
4 in ω-conotoxins, amino acids that can be encoded by two codons are actually encoded by
1.059 codons, indicating marked codon bias at this site).
However, it is worth noting that comparisons between different redundancy classes
cannot be readily made, as a consequence of our removing any assumptions about amino
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acids that are not present or underrepresented. Consequently, we cannot readily compare
the codon bias at Site 4 in ω-conotoxins for amino acids that can be encoded by two codons
(effectively, 1.059 codons) with the codon bias at the same site for amino acids that can be
encoded by six codons (effectively, 2.145 codons), despite both showing notable codon bias
and their representing the same site in the same family of sequences.
5.2.2.3 Theoretical Buildup
For clarity, we use different indices to designate different ‘levels’ of information: i is for
codon-level information; j is for amino acid level information; k is for redundancy class
information. Although we consider only one at a time, in some cases more than one index
is shown in order to clearly show the origins of each calculation.
To begin, each amino acid is placed into a “redundancy class,” which designates the
number of distinct, synonymous codons that can encode that amino acid. In the standard
genetic code, two amino acids (M, W) can be encoded by one codon; nine amino acids (C,
N, D, Q, E, H, K, F, Y) can be encoded by two codons; isoleucine can be encoded by three
codons; five amino acids (A, G, P, T, V) can be encoded by four codons, and three amino
acids (R, L, S) can be encoded by six codons. This method can be readily applied to any
non-standard genetic code, as long as the amino acids encoded by each codon are known.




the total number of occurrences of the selected amino acid, and the probability of codon i is
simply the number of occurrences of that codon divided by the total number of occurrences
of that amino acid, pi =
ni
















indicating that 0 ≤ Fˆj ≤ 1; however, if Fˆj = 0, then it is disregarded, as this can only result
from very few instances of amino acid j at that site (n ≤ 2), indicating that amino acid is
underrepresented and should be excluded from the analysis at this site.
The homozygosity of each amino acid (Fˆj) is readily translated into the number of
equally frequent codons that would show the same degree of homozygosity for that amino






Here is where we diverge from Wright’s treatment (except that we were grouping sets of
codons by site across a family of genes, rather than in a gene). Since there is significant bias
towards certain residues at certain sites in our alignment (for instance, cysteine residues
at cysteine sites, or the site used in the sample calculation), we decided to use a weighted
average of Nˆe(j) values, averaged within each redundancy class (however, the redundancy
classes cannot be compared, in order to avoid assumptions about amino acids that are not
present or underrepresented).
In order to determine a weighted average, we define a new coefficient, pj , as the fraction
of redundancy class k that encodes amino acid j (this is analogous to pi, except that it uses
amino acid level information, indicated by the j index), in terms of counts of the codons at
that site. Using this, we can determine the number of equally frequent codons that would
show the same level of homozygosity for that redundancy class, or the effective number of




(pj · Nˆe(j)) (5.S3)
where l is the number of nonexcluded members of the redundancy class (exclusion as
described for Eq. 5.S1).
Λk can be interpreted as the effective number of (or, number of equally frequent) codons
that are actually used at that site, for that redundancy class. So for redundancy class k,
a value of 1 would indicate that only one codon was used for each amino acid, whereas
a value of k would indicate that every available codon was used indiscriminately for each
amino acid.
5.2.2.4 Sample Calculation
For the sample calculation, we use the data from site 10 (counting from the first cysteine,
as in Figure 5.3 in the main text) of the published ω-conotoxin genes in a multiple sequence
alignment.
First, the codons for each amino acid are counted, and placed into bins based on the
redundancy classes. We will deal with each redundancy class separately; we will not discuss
the non-redundant class (M and W) because these can only be encoded by one codon, and
therefore Λ1 = 1 in all cases.
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We will first address redundancy class 2, whose values are shown in Table 5.S1. Not all
amino acids are shown, but if there is an occurrence of that amino acid, all possible codons
for that amino acid are shown.
The next step is to determine the homozygosity for each amino acid. Using the data for
glutamine because there are instances of both codons, pCAA =
9


















For any amino acid that has occurrances of only one of the codons, the homozygosity is
one, since one of the pi values is one, and the other(s) are 0. So, doing the calculation for
tyrosine will tell us the homozygosity values for all of the twofold redundant amino acids












24− 1 = 0.84058.
Now, adding the homozygosity, the number of equally frequent codons (the reciprocal
of Fˆj), and the fraction of each redundancy class that is the given amino acid (pj) to Table
5.S1 results in Table 5.S2.
And, taking the product of the last two columns, and summing the results, we get the
number of equally frequent codons per amino acid at site 10 of the ω-conotoxins, for the

























To do the same calculation for the other redundancy classes, we show only the resultant
final table; the calculations at each step are exactly the same as those above, but the sums
are longer because of the increased number of codons for each amino acid.
For the redundancy class that includes only isoleucine, only one codon was used. These
calculations are not shown because they reduce to the trivial case.
Note that there is only one instance of threonine, so this data point is excluded from
the analysis.
The data for amino acids that can be encoded by four possible codons is shown in Table
5.S3.
The same can be done for the amino acids encoded by six possible codons, and is shown
in Table 5.S4.
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Table 5.S1. Codon usage counts for site 10 in multiple sequence alignment of published
ω-conotoxin genes.






















Table 5.S2. Nˆe(j) at site 10 of a multiple sequence alignment of published ω-conotoxins
for amino acids that can be represented by two possible codons and their relative weights.
Amino Acid Codon Count Fˆj Nˆe(j) pj
N
AAT 7
1 1 775AAC 0
D
GAT 2
1 1 275GAC 0
Q
CAA 9
0.8 1.25 1075CAG 1
H
CAT 11
1 1 1175CAC 0
K
AAA 0
1 1 1375AAG 13
F
TTT 8
1 1 875TTC 0
Y
TAT 22
0.84058 1.1897 2475TAC 2
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Table 5.S3. Determination of the effective number of codons per amino acid for amino acids
with four possible codons (Λ4) at site 10 in a multiple sequence alignment of ω-conotoxins.
Redundnacy Class 4

































Table 5.S4. Determination of the effective number of codons per amino acid for amino acids
with six possible codons (Λ6) at site 10 in a multiple sequence alignment of ω-conotoxins.
Redundnacy Class 6



























5.2.2.5 Data for Redundancy Classes 4 and 6
In order to compare the relative conservation of cysteine to the other amino acids in the
intercysteine loops, only the twofold redundant codons were used for analysis in the main
paper. However, every redundancy class was analyzed for each site, in order to assess the
extent of codon conservation within each redundancy class.
For almost every site, isoleucine was not sufficiently prevalent to merit analysis of the
redundancy class with three possible codons. While these calculations were performed, they
are excluded from this presentation because we believe them to be artificially skewed by
small sample size effects.
In Figures 5.S2 and 5.S3, the axes are scaled to the maximum possible value, which
would represent indiscriminate usage of every possible codon for that amino acid. In most
cases, the actual values are markedly lower than the maximum possible value, indicating
that there is a global codon bias across all redundancy classes at almost every site. The
bars are also color-coded by the number of sequences included in the analysis at that site, to
indicate the risk of small sample size effects at the specified site for the specified redundancy
class. Red or blue indicates that at least 30 sequences were analyzed; grey indicates that
between 15 and 30 sequences were analyzed; white indicates that fewer than 15 sequences
were analyzed.
5.2.3 Phylogenetic Trees for O1 Superfamily
The following phylogenetic trees show the toxin diversification for the O1 superfamily,
using all published sequences (see Section 5.2.4). As mentioned in the main text, it is
evident from these trees that there is no counter-selection to revert to the canonical cysteine
residue at that site. Tree reconstruction was performed on the Cipres Science Gateway
(http://www.phylo.org/portal2), using RAxML-HPC2 on TG tool; robustness of the nodes
was assessed with a bootstrap analysis (1000 replicates). The evolution of cysteine codons
was assessed with Mesquite V2.74 [36], using the option “tracing character history” and the
parsimony ancestral reconstruction method. Each tree shows the codon usage for a single
cysteine.
The tree for cysteine 1 is shown in Figure 5.S4; cysteine 2 is shown in Figure 5.S5;
cysteine 3 is shown in Figure 5.S6; cysteine 4 is shown in Figure 5.S7; cysteine 5 is shown in
Figure 5.S8; cysteine 6 is shown in Figure 5.S9. Each of these trees differs from the others
only in which lines are hollow/shaded, indicating which cysteine codon is used at that site
for the indicated conotoxin, allowing facile comparison of the evolutionary relationships of
the codon usage patterns for each cysteine.
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Figure 5.S2. Codon bias in the ω- (A) and δ- (B) Conotoxins, showing the bias for
amino acids that can be represented by four possible codons. Because the length of the
intercysteine loops differ between these two classes of conotoxins, residues that are specific
to each class are marked with the class to which they are specific, as in Figure 5.3. **
indicates cysteine sites, which are blank because there are two possible codons for cysteine.
A value of 1 indicates that only one of the four possible codons is used for each residue, and
a value of 4 would indicate that each of the four possible codons for each amino acid are used
indiscriminately. Axes are scaled to the maximum possible value. Bars are color-coded to
the size of the sample set being analyzed (the number of sequences with fourfold redundant
codons at that site): blue/red indicates at least 30 sequences and grey indicates between
15 and 30 sequences.
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Figure 5.S3. Codon bias in the ω- (A) and δ- (B) Conotoxins, showing the bias for
amino acids that can be represented by six possible codons. Because the length of the
intercysteine loops differ between these two classes of conotoxins, residues that are specific
to each class are marked with the class to which they are specific, as in Figure 5.3. **
indicates cysteine sites, which are blank because there are two possible codons for cysteine.
A value of 1 indicates that only one of the six possible codons is used for each residue, and
a value of 6 would indicate that each of the six possible codons for each amino acid are used
indiscriminately. Axes are scaled to the maximum possible value. Bars are color-coded to
the size of the sample set being analyzed (the number of sequences with sixfold redundant
codons at that site): blue/red indicates at least 30 sequences, grey indicates between 15










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.S4. Phylogenetic tree for the O1 superfamily, showing codon usage for Cysteine
1. Hollow bars indicate TGC; shaded bars indicate TGT. Bootstrap values are shown at











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.S5. Phylogenetic tree for the O1 superfamily, showing codon usage for Cysteine
2. Hollow bars indicate TGC; shaded bars indicate TGT. Bootstrap values are shown at











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.S6. Phylogenetic tree for the O1 superfamily, showing codon usage for Cysteine
3. Hollow bars indicate TGC; shaded bars indicate TGT. Bootstrap values are shown at











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.S7. Phylogenetic tree for the O1 superfamily, showing codon usage for Cysteine
4. Hollow bars indicate TGC; shaded bars indicate TGT. Bootstrap values are shown at











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.S8. Phylogenetic tree for the O1 superfamily, showing codon usage for Cysteine
5. Hollow bars indicate TGC; shaded bars indicate TGT. Bootstrap values are shown at











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.S9. Phylogenetic tree for the O1 superfamily, showing codon usage for Cysteine
6. Hollow bars indicate TGC; shaded bars indicate TGT. Bootstrap values are shown at
each branching point. GenBank Accession numbers and species of origin are indicated for
each sequence.
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5.2.4 Sequences Used for Analysis
5.2.4.1 ω-Conotoxin Sequences
We used published sequences of ω-conotoxins for these analyses. The GenBank accession
numbers for these sequences are shown in Table 5.S5 (349 total sequences).
5.2.4.2 δ-Conotoxin Sequences
We used published sequences of δ-conotoxins for these analyses. The GenBank accession
numbers for these sequences are shown in Table 5.S6 (262 total sequences).
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Table 5.S5. GenBank accession numbers of all sequences of ω-conotoxins used in this
study. This table continues on the following page.
GenBank Accession Numbers of ω-Conotoxin Sequences Analyzed
DQ141146.1 DQ141149.4 AF090041.1 AF090042.1 AF090043.1 AF090044.1
AF090045.1 AF090046.1 AF090047.1 AF090048.1 AF090050.1 AF090051.1
AF090052.1 AF090054.1 AF090073.1 DQ644547.1 EF108269.1 EF108272.1
AF090055.1 AF090056.1 AF090057.1 AF090058.1 AF090059.1 AF090060.1
AF090061.1 AF090063.1 AF090064.1 AF090065.1 AF090066.1 AF090067.1
AF090068.1 AF090069.1 AF090071.1 AF090072.1 DQ644546.1 EU423370.1
EU423371.1 EU423372.1 EU423373.1 EU423374.1 EU423375.1 EU423376.1
EU423377.1 EU423378.1 EU423379.1 EU423380.1 EU423381.1 EU423382.1
EU423383.1 AF215040.1 AF215041.1 AF215042.1 DJ379450.1 AF089971.1
AF089972.1 AF089973.1 AF089974.1 AF089975.1 AF089976.1 AF089977.1
AF089978.1 AF089979.1 AF089980.1 AF089981.1 AF089982.1 AF089983.1
AF089984.1 AF089985.1 AF089986.1 AF089987.1 AF089988.1 AF089989.1
AF089990.1 AF089991.1 AF089992.1 AF089993.1 AF089995.1 AF089996.1
AF089997.1 AF089998.1 AF089999.1 AF090000.1 AF090001.1 AF090002.1
AF090003.1 AF090004.1 AF090005.1 AF090006.1 AF090007.1 AF090008.1
AF090009.1 AF090010.1 AF090011.1 AF090012.1 AF090013.1 AF090014.1
AF090015.1 AF090016.1 AF090017.1 AF090018.1 AF090019.1 AF090020.1
AF090021.1 AF090022.1 AF090023.1 AF090024.1 AF090025.1 AF090026.1
AF090027.1 AF090028.1 AF090029.1 AF090030.1 AF090031.1 AF090032.1
AF090033.1 AF090035.1 AF090036.1 AF090037.1 AF090038.1 AF090039.1
AF090053.1 AF090049.1 AF174268.1 AF174269.1 AF174271.1 AF174272.1
AF174273.1 AF174274.1 AF174275.1 AF174276.1 AF174277.1 AF174278.1
AF174279.1 AF174280.1 AF174281.1 AF174282.1 AF174283.1 AF174284.1
AF174285.1 AF174286.1 AF174287.1 FJ613506.1 FJ613512.1 FJ613513.1
FJ613517.1 FJ716817.1 FJ716824.1 FJ804530.1 FJ804531.1 FJ804532.1
FJ804533.1 FJ804534.1 FJ804535.1 FJ804536.1 FJ834437.1 AF090074.1
AF090075.1 AF090076.1 AF090077.1 AF090078.1 AF090079.1 AF090080.1
DQ644543.1 DQ644544.1 DQ644545.1 DQ644548.1 DQ644549.1 EF108267.1
EF108268.1 EF108270.1 EF108271.1 EF108273.1 EF108274.1 EF108275.1
EF108276.1 EF108277.1 EF108278.1 EF108279.1 EF108280.1 EF108281.1
EF108282.1 EF108283.1 EF108284.1 EF108285.1 EF108286.1 EF108287.1
AF132130.1 AF215060.1 AF215057.1 DD012749.1 DD012687.1 DD012688.1
DD012685.1 DD012686.1 DD012689.1 DD012778.1 DD012779.1 DD012780.1
DQ141148.1 DQ345369.1 AJ851170.1 AF146349.1 AJ851172.1 DD012762.1
DD012714.1 AF174214.1 AF174215.1 AF174216.1 AF174217.1 AF174218.1
AF174219.1 AF174220.1 AF174221.1 AF174222.1 AF174223.1 AF174224.1
AF174225.1 AF174226.1 AF174227.1 AF174228.1 AF174229.1 AF174230.1
AF174231.1 AF174232.1 AF174233.1 AF174235.1 AF174236.1 AF174237.1
AF174238.1 AF174239.1 AF174240.1 AF174241.1 AF174242.1 AF174243.1
AF174244.1 AF174245.1 AF174246.1 AF174247.1 AF174248.1 AJ851175.1
AF146350.1 DD012769.1 DD012696.1 DD012700.1 DD012775.1 DD012711.1
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Table 5.S5, continued . Continued from previous page. GenBank accession numbers of
all sequences of ω-conotoxins used in this study.
GenBank Accession Numbers of ω-Conotoxin Sequences Analyzed
DD012719.1 DJ379574.1 DD012709.1 AF480312.1 DD012713.1 AF174267.1
DD012697.1 AF146348.1 AF146346.1 DD012710.1 DD012751.1 M84612.1
FJ959111.1 DD012715.1 DD012741.1 DD012745.1 DD012746.1 DD012764.1
DD012767.1 DD012726.1 DD012699.1 DD012701.1 DD012776.1 DD012708.1
DD012755.1 DD012759.1 DD012773.1 DD012716.1 DD012718.1 DD012724.1
DD012725.1 DD012781.1 BD241823.1 DD012772.1 DD012771.1 DD012774.1
DD012750.1 DD012722.1 DD012752.1 AF480313.1 AF480314.1 AF480315.1
AY236862.1 AY236863.1 AF174249.1 AF174250.1 AF174251.1 AF174252.1
DD012760.1 DD012720.1 DD012698.1 AJ851171.1 DD012712.1 DD012742.1
DD012777.1 DD012736.1 DD012717.1 DD012765.1 DD012761.1 EF467318.1
DD012733.1 DD012734.1 DD012735.1 DQ345370.1 DD012753.1 DD012754.1
AF174253.1 AF174254.1 AF174255.1 AF174256.1 AF174257.1 AF174258.1
AF174259.1 AF174260.1 AF174262.1 AF174263.1 AJ851173.1 DD012768.1
AF146347.1 AF174264.1 AF146360.1 AF146361.1 AF174265.1 AF174266.1
AF215043.1 AF215044.1 AF215045.1 AF215056.1 AF215058.1 DD012690.1
DD012691.1 DD012702.1 DD012684.1 AF215059.1 DD012721.1 DD012756.1
DD012757.1 DD012758.1 AF548000.1 DQ141151.1 DQ141169.1 DQ141173.1
DD012744.1
Table 5.S6. GenBank accession numbers of all sequences of δ-conotoxins used in this study.
This table continues on the following page.
GenBank Accession Numbers of δ-Conotoxin Sequences Analyzed
AF089901.1 AF089902.1 AF089903.1 AF089904.1 AF089905.1 AF089906.1
AF089907.1 AF089908.1 AF089910.1 AF089911.1 AF089912.1 AF089913.1
AF089914.1 AF089915.1 AF089916.1 AF089917.1 AF089918.1 AF089919.1
AF089920.1 AF089921.1 AF089922.1 AF089923.1 AF089924.1 AF089925.1
AF089926.1 AF089927.1 AF089928.1 AF089929.1 AF089930.1 AF089931.1
AF089932.1 AF089933.1 AF089934.1 AF089935.1 AF089936.1 AF089937.1
AF089938.1 AF089939.1 AF089940.1 AF089941.1 AF089942.1 AF089943.1
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Table 5.S6, continued . Continued from previous page. GenBank accession numbers of
all sequences of δ-conotoxins used in this study.
GenBank Accession Numbers of δ-Conotoxin Sequences Analyzed
AF089944.1 AF089945.1 AF089946.1 AF089947.1 AF089948.1 AF089949.1
AF089950.1 AF089951.1 AF089952.1 AF089953.1 AF089954.1 AF089955.1
AF089956.1 AF089957.1 AF089958.1 AF089959.1 AF089960.1 AF089961.1
AF089962.1 AF089963.1 AF089964.1 AF089965.1 AF089966.1 AF089967.1
AF089968.1 AF089969.1 AF089970.1 AF215054.1 EF467317.1 AJ851177.1
AJ851178.1 AJ851179.1 AJ851180.1 AJ851181.1 AJ851182.1 AJ851183.1
DQ141147.1 DQ345368.1 DQ141179.1 AF215051.1 AF215052.1 AF215046.1
AF215047.1 AF215048.1 AF215049.1 AF215050.1 AF215053.1 DQ141150.1
DQ141171.1 DQ141168.1 DQ141167.1 AJ851184.1 AF215055.1 DQ141174.1
DQ345371.1 DQ345372.1 HQ897690.1 DQ141170.1 AY151285.1 DQ141172.1
EF108288.1 AF215061.1 AF193254.1 AF146357.1 AF193255.1 AF193268.1
AF193269.1 DQ141166.1 DQ141177.1 AY316159.1 AY316160.1 AF193270.1
AF193271.1 DJ379427.1 DJ379425.1 DJ379448.1 DJ379475.1 DJ379447.1
DJ379424.1 DJ379426.1 DJ379452.1 AF146355.1 AF146356.1 DJ379449.1
DJ379451.1 AF146351.1 AF146354.1 AF193259.1 AF193272.1 AF146359.1
AF193260.1 AF193261.1 AF193263.1 AF193264.1 AF193265.1 AF193266.1
AF193267.1 AF215033.1 AF215034.1 AF215035.1 AF193256.1 AJ851190.1
AF193257.1 BD280191.1 AF215039.1 AJ851174.1 AJ851176.1 AJ851185.1
AJ851186.1 AJ851187.1 AJ851188.1 AJ851189.1 DJ379400.1 DJ379437.1
DJ379444.1 DJ379453.1 DJ379454.1 DJ379455.1 DJ379456.1 DQ141175.1
DJ379483.1 DJ379484.1 DJ379488.1 DJ379493.1 DJ379489.1 DJ379492.1
DJ379571.1 DQ141160.1 DQ141178.1 DQ512803.1 JF322901.1 JF322917.1
JF322918.1 JF322919.1 JF322920.1 S78990.1 X53283.1 X53284.1
X53285.1 DJ379432.1 DJ379419.1 DJ379394.1 DJ379404.1 DJ379405.1
DJ379498.1 DJ379442.1 DJ379443.1 BD280184.1 DJ379502.1 DJ379501.1
DJ379395.1 DJ379406.1 DJ379393.1 DJ379407.1 DJ379438.1 DJ379494.1
AF215106.1 AF215038.1 EF467316.1 EF467319.1 DJ379396.1 DJ379397.1
DJ379385.1 DJ379487.1 DJ379420.1 DJ379421.1 DJ379422.1 DJ379423.1
DJ379478.1 DJ379491.1 DJ379434.1 DJ379392.1 DJ379399.1 DJ379435.1
DJ379436.1 DJ379568.1 DJ379479.1 DJ379401.1 DJ379402.1 DJ379403.1
DJ379388.1 DJ379439.1 DJ379408.1 DJ379409.1 DJ379410.1 DJ379411.1
DJ379433.1 DJ379570.1 DJ379441.1 DJ379440.1 DJ379500.1 DJ379572.1
DJ379573.1 DJ379485.1 DJ379391.1 DJ379486.1 BD280183.1 BD280187.1
AF215032.1 AF132129.1 DJ379482.1 BD280190.1 DQ141182.1 DJ379398.1
AF146358.1 AF193262.1 DJ379495.1 DJ379457.1 AF193258.1 DJ379480.1
DJ379481.1 DQ141162.1 AF215036.1 AF215037.1 DJ379499.1 DJ379569.1
DJ379477.1 DJ379389.1 DJ379390.1 DJ379387.1
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APPENDIX A
DERIVATION OF THE NUMBER OF
POSSIBLE DISULFIDE ISOMERS
To derive the number of possible disulfide isomers (assuming that the maximum number
of possible disulfide bridges are present in the final product), we will take an arbitrary
peptide containing n cysteine residues. The intended goal will be to show that the number
of possible disulfide isomers, p, can be expressed as the product of all odd numbers from 1
to n, arriving at the final formula
p(n) = n!! =
n!




which is also given in the text as Eq. 1.1 (except here, p is stated explicitly as a function
of n, where this was implicit in the form given in Eq. 1.1).
The derivation will focus on chemical interpretations, rather than using the most
straightforward mathematical explanation. The derivation will be divided into two parts,
comprising the two sub-cases of having an even or odd total number of cysteine residues.
The general approach will be a slight twist on proof by induction, solving first the trivial
cases, then showing for odd values of n, p(n) = n ·p(n−1), and for even values of n, p(n) =
p(n− 1), with the resultant expression that for odd n, p(n) = n · p(n− 2) = n · (n− 2) · ...1.
This is equivalent to showing that p(n) = n!!.
A.1 Trivial Cases
For n = 1, there are no possible disulfides to form, since each disulfide requires two
cysteine residues. Consequently, there is 1 possible “disulfide isomer.”
For n = 2, there is only one possible disulfide; consequently, there is 1 possible disulfide
isomer.
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A.2 Odd Values of n
If n is odd, then any disulfide isomer containing a maximum number of disulfides must
contain one cysteine residue that is not part of a disulfide bond. Since there are n total
cysteines, there are thus n possible choices for the cysteine that is not disulfide-bonded.
For the remaining n − 1 cysteines, there are p(n − 1) possible disulfide isomers (by
definition).
Thus, for odd values of n, the number of possible disulfide isomers, p(n) is given by
p(n) = n · p(n− 1)
A.3 Even Values of n
Intuitively, adding one more cysteine to a peptide with an odd number of cysteines will
not change the number of possible disulfides because the free cysteine now has a disulfide
bonding partner.
To show this more rigorously, I will seek to show that for n even, p(n) = p(n − 1). I
will use proof by contradiction to show this, disproving first that p(n) < p(n − 1), then
disproving p(n) > p(n − 1). Since p(n) is neither greater nor less than p(n − 1), we can
deduce that p(n) = p(n− 1).
A.3.1 Case 1
Assume p(n) < p(n− 1). This would mean that there is a disulfide isomer that can be
formed with n − 1 cysteines that cannot be formed by n cysteines. However, since all our
cysteines are being treated as equivalent, any disulfide isomer that can be formed by n− 1
cysteines could also be formed by n cysteines. Contradiction.
A.3.2 Case 2
Assume p(n) > p(n − 1). This would mean that there is at least one disulfide isomer
that can be formed by n cysteines which cannot be formed by n − 1 cysteines. Because n
is even, and we are assuming the maximum number of disulfide bonds present, there are no
free thiols.
Consider one such disulfide isomer that can be formed by n cysteines, but cannot be
formed by n− 1 cysteines. Removing one cysteine from this system would break a disulfide
bond, resulting in one free cysteine. By our assumption, this disulfide isomer is not in the
set of disulfide isomers for n − 1 cysteines. However, the set of disulfide isomers for n − 1
cysteines is complete, by definition (with p(n− 1) members). Contradiction.
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A.4 Tying Together
Having shown that for odd values of n, p(n) = n · p(n− 1), and that for even values of
n, p(n) = p(n− 1), we can thus deduce:
1. For odd values of n, p(n) = n · p(n− 2).
2. For even values of n, p(n) = p(n− 1).
Combining these together, we get that for any n, p(n) is given by the product of all odd
numbers between 1 and n. Thus, p(n) = n!!.
To show equivalence to the other statement (p(n) = n!bn
2
c!·2bn2 c ), the cases of n being even
and odd will be considered separately again.









bmc! · 2bmc =
(2m)!
m! · 2m
And since m! · 2m is equivalent to the product of the even numbers between 2 and 2m,
we can simply factor these out from (2m)!, giving (2m)!!, or n!!.
For odd values of n, the floor functions are critical. Since n is odd, there is some r such
that n = 2r + 1. Thus,
p(2r + 1) =
(2r + 1)!











c = (2r + 1) ·
(2r)!
r! · 2r
Thus, applying the same principles as for the case of n being even, it follows that (2r)!r!·2r is
equivalent to the product of all odd numbers between 1 and 2r, so (2r+1)· (2r)!r!·2r is equivalent
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Background: Conotoxins can be utilized to investigate enzyme-assisted folding of disulfide-rich peptides.
Results: Various ER-resident cone snail enzymes act in concert to accelerate the oxidative folding of conotoxins and modulate
their conformation by reconfiguring disulfide connectivities.
Conclusion: The folding of conotoxins is a tightly regulated multienzyme-assisted process.
Significance:Modulation of the conformation of conotoxins increases their molecular and functional diversity.
The oxidative folding of large polypeptides has been investi-
gated in detail; however, comparatively little is known about
the enzyme-assisted folding of small, disulfide-containing pep-
tide substrates. To investigate the concerted effect of multiple
enzymes on the folding of small disulfide-rich peptides, we
sequenced and expressed protein-disulfide isomerase (PDI),
peptidyl-prolyl cis-trans isomerase, and immunoglobulin-bind-
ing protein (BiP) from Conus venom glands. Conus PDI was
shown to catalyze theoxidation and reductionof disulfidebonds
in two conotoxins,-GI and-ImI.Oxidative folding rateswere
further increased in the presence of Conus PPI with the maxi-
mum effect observed in the presence of both enzymes. In con-
trast, Conus BiP was only observed to assist folding in the pres-
ence of microsomes, suggesting that additional co-factors were
involved. The identification of a complex between BiP, PDI, and
nascent conotoxins further suggests that the folding and assem-
bly of conotoxins is a highly regulated multienzyme-assisted
process. Unexpectedly, all three enzymes contributed to the
folding of the ribbon isomer of -ImI. Here, we identify this
alternative disulfide-linked species in the venomofConus impe-
rialis, providing the first evidence for the existence of a “non-
native” peptide isomer in the venom of cone snails. Thus, ER-
resident enzymes act in concert to accelerate the oxidative
folding of conotoxins and modulate their conformation and
function by reconfiguring disulfide connectivities. This study
has evaluated the role of a number of ER-resident enzymes in the
folding of conotoxins, providing novel insights into the enzyme-
guided assembly of these small, disulfide-rich peptides.
During synthesis on the ribosome, the nascent polypeptide
chain enters the crowded environment of the ER,2 where it
engages in a variety of intra- and intermolecular interactions.
The newly synthesized protein associates with a number of ER-
resident chaperones and foldases that accelerate rate-limiting
steps along the folding pathway. The three enzymes that have
repeatedly been implicated in the folding of protein substrates
in the ER are protein-disulfide isomerase (PDI), peptidyl-prolyl
cis-trans isomerase (PPI), and immunoglobulin-binding pro-
tein (BiP).
Polypeptides containing one or more disulfides in their
native state are likely to become substrates for PDI, the enzyme
that catalyzes the oxidation, isomerization, and reduction of
disulfide bonds. PDI contains four thioredoxin-like domains,
two of which have the catalytic CXXC motif (1). The thiol-
disulfide redox state of the catalytic sites determines the direc-
tion of the reaction. Conversion of the disulfide site to a dithiol
leads to oxidation of a substrate protein, whereas the alteration
from a dithiol to a disulfide results in reduction of the substrate
(2). Isomerization occurs either directly or through cycles of
reduction and reoxidation (3). To date, 19 members of the PDI
family have been identified in humans that significantly differ in
their primary amino acid sequence, domain organization, cat-
alytic activity, or mass (4, 5).
In addition to disulfide bond formation, the cis-trans isomer-
ization of peptidyl-prolyl bonds can impede folding of proline-
containing proteins. Peptide bonds to proline are synthesized in
the trans conformation. Although the majority of these bonds
remain in trans, some peptidyl-prolyl bonds need to undergo
trans-cis isomerization. The enzyme that catalyzes this other-
* This work was supported, in whole or in part, by National Institutes of
Health, NIGMS, Program Project GM48677. This work was also supported
by Australian Research Council Grant DP110101331.
1 A National Health and Medical Research Council of Australia Senior
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2 The abbreviations used are: ER, endoplasmic reticulum; PDI, protein-disul-
fide isomerase; PPI, peptidyl-prolyl cis-trans isomerase; BiP, immunoglobu-
lin-binding protein; IP, immunoprecipitation; ACN, acetonitrile; RP-HPLC,
reversed-phase HPLC; ESI, electrospray ionization; Fmoc, N-(9-fluorenyl)me-
thoxycarbonyl; BN, blue native; BisTris, 2-[bis(2-hydroxyethyl)amino]-2-(hy-
droxymethyl)propane-1,3-diol; Tricine,N-[2-hydroxy-1,1-bis(hydroxymethyl)-
ethyl]glycine.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 41, pp. 34288–34303, October 5, 2012
© 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
34288 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 41•OCTOBER 5, 2012
 at UNIV O
F UTAH on O










wise slow reaction is PPI, a ubiquitous protein that is present in
almost all cellular compartments (6). In mammalian cells, a
number of ER-resident PPIs have been identified, including PPI
B. Interestingly, in addition to accelerating folding rates via
isomerization of peptide bonds to proline, PPI was also shown
to improve the efficiency of PDI-mediated folding of ribonucle-
ase T1 by providing partially folded protein chains with the
correct proline isomers (7). Similarly, oxidative folding rates of
maurotoxin, a disulfide-rich peptide from scorpion venom,
were highest in the presence of PDI and FKBP-12, a PPI isoform
located in the cytosol (8).
Another enzyme known to cooperate with PDI in the folding
of disulfide-containing proteins is BiP, a member of the heat
shock protein 70 (Hsp70) family. BiP binds to unfolded and
partially misfolded proteins upon their entry into the lumen of
the ER and limits protein misfolding and aggregation. It is also
a key enzyme in the retrograde transport of misfolded proteins
from the ER to the proteasome (9). In recent years, a number of
studies have addressed the potential cooperative folding of dis-
ulfide-containing proteins by PDI and BiP. Investigations into
the folding of antibody chains revealed that both enzymes
cooperatively act in the refolding of Fab fragments in vitro (10).
It has been suggested that BiP binds the unfolded polypeptide
chains and keeps them in a conformation in which the cysteine
residues are accessible for PDI (10). Immunoprecipitation
experiments further revealed that PDIA6, a member of the PDI
family, forms a non-covalent complexwith BiP and shows spec-
ificity toward BiP client proteins in human fibroblast cells (11).
Subsequently, the in vitro interaction between another PDI
family member, PDIA3, and BiP was shown to improve folding
rates of ribonuclease B and -lactalbumin (12).
Together, these findings indicate that members of the PDI
family can recruit or are themselves recruited by other ER-res-
ident enzymes and chaperones, such as BiP and/or PPI B, to
cooperatively act in the oxidative folding of at least some client
substrates. Recently, an ER-resident complex comprising PDI,
PPI B, and BiP was identified in human hepatoma and mouse
lymphoma cells (13), reflecting tightly regulated compartmen-
talization of protein folding in the ER.
Although our understanding of enzyme-guided folding of
proteins is constantly improving, comparatively little is known
about the folding and assembly of small, disulfide-rich peptides.
Disulfide-rich peptides are widely distributed in the plant and
animal kingdoms,where they serve diverse functions. Examples
include antimicrobial peptides, such as the defensins; various
protease inhibitors; hormones, including insulin; and a wide
range of neurotoxins found in animal venoms (Table 1). Pred-
atory marine snails of the genus Conus synthesize a great
diversity of disulfide-rich peptides that often carry additional
post-translational modifications, most commonly proline
hydroxylations, -carboxylations, and C-terminal amidations
(14). The diversity of peptides generated by cone snails is aston-
ishing. Each of the 500–700 species of cone snail is estimated to
synthesize hundreds of different peptideswith distinct disulfide
connectivities (15). With their vast structural diversity, cono-
toxins can therefore be regarded as model disulfide-rich pep-
tides for understanding general mechanisms of peptide folding,
including the formation of correct disulfide bonds.
The concerted effect of PDI, PPI, and BiP on the folding of
these and other disulfide-rich peptides has not been systemat-
ically explored. Although PDI and PPI have been identified in
the venom gland of Conus (16) and are known to play a role in
the in vitro folding of conotoxins (17, 18), their combined effect
has not been investigated. We recently sequenced Conus BiP
from the venom gland of Conus novaehollandiae and demon-
strated it to be highly expressed in the venom glandular cells
(16).Whether BiP plays a functional role in the folding of cono-
toxins was not addressed in our earlier study. To investigate
TABLE 1
Diversity of disulfide-rich peptides and enzymes implicated in their biosynthesis
* C-terminal amidation, O hydroxyproline, prolines and hydroxyprolines are highlighted in gray, cysteine residues are shown in boldface type.
# Findings were based on kinetic modeling.
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multienzyme-assisted folding of conotoxins, we cloned and
expressed PDI, PPI B, and BiP from C. novaehollandiae and
tested their potential in assisting in the oxidative folding of
-conotoxins GI and ImI. Here, we show that all three enzymes
play a role in the oxidative folding of these two peptides and, in
the case of PDI, also in the unfolding of disulfide bonds under
reducing conditions. Importantly, a direct interaction between
PDI and conotoxin-GI was confirmed by affinity purification.
We further reveal the presence of a complex between PDI and
BiP, suggesting a concerted action of these enzymes, similar to
what has been observed for the folding of larger proteins. Our
findings indicate that the proper assembly of conotoxins relies
upon the action of a number of ER-resident enzymes, including
PDI, PPI B, and BiP. Importantly, these enzymes appear to
modulate the disulfide isomers of conotoxins, a process that not
only generates additional conformational diversity but also has
the potential to enhance the functional diversity of these
molecules.
EXPERIMENTAL PROCEDURES
Depending on the experimental requirements, a number of
different cone snail species were utilized in this study. Conus
PPI B andBiPwere previously sequenced from the venomgland
of C. novaehollandiae. Consequently, C. novaehollandiae was
selected formolecular sequencing of PDI. Conotoxin-ImIwas
originally isolated from the venom of Conus imperialis. Inves-
tigations into the presence of different isoforms of -ImI were
carried out on the venom of this species. Investigations of pro-
tein complexes were performed on the venom gland of Conus
victoriae. This species has a particularly large venom gland,
allowing the isolation of sufficient material. Conotoxin -GI
was originally isolated from the venom of Conus geographus.
Co-immunoprecipitation (co-IP) experiments using the biotin-
labeled propeptide of -GI were performed on venom glands
from this species.
Specimen Collection and Tissue Preparation—Specimens of
C. novaehollandiae and C. victoriae were collected from
Broome,Western Australia. Live animals were shipped toMel-
bourne, Australia, and processed within 24 h of collection.
Venom ducts were extracted, snap-frozen and stored at
80 °C. Specimens ofC. imperialis andC. geographuswere col-
lected from Marinduque Island, the Philippines. Venom ducts
were prepared as described above. Prior to freezing, venomwas
extruded from isolated venom ducts of C. imperialis, air-dried,
and stored at80 °C.
Venom Extraction and Analysis—Twenty mg of dried
C. imperialis venom was reconstituted in 1 ml of 40% acetoni-
trile (ACN), 0.1% trifluoroacetic acid (TFA) and homogenized
using a Dounce tissue grinder. Insoluble material was pelleted
by centrifugation at 12,000 g for 10min. The supernatant was
collected, dried by vacuumcentrifugation, and stored at80 °C
until processing. Four mg of crude venom was separated by
reversed-phase high performance liquid chromatography (RP-
HPLC) on a semipreparative C18 column (5-m particle size,
10  250 mm, Vydac-Grace) using a linear gradient from 5 to
100% buffer B (90% ACN, 0.1% TFA) over 80 min. Peaks were
manually collected and further analyzed by electrospray ioniza-
tion tandem mass spectrometry (ESI-MS/MS) and matrix-as-
sisted laser desorption ionization mass spectrometry (MALDI-
MS). For ESI-MS/MS, samples were analyzed using a high
resolution linear ion trap mass spectrometer (LTQ XL
Orbitrap, Thermo Scientific). For MALDI-MS, peptides were
spotted ontomatrix-coatedMALDI plates and analyzed using a
MALDI-time of flight (TOF) mass spectrometer in positive
reflector mode (Voyager, AB SCIEX).
Preparation of Rat Liver Microsomal Proteins—Microsomal
proteins were prepared as described previously (19). Briefly, 20
mg of frozen rat liver tissue was homogenized in 20 ml of ice-
cold homogenization buffer (10mMTris, 150mMNaCl, pH 7.5,
1protease inhibitormixture (RocheApplied Science)) using a
Dounce tissue grinder. Cellular debris was removed by centrif-
ugation at 12,000  g for 15 min. Membranous material con-
taining microsomes was pelleted by ultracentrifugation at
100,000  g for 1 h. Following ultracentrifugation, pellets
were washed twice with homogenization buffer. Closed ves-
icles were converted to open membranes to release micro-
somal proteins by incubating with ice-cold 0.1 M sodium
carbonate buffer (pH 11) for 20 min. Membranous material
was removed by ultracentrifugation as described above. The
pH of the supernatant was adjusted to 7.5 with 2 N HCl solu-
tion. Microsomal protein preparations were examined by
SDS-PAGE, and protein concentrations were determined
using Bradford reagent (Sigma-Aldrich). Protein-bound and
free sulfhydryl groups were determined spectrophotometri-
cally using Ellman’s reagent (5,5-dithiobis(2-nitrobenzoic
acid)) as described previously (20).
Molecular Sequencing—We previously obtained full-length
sequences of PPI B and BiP from the venom gland of C. novae-
hollandiae (accession numbers GU046312 and HM627497,
respectively). In order to sequence Conus PDI, frozen venom
glands from C. novaehollandiae were ground under liquid
nitrogen, and total RNA was extracted using TRIzol reagent
(Invitrogen) and DNase I treated with Turbo DNase (Ambion
Inc). RNA extraction and DNase treatment were performed
according to the manufacturers’ instructions. cDNA was
reverse transcribed from 1 g of DNase-treated RNA using the
Superscript VILO cDNA synthesis kit (Invitrogen) with a 1:1
mixture of oligo(dT)s and random hexamers. Primary reverse
transcription PCR (RT-PCR) was performed in volumes of 50
l containing 4 l of cDNA (200 ng), 0.5 l of Velocity Taq
DNA polymerase (Bioline), 1 PCR buffer (Bioline), 200 M
each deoxynucleoside triphosphate (dNTPs; Invitrogen), and
0.2 M PDI sense (CGACCATATGGATGATATCAAACA
GGA GGA A) and antisense oligonucleotide primers (CGC
TCG AGC AGT TCA TCT CTT GGC AGA TC). PCR ampli-
cons were analyzed by gel electrophoresis, cloned, and
sequenced as described previously (17). The novel Conus PDI
sequence was deposited in GenBankTM (National Center for
Biotechnology Information, United States National Library of
Medicine, Bethesda, MD). Nucleotide sequences were trans-
lated into the predicted amino acid residues, and the putative
signal peptide was predicted using SignalP software (21).
Cloning, Expression, and Purification of Recombinant
Enzymes—ConusPPI Bwas expressed and purified as described
previously (17). Conus PDI and BiP lacking the N-terminal sig-
nal sequences were cloned into the pET22b and pET30c
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expression vector, respectively (Novagen). Briefly, transcripts
were PCR-amplified from venom gland cDNA prepared as
described above and ligated into pET22b using the NdeI (5)
andXhoI (3) restriction sites and into pET30cwith the endo-
nucleases NdeI (5) and HindIII (3) (New England Biolabs).
Sequences were verified by nucleotide sequencing. The con-
structs, containing a C-terminal His6 tag, were transformed
into Escherichia coli (Rosetta strain, Novagen) by heat treat-
ment. For expression of recombinant proteins, LB broth con-
taining antibiotics (100 g/ml ampicillin for pET22b and 50
g/ml kanamycin for pET30c) was inoculated with overnight
cultures and incubated at 37 °C with shaking until the A600
spectrophotometric reading was 0.6. Expression was induced
by adding 0.1 mM isopropyl--D-thiogalactopyranoside fol-
lowed by incubation for 3 h at 25 °Cwith shaking. Bacteria were
harvested and resuspended in native lysis buffer (50 mM
NaH2PO4, 300 mM NaCl, and 10 mM imidazole, pH 8.0) con-
taining 1 protease inhibitor mixture (EDTA-free; Roche
Applied Science). Bacterial cells were lysed by probe tip sonica-
tion. Cellular debris and insoluble protein were pelleted by cen-
trifugation at 15,000 g for 20 min, and the supernatants were
used for subsequent protein purifications.
Recombinant proteins were purified on a 1-ml immobilized
metal affinity column under native conditions (Bio-Scale Mini
Profinity IMAC cartridge, Bio-Rad). Purification was per-
formed using the Bio-Rad Profinia protein purification system.
Protein lysates were loaded onto the column at 0.5ml/min, and
nonspecifically bound proteins were removed with native
buffer (300 mM KCl, 50 mM KH2PO4, pH 8.0) containing 5 mM
imidazole at 2ml/min for 6min, followedby a secondwashwith
native buffer containing 15mM imidazole for 5min. His-tagged
proteins were eluted with 250 mM imidazole in native buffer at
1 ml/min for 4 min. Further purification and buffer exchange
into 10mMTris-HCl, 150mMNaCl, pH 8, was accomplished by
size exclusion chromatography (Superdex 200, HiLoad 16/60,
GEHealthcare) at 1ml/min.Thepurified recombinant proteins
were analyzed by SDS-PAGE and sequence-verified by in-gel
digestion and analysis of proteotypic tryptic peptides as
described previously (17). Protein concentrations were deter-
mined spectrophotometrically using the proteins’ molar
absorption coefficients (22).
Functional Enzyme Analyses—The insulin reduction assay
was performed using a modification of the insulin turbidity
assay described previously (23). Briefly, recombinant PDI (0.5
and2.5Mfinal concentration)was incubatedwith2mMdithio-
threitol (DTT) for 15minprior to adding the assaymixture (100
mM potassium phosphate, 2 mM EDTA, 2 mM DTT, and 0.85
mg/ml insulin, pH 6.5). The absorbance at 650 nm was mea-
sured for 1 h at 30 °C.
The peptidyl-prolyl cis-trans isomerase activity of recombi-
nant PPI B was determined using the coupled chymotrypsin
assay (24) with modifications as described previously (17).
Briefly, 0.3 or 3 M PPI B was incubated in 100 mM Tris-HCl,
pH 8, at 25 °C for 2min. Samples were transferred to 10 °C for 5
min before the addition of 30 l of 600 mM chymotrypsin
(Sigma-Aldrich). After 5min at 10 °C, reactions were initialized
by adding the substrate N-succinyl-Ala-Ala-Pro-Phe-p-nitroa-
nilide at a final concentration of 78 M (Bachem AG; stock
made in trifluoroethanol in the presence of 0.45 M LiCl (Sigma-
Aldrich)). The cis-trans isomerization wasmeasured by follow-
ing the absorbance at 390 nM for 3 min.
The ATPase activity of recombinant BiP was verified using a
modification of the NADH-coupled photometric assay described
previously (25). The assay relies on the hydrolysis of ATP to ADP
bytheATPaseactivityofBiP.UponATPhydrolysis, phosphoenol-
pyruvate is converted to pyruvate by pyruvate kinase, followed by
further conversion into lactate by lactate dehydrogenase. The lat-
ter reaction requires oxidationofNADH, resulting in adecrease in
absorbance at 340 nm. Briefly, reaction buffer containing 30 mM
Tris (pH 7.6), 30 mM KCl, 5 mM MgCl2, 0.15 mM NADH, 4 mM
phosphoenolpyruvate, 25 g/ml lactate dehydrogenase, and 25
g/ml pyruvate kinasewas incubated at 25 °C for 10min. For con-
trol reactions, ADP was added to a final concentration of 10 mM,
andNADHdepletionwasmonitored at 340nm.Todetermine the
ATPase activity of BiP, ATPwas added to a final concentration of
10 mM. After base-line stabilization, BiP was added at a final con-
centration of 2.5 and 5M, and the absorbancewasmonitored for
35min at 25 °C.
Peptide Synthesis—Based on their well characterized folding
properties, the two -conotoxins GI and ImI were selected for
oxidative folding studies. Conotoxin -ImI was obtained from
the peptide synthesis core facility at the University of Utah.
Conotoxin -GI was synthesized with an Apex 396 automated
peptide synthesizer (AAPPTec) using a standard solid-phase
Fmoc protocol. The peptide was constructed on preloaded
Fmoc-Rink Amide MBHA resin (substitution, 0.4 mmol/g;
Peptides International Inc.) on a 50-mol scale. All amino acids
were purchased form AAPPTec, and side-chain protection for
the following amino acidswas as follows:Glu,O-tert-butyl; Arg,
2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl; Tyr and
Ser, tert-butyl; Asn, Cys, andHis, trityl. Coupling activationwas
achievedwith 1 eq of 0.4Mbenzotriazol-1-yl-oxytripyrrolidino-
phosphonium hexafluorophosphate and 2 eq of 2 M N,N-diiso-
propylethyl amine inN-methyl-2-pyrrolidone as the solvent. A
10-fold excess of each amino acid was used, and each coupling
reaction was conducted for 60 min. The Fmoc deprotection
reaction was carried out for 20minwith 20% piperidine in dim-
ethylfluoride. Peptides were cleaved from the resin by treat-
ment with reagent K (TFA/thioanisole/ethanedithiol/water/
phenol (82.5:5:2.5:5:5 by volume)) for 3 h and 3.5 h for-GI and
-ImI, respectively. The peptides were subsequently filtered,
precipitated, andwashedwith coldmethyl tert-butyl ether. Lin-
ear peptides were purified by RP-HPLC on a semipreparative
C18 column (5-m particle size, 10  250 mm, Vydac-Grace)
using a linear gradient from 5 to 40% buffer B (90% ACN, 0.1%
TFA) over 20 min. Buffer A was 0.1% TFA, water. Absorbance
was monitored at 220 nm. Concentrations were determined
spectrophotometrically using the peptides’ molar absorption
coefficient at 280 nm. For co-elution experiments, correctly
folded -GI and -ImI were obtained from the peptide synthe-
sis facility at the Salk Institute.
The biotin-labeled propeptide of -conotoxin GI (pro-GI;
biotin-FPSERASDGRDDTAKDEGSDMEKLVEKKECCNPA-
CGRHYSC-NH2) was synthesized as described previously (26)
with the exception that the peptide was C-terminally tagged
with biotin followed by 6-aminohexanoic acid (GL Biochem)
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and not oxidized prior to purification. The biotin-labeled con-
trol peptide (biotin-YARFQSQTTLKQKT) was purchased
from the peptide synthesis facility at Monash University.
Oxidative Folding Studies—Oxidative folding reactions were
carried out at room temperature in the presence of 0.1 M Tris-
HCl (pH 7.5), 1 mMMgCl2, 10 mM ATP, 0.1 mM GSSG, 0.1 mM
GSH, 3MPPI B and/or 1MPDI and/or 2MBiP. Because the
exact concentrations of PDI, PPI B, and BiP in the ER are not
known, the enzyme/substrate ratios were chosen to be in agree-
ment with previous studies (7, 8). Folding was initiated by add-
ing the linear peptide at a final concentration of 20M.Aliquots
were taken at various time points, and reactions were quenched
by acidification with formic acid to a final concentration of 8%.
Folding reactions were analyzed by RP-HPLC on a C18 column
(5-m particle size, 4.6  250 mm, Vydac-Grace) using the
conditions described above. For samples spiked with rat liver
microsomal proteins, separation was performed on a diphenyl
column (5-mparticle size, 4.6 250mm,Vydac-Grace) using
the same conditions. Native peptides were distinguished from
linear forms based on characteristic elution profiles (27–29),
co-elution experiments, and mass spectrometric (MS) analyses
of manually collected reversed-phase fractions (MALDI-TOF
mass spectrometer, positive reflector mode, Voyager, AB
SCIEX). Statistical analyses were performed using two-tailed
Student’s t tests with unequal variance.
Conotoxin Reductase Assay—For reductase assays, 1 M PDI
was preincubated in reductase buffer (0.1 M Tris-HCl, 1 mM
MgCl2, 10 mM ATP, 5 mM GSH, pH 7.5) for 1 h at room tem-
perature. Peptide reduction was initiated by adding the folded
peptide at a final concentration of 20 M. Quenching and anal-
ysis were performed as described above.
Blue Native PAGE—Blue Native (BN)-PAGE techniques
were adapted from those described previously (30). Briefly, fro-
zen venom glands from C. victoriae were homogenized in ice-
cold buffer (20 mM Tris-HCl, 50 mM NaCl, 10% glycerol, 1 mM
PMSF, pH 7.5, containing 1 protease inhibitormixture) using
a Dounce tissue grinder. Cellular debris was removed by cen-
trifugation at 6,000 g for 8 min at 4 °C. The supernatant was
collected and ultracentrifuged at 100,000 g for 1 h at 4 °C to
separate soluble proteins frommembranousmaterial. Superna-
tants and pellets were collected, and proteins were solubilized
by adding between 1 and 3% of digitonin or CHAPS followed by
incubation for 20min on ice. An aliquot of the soluble andmem-
branous protein sample was mixed with 5 BN-PAGE loading
buffer (5%CoomassieBrilliantBlueG-250, 500mM(E)-aminocap-
roic acid in 100 mM BisTris, pH 7) and loaded onto NuPAGE
Native 4–16% gels (Invitrogen) along with an in-housemolecular
weight marker (kindly provided by Srgjan Civciristov). Samples
were separated in the presence of blue cathode buffer (50mMTri-
cine, 15mMBisTris, 0.02%Coomassie Brilliant Blue G-250, pH 7)
and anode buffer (50mMBisTris, pH7) for 50min at 150Von ice.
The blue cathode buffer was then replaced with cathode buffer
withoutCoomassie dye, andelectrophoresiswas completed at 200
V.Gelswereeither stainedwithCoomassieBlue followedby in-gel
tryptic digest or seconddimensionSDS-PAGEor further analyzed
by immunoblotting.
For second dimension SDS-PAGE, gel bands were excised
and soaked in 1% SDS and 1%mercaptoethanol for 2 h followed
by two washes in water. Gel bands were placed into wells on
12% NuPAGE BisTris gels (Invitrogen). Gels were run for 20
min at 100 V followed by 40 min at 200 V. Following SDS-
PAGE, gels were either stained with Coomassie Blue or ana-
lyzed by in-gel tryptic digest or immunoblotting.
Immunoblotting—Proteins were transferred from gels onto
polyvinylidene fluoride (PVDF) membranes and blocked with
5% skim milk in phosphate-buffered saline, 0.05% Tween 20
(PBS-T) followed by immunoblotting. Primary antibodies were
rabbit polyclonal anti-BiP antibody raised against a synthetic pep-
tide sequence derived fromhumanBiP (anti-GRP78BiP antibody,
ab21685, Abcam) and rabbit polyclonal anti-PDI antibody raised
against recombinant rat liver PDI (courtesy of Prof. M. Hubbard);
The secondary antibody was sheep anti-rabbit, HRP-conjugated
(Abcam). Incubations were carried out at room temperature for
1 h. Antibody stocks were diluted 1:2,000 in 2.5% skim milk,
PBS-T. Detection was performed with ECL reagent (PerkinElmer
Life Sciences). For immunoblotting following BN-PAGE, gels
were briefly soaked in transfer buffer containing 0.1%SDSprior to
transfer onto PVDFmembranes. After transfer, membranes were
washed inmethanol for 3min to remove residual Coomassie dye.
For reprobing,membraneswerewashed 5min inPBS-T, followed
by incubation in 62 mM Tris-HCl, 100 mM mercaptoethanol, 2%
SDS, pH 6.8, for 30 min at 70 °C. Membranes were washed three
times for 10 min each in PBS-T, and immunoblotting was per-
formed as described above.
Co-immunoprecipitation and Affinity Pull-down Studies—
Co-IP assays were performed using either a polyclonal anti-PDI
or anti-BiP antibody or a biotin-labeled propeptide of the
-conotoxin GI. Briefly, venom glands were homogenized in
1% digitonin in Tris-buffered saline (TBS; 100mMTris, 150mM
NaCl, pH 7.5) containing 1 protease inhibitor mixture by
Dounce homogenization followed by incubation on ice for 30
min. Cellular debris was removed by centrifugation at 12,000
g for 20min, and supernatantswere preclearedwith either 70l
of Protein A-Sepharose pre-equilibrated in lysis buffer, Mab-
Select, GEHealthcare) or 70l of streptavidin-agarose (Sigma-
Aldrich) for 1 h at 4 °C with mixing. Precleared supernatants
were incubated with 40 l of anti-PDI- or anti-BiP-conjugated
Protein A-Sepharose slurry or pro-GI-conjugated biotin/
streptavidin-agarose for 1 h at 4 °C with mixing. Non-immu-
nized rabbit serum (Sigma-Aldrich) and a random biotin-labeled
control peptide (YARF) were used to establish nonspecific bind-
ing. Following incubation, beads were washed six times with 0.1%
digitonin inTBScontaining1protease inhibitormixture.Bound
proteins were eluted by incubating with Laemmli sample buffer
with andwithout 100mMDTT for 10min at 100 °C. Proteinswere
analyzed by SDS-PAGE followed by in-gel tryptic digest or immu-
noblotting as described above.
In-gel Digestion and Protein Identification—In-gel digestion
was performed as described previously (31) with minor modi-
fications. Briefly, gel spots were excised, washed in 50% ACN,
triethylammoniumbicarbonate, and reducedwith 20mMDTT,
followed by alkylation in 100 mM iodoacetamide. In-gel diges-
tion was performed using sequencing grade trypsin (Sigma-Al-
drich) at a final concentration of 10 g/ml in 25 mM triethyl-
ammonium bicarbonate. Peptides extracted after overnight
digestions were separated on a C18 reversed-phase column
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sions 75 m  100 mm, SGE Analytical Sciences) and analyzed
using a Hybrid Quadrupole-TOF LC-MS/MSmass spectrometer
(QSTAR Elite, AB SCIEX). Acquired data were analyzed using
Analyst QS software (version 2.0, AB SCIEX). MS/MS data were
searched against an in-house database that contained all mollus-
canproteins submitted toUniProt (n47,252)usingProteinPilot
software (version 3.0, AB SCIEX) with the following selections:
iodoacetamide, trypsin gel-based identification, biologicalmodifi-
cations, thorough ID.The falsediscovery rate cut-offwas set to5%.
Peptides with confidence scores of99 were selected for protein
identifications.
RESULTS
cDNA Sequencing of PDI—Conus PDI was successfully
sequenced from the venom gland of C. novaehollandiae.
MatureC. novaehollandiae PDI is encoded by 1449 nucleotides
translating to a putative protein of 54,682 Da (GenBankTM
accession number JQ745296). The predicted protein is most
homologous to PDI sequenced from Conus virgo (92% amino
acid sequence identity, 97% homology, GenBankTM accession
number ADZ76590) and shares 61% sequence identity (77%
homology) with the human homologue (GenBankTM accession
numberNP_000909).C. novaehollandiae PDI exhibits the clas-
sical PDI domain organization with two catalytic a and a
domains and the non-catalytic b and b domains. The active site
motif is -CGHC- in both catalytic domains.
Characterization of Recombinant Proteins—All three
enzymes were expressed without their N-terminal signal
sequence and purified to90% purity bymetal affinity and size
exclusion chromatography (Fig. 1). The identity of recombi-
nant proteins was confirmed by in-gel tryptic digestion of SDS-
polyacrylamide gel bands (data not shown). Functional integrity
was validated by enzyme-specific activity assays (Fig. 1). To assess
enzymatic activity of Conus PDI, the insulin turbidity assay was
performed. In the absence of PDI, insulin was slowly reduced by
DTT,asobservedbyan increase inabsorbanceat650nm(Fig. 1A).
The addition of PDI led to a substantial increase of insulin reduc-
tion, confirming that the active site cysteines efficiently unfolded
the disulfide bonds of insulin (Fig. 1A).
Enzymatic activity of PPI Bwas tested using the coupled chy-
motrypsin assay. In the absence of enzyme, the peptidyl-prolyl
bond of the oligopeptide N-succinyl-Ala-Ala-Pro-Phe-p-ni-
troanilide slowly underwent cis to trans isomerization, result-
ing in proteolytic cleavage by chymotrypsin. Accumulation of
liberated p-nitroanilide led to an increase in absorbance at 390
nm (Fig. 1B). This reaction was accelerated in the presence of
Conus PPI B, confirming the cis-trans isomerization activity of
the recombinant enzyme (Fig. 1B).
To determine the ATPase activity of BiP, the NADH depletion
assay was employed (25). In the absence of BiP, the addition of
ADP led to a rapid depletion ofNADH, verifying the functionality
of theassay (Fig. 1C,blackarrows). In thepresenceofBiPandATP,
NADH was depleted via BiP-catalyzed ATP hydrolysis over the
time course of the experiment, whereas depletion was not
observed in the no enzyme control (Fig. 1C).
Enzyme-assisted Oxidative Folding Studies—To investigate
the role ofConus PDI, PPI B, and BiP in the folding of disulfide-
rich peptides, the two -conotoxins GI and ImI were tested as
folding substrates (Fig. 2). Peptides were selected based on their
well characterized in vitro oxidative folding properties (27–29).
All -conotoxins contain 4 cysteine residues that can poten-
tially adopt three disulfide conformations (Fig. 2). The Cys1-3
and Cys2-4 disulfide pairing has been confirmed for a number
of -conotoxins and is generally referred to as the native, glob-
ular fold. Although the three-dimensional conformation and
bioactivity of the other two isomers, the ribbon and the bead
form (Cys1-4 plus Cys2-3 and Cys1-2 plus Cys3-4, respec-
tively), have been studied in detail, these isoforms have not been
found in the venom (28, 32).
Conotoxins -GI and -ImI are 13 and 12 amino acids in
length, respectively. Both peptides are C-terminally amidated
and contain one proline. In -GI, the proline is in position 5,
and the Asn4–Pro5 bond most likely adopts a trans configura-
tion (32). This peptide belongs to the 3/5 subfamily of -cono-
toxinswith 3 residues between the first and second cysteine and
5 amino acids between the third and fourth. While sharing the
characteristic disulfide pattern with GI, conotoxin ImI belongs
to the 4/3 subgroup of the -conotoxins with 4 and 3 residues
between the first and second set of cysteines, respectively (Fig.
2). ImI contains one proline in position 6, and the Asp5–Pro6
bond has a trans orientation (33).
All reversed-phase elution profiles of oxidative folding reac-
tions concurred with those previously reported for these two
peptides (27–29), and the molecular masses of the collected
peaks agreed with the calculated masses as determined by
MALDI-TOFMS analysis (data not shown). Identities of linear
and native peptides were further confirmed by co-elution
experiments using commercially purchased peptides as a refer-
ence (data not shown). Oxidative folding reactions were
quenched by acidification. Previous studies have reported insuffi-
cient quenching by acidification of enzyme-assisted folding reac-
tions in some cases (34). To ensure efficient termination of the
reaction, replicate samples were analyzed in random order within
12 h following folding assays. No differences were observed
between replicate samples run between 1 and 12 h following acid-
ification, indicating efficient termination of the folding assay.
Effect of PDI on the Folding of -GI and -ImI—All oxidative
folding reactions were carried out in 0.1 M Tris-HCl (pH 7.5), 1
mMMgCl2, 10mMATP, 0.1mMGSH, and 0.1mMGSSG.Under
these conditions, steady state accumulation of native -GI
occurred after 64 min (Fig. 3A) with a final yield of 63.2% 
2.0 (mean  S.D.). The addition of PDI did not affect final
folding yields but significantly increased folding rates (Fig. 3A).
This effect was most apparent between 8 and 32 min of folding
(Fig. 3A). The effect of PDI on the folding of-GI was abolished
when PDI was inactivated by denaturation for 20 min at 95 °C
prior to the folding assay (data not shown).
Conotoxin -ImI exhibited faster folding kinetics with
steady state conditions reached after 16 min (Fig. 3, B and
C). Unlike -GI, this peptide folds into two distinct isomers
in vitro, the globular and the ribbon form, with almost equal
yields at steady state conditions (Fig. 3, B and C). Interest-
ingly, PDI had little effect on the folding rates of globular
-ImI (Fig. 3B) but significantly increased the folding rates
of the ribbon isomer (Fig. 3C).
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In addition to its oxidation and isomerization activity, PDI is
known to catalyze the reduction of disulfide bonds (4). To
assess its reductase activity on-GI and-ImI, reductase assays
were carried out in the presence of 5mMGSHwith andwithout
PDI. The addition of PDI significantly accelerated unfolding
rates of -GI with a 6-fold decrease in the half-time of disap-
pearance of the folded form when PDI was present (Fig. 3D). A
similar effect, although less distinct, was observed for the rib-
FIGURE 1. Purity and integrity of recombinant Conus enzymes as determined by SDS-PAGE and enzyme-specific activity assays. The purity of recom-
binant enzymes was determined by SDS-PAGE (right panels). A total of 3 g of recombinant protein was separated on 12% Tris-glycine gels under reducing
conditions. Proteinswere visualized by Coomassie staining.A, PDI activitywasmeasured using the insulin reductase assay. The addition of PDI (0.5 and 2.5M)
caused rapid reduction of insulin, as observed by an increase in absorbance at 650 nm. This effect was concentration-dependent. B, the cis-trans isomerase
activity of PPI B was measured using the coupled chymotrypsin assay. The addition of PPI B (0.3 or 3 M) resulted in an increase in the rate of cis-trans
isomerizationof theoligopeptideN-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, a substrate of chymotrypsin (mean S.D.). Enzymatic cleavage leads to liberation
of p-nitroanilide and an increase in absorbance at 390 nm. This reactionwas concentration-dependent. C, the ATPase activity of BiP was determined using the
NADH-coupled photometric assay. Hydrolysis of ATPwas followed bymonitoring depletion of NADH at 340 nm. The addition of ADP led to a sudden decrease
in absorbance, confirming the functionality of the assay. In the presence of BiP (2.5 and 5M), absorbance slowly decreased over the time course of the assay,
whereas no effect was observed for the no enzyme control. This effect was concentration-dependent.
FIGURE 2. Amino acid sequences and possible disulfide connectivities of
-conotoxins used in this study. Cysteine residues are highlighted in gray.
Both peptides are C-terminally amidated. Potential disulfide linkages of the
three isomers, the globular, ribbon, and bead form, are depicted.
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bon isomer of -ImI (Fig. 3F). The addition of PDI led to a
2-fold decrease in the half-time of the disappearance of this
peptide. Unfolding kinetics of the globular form remained
unchanged (Fig. 3E).
Effects of PDI and PPI B—To elucidate the effect of PDI in
combination with PPI B, folding assays were carried out as
described above in the presence of Conus PDI, PPI B, or both
PDI and PPI B. The fastest folding rates for -GI were observed
in the presence of both PDI and PPI B, although both enzymes
individually afforded a rate increase over the uncatalyzed reac-
tion (Fig. 4). At 16 min, accumulation of the native peptide
increased from 28.0  0.33 to 32.0  0.57% (p  0.01) and
42.6 1.35% (p 0.01) in the presence of PPI B or PDI, respec-
tively (Fig. 4 and Table 2). This further increased to 48.2 
0.25% in the presence of both enzymes.
PDI and PPI B significantly increased the folding rates of the
ribbon form of-ImI (Fig. 5,B andC, and Table 2) but had little
effect on the appearance of the globular form (Fig. 5A). Again,
the fastest folding rateswere achievedwhen both enzymeswere
present. At 4 min, accumulation of ribbon -ImI increased
from 11.5  0.28% to 15.6  0.29% (p  0.001) and 22.8 
1.18% (p 0.001) in the presence of PPI B and PDI, respectively
(Fig. 5, B and C, and Table 2). This further increased to 31.1
0.18% (p 0.001) when both enzymes were present. The addi-
tion of PDI and PPI B significantly affected the folding rates of
-GI and ribbon-ImI but did not alter their final folding yields
(Figs. 4A and 5B and Table 2). Enzyme-mediated changes in
folding rates were abolished when PDI and PPI B were heat-
inactivated for 20 min at 95 °C prior to folding assays (data not
shown).
Effects of PDI and BiP—To investigate the effect of PDI in
combinationwith BiP, oxidative folding assays were carried out
in the presence of Conus PDI, BiP, or both PDI and BiP. Conus
BiP alone did not exhibit any apparent effect on the oxidative
folding rates of -GI and -ImI under various enzyme concen-
trations and redox conditions tested. Although PDImaintained
the ability to accelerate folding rates of -GI and the ribbon
isomer of -ImI, no additional effect was observed when BiP
was added (data not shown). To investigate whether recombi-
nant BiP required additional co-factors for proper action, fold-
ing reactions were supplemented with rat microsomal extracts.
Changes in the accumulation of folded peptides were deter-
FIGURE 3. Analysis of PDI-assisted folding and reduction of -GI and -ImI. A–C, oxidative folding was carried out in the presence of 0.1 mM GSH, 0.1 mM
GSSG, and 20M linear peptide with and without Conus 1M PDI. D–F, peptide reduction studies were performed in the presence of 5 mM GSH, 20M folded
peptide with and without Conus PDI. Folding and reduction reactions were terminated by acid quenching and analyzed by reversed-phase chromatography
(C18 column, Vydac-Grace). Relative abundances of fully folded globular -GI (A and D), globular -ImI (B and E), and ribbon -ImI (C and F) were determined
from three independent experiments (mean S.D. (error bars)).
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mined at early time points of folding. Reactions were quenched
at 4 and 8min for-ImI and-GI, respectively. The addition of
microsomal proteins alone led to an increase in the accumula-
tion of folded -GI (13.1  0.19% versus 5.8  0.16% without
microsomes) and more rapid disappearance of the linear form
after 8 min of folding (Fig. 6A), indicating the presence of fol-
dases and/or chaperones in these preparations. This effect was
only slightly reduced when microsomal proteins were heat-
treated prior to folding (10.4  0.07%), suggesting incomplete
denaturing or renaturing of foldases and chaperones or the
presence of non-protein co-factors. In the presence of micro-
somal proteins, the addition of PDI or BiP led to a significant
increase in the accumulation of folded -GI (28.7  0.62 and
18.9 0.3%, respectively (p 0.001); Fig. 6A). Foldingwasmost
efficient when both enzymes were present in the same reaction
(32.2  0.27% (p  0.05); Fig. 6A). For -ImI, the addition of
microsomal extracts alone had little effect on the accumulation
of fully folded peptide but affected the disappearance of the
linear form (Fig. 6B). However, the addition of PDI or BiP led to
a significant increase in the accumulation of the folded ribbon
isomer (20.1  1.28 and 24.6  0.75%, respectively, versus
10.9  0.48% without enzyme (p  0.01); Fig. 6B). This effect
was further enhanced when both enzymes were present in the
same reaction (30.1 0.98% (p 0.01); Fig. 6B). Interestingly,
accumulation of the globular form was affected to a lesser
extent. Although PDI and BiP individually increased the accu-
mulation of the globular form (28.4  0.89 and 28.8  1.37%,
respectively, versus 17.8  0.60% without enzyme (p  0.01);
Fig. 6B), no additive effect was observed in the presence of both
enzymes (28.5 0.71%; Fig. 6B).
Gel electrophoresis of microsomal extracts revealed a com-
plex mixture of proteins characteristic of these preparations
(Fig. 6C). To determine the concentration of protein-bound
and free sulfhydryl groups that could potentially affect PDI-
mediated thiol-disulfide exchange reactions, microsomal
extracts were analyzed using Ellman’s reagent. The concentra-
tion of protein-bound thiols was 67  1.4 M, and that of free
sulfhydryl groups was below the detection limit of the assay
(15 M).
In summary, all three recombinant enzymes affected the oxi-
dative folding kinetics of -GI and the ribbon isomer of -ImI,
a disulfide species believed to be absent from the venom. Fold-
ing rates of globular, so-called native -ImI remained
unchanged. These observations led us to subsequently investi-
gate the presence of the ribbon isomer of-ImI in the venomof
C. imperialis.
Detection of-ImI Isomers in the Venom of C. imperialis—To
determine the presence of different isomers of -ImI in the
venom of C. imperialis, reversed-phase elution profiles of syn-
thetic ribbon and globular -ImI were compared with those of
the crude venom. Using a linear gradient from 5 to 100% buffer
B (90% ACN, 0.1% TFA) over 80 min, the synthetic ribbon and
globular isomers eluted at 28.1 min (23.8% ACN) and 29.5 min
(25.3%ACN), respectively (Fig. 7,A andB, yellow line). Analysis
of the venom of C. imperialis revealed the presence of two cor-
responding peaks (Fig. 7, A and B, green line). Both peaks
strongly increased in size upon the addition of synthetic pep-
tides (Fig. 7,A and B, blue line), suggesting the presence of both
isomers in the crude venom. The two corresponding venom
fractions were collected and subjected to MALDI-MS analysis.
Peptides with identical masses to folded -ImI were identified
in both peaks (m/z 1351.5; Fig. 7, C andD), whereas no mass
matches were observed in interjacent fractions (data not
shown). To further verify the presence of the two isomers in the
venom, venom fractions were subjected to ESI-MS/MS analy-
sis. Comparison of the venom peptides with their co-eluting
synthetic analogues revealed the presence of two characteristic
fragment ions only present in the co-eluting synthetic and
venom-derived globular isomer (m/z 668.3 and 1099.3; data
not shown). The absence of these peaks in both the synthetic
and venom-derived co-eluting ribbon fractions strongly sug-
gests a different disulfide connectivity of these two isobaric
peptides. Collectively, reversed-phase chromatography and
mass spectrometric analysis led to the identification of the rib-
bon isomer in the venom of C. imperialis and confirmed the
presence of its globular form.Toour knowledge, this represents
the first evidence for the existence of a “non-native” peptide
isoform in the venom of Conus.
Investigation of Protein Associations in the VenomGlandular
Cells—Our findings on enzyme-assisted folding and unfolding
of conotoxins strongly indicate that their proper assembly is a
multienzyme-assisted process. To determine whether PDI, PPI
B, and BiP form a complex in the ER of the secretory cells of the
venom gland, BN-PAGE and co-IP experiments were per-
formed on the venom gland of C. victoriae. Soluble complexes
were separated from membrane-associated ones by ultracen-
FIGURE 4.Analysis of PDI- and PPI-assisted folding of-GI.Oxidative fold-
ing studies were performed in the presence of 0.1mMGSH, 0.1mMGSSG, and
20 M linear peptide with and without Conus PDI and/or PPI. Folding reac-
tions were acid-quenched at 0, 4, 8, 16, 32, and 64 min and analyzed by
reversed-phase chromatography. A, relative abundance of the fully folded,
globular peptide was determined by reversed-phase chromatography as
shown in B and plotted against time points of folding. Plotted values are
averages from three independent experiments (mean  S.D. (error bars)).
B, reversed-phase chromatograms of folding reactions quenched after 16
min. White circles denote the folded, globular peptide as determined by its
characteristic elution profile (27, 29) and co-elution experiments.
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trifugation. Initial experiments showed that the best solubiliza-
tion of protein complexes was achieved with 1% digitonin for
soluble and 2% CHAPS for membrane preparations. Under
these conditions, a complex with immunopositive staining for
BiP and PDI was identified in both protein preparations (Fig.
8A, black arrows). To further verify the identity of BiP and PDI,
bands were excised from BN-polyacrylamide gels (Fig. 8A, box
Bi and Bii) and subjected to either in-gel tryptic digest com-
bined withmass spectrometric identification or second dimen-
sion denaturing SDS-PAGE followed by immunoblotting. Both
techniques confirmed the presence of PDI and BiP in the solu-
ble and membrane protein preparations (Fig. 8, B and E). The
soluble complex appeared smaller (200–300 kDa) and may
have separated from the larger, membrane-bound complex
(300–400 kDa) during protein preparation (Fig. 8A). Interest-
ingly, besides the 55-kDa PDI protein, an additional PDI iso-
form of 120 kDa was observed in the soluble fraction (Fig.
8Bi). This 120-kDa protein is unlikely to represent a dimer of
PDI because BN-polyacrylamide gel slices were incubated in
denaturing buffer under strongly reducing conditions prior to
second dimension electrophoresis (30 min in 2% SDS and 100
mM mercaptoethanol). A faint band of120 kDa was also vis-
ible in the membrane fraction (Fig. 8Bii), with the main PDI
isoformmigrating at90 kDa. In a previous study (16), immu-
noblotting of two-dimensional gels revealed the presence of
largermolecular weight isoforms of PDI in the venom glands of
C. victoriae and C. novaehollandiae. Whether the 90 kDa band
represents a different PDI isoform remains to be determined
because proteins excised from BN-PAGE can exhibit deviating
migration patterns due to the presence of encasing BN gel mat-
rices.3 Seconddimension SDS-PAGE illustrated the presence of
additional proteins of unknown identity, particularly for the
membrane complex (Fig. 8,Bi andBii). Bands corresponding to
the size of PPI B (20 kDa) and Hsp40 (40 kDa) were
observed. Unfortunately, due to low protein concentrations
and/or a lack of sequence homology to published protein
sequences, mass spectrometry could not resolve the identity of
these species. Furthermore, immunoblotting using an anti-PPI
B antibody was unsuccessful because commercial polyclonal
antibodies raised against human PPI B did not cross-react with
the Conus enzyme. Future studies using antibodies raised
againstConus PPI Bwill determine whether PPI B forms part of
the BiP-PDI complex.
3 H. Safavi-Hemami, unpublished observations.
TABLE 2
Foldingyieldsofglobular-GI andglobular and ribbon-ImIobtainedatearly and late timepointsof folding in thepresenceandabsenceofPDI
and/or PPI B
Values represent mean S.D. calculated from three independent experiments.
Peptide Time point
Percentage of folded peptide
No enzyme PDI PPI PDI PPI
min % % % %
Globular -GI 16 28.0 0.33 42.6 1.35 32.0 0.57 48.2 0.25
64 (end point) 63.2 1.98 64.2 0.18 62.3 0.26 66.8 1.94
Globular -ImI 4 35.4 0.72 35.3 0.93 38.8 1.43 35.0 0.47
16 (end point) 43.5 0.17 43.9 0.19 40.3 0.6 43.2 1.94
Ribbon -ImI 4 11.5 0.28 22.8 1.18 15.6 0.29 31.1 0.18
16 (end point) 45.6 2.0 45.12 0.19 44.2 0.6 45.3 1.94
FIGURE 5.Analysis of PDI- and PPI-assisted folding of-ImI.Oxidative folding studies were performed in the presence of 0.1mMGSH, 0.1mMGSSG, and 20
M linear peptidewith andwithout Conus PDI and/or PPI B. Folding reactions were acid-quenched at 0, 2, 4, 8, 16, and 32min and analyzed by reversed-phase
chromatography. Relative abundances of the fully foldedglobular (A) and fully folded ribbonpeptide (B)weredeterminedby reversed-phase chromatography
as shown in C and plotted against time points of folding. Plotted values are averages from three independent experiments (mean  S.D. (error bars)).
C, reversed-phase chromatogramsof folding reactions quenched after 4min.White circlesdenote the foldedglobular peptide, andgray circles show the ribbon
isomer, as determined by their characteristic elution profiles (28) and co-elution experiments.
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Because proteins that co-migrate on BN-polyacrylamide gels
do not necessarily interact, co-IP experiments were performed
to confirm the direct association betweenPDI andBiP. Initial IP
approaches using the polyclonal anti-PDI antibody did not
result in efficient immunoprecipitation of PDI, rendering this
antibody unsuitable for co-IP experiments. However, the inter-
action between PDI and BiP was successfully confirmed using
the anti-BiP-specific antibody (Fig. 8C). Co-immunoprecipi-
tated proteins were separated by SDS-PAGE alongside whole
lysates under reducing and non-reducing conditions (Fig. 8C).
A band that was subsequently identified as Conus BiP was
observed in co-IP samples, illustrating that the BiP antibody
was suitable for IP experiments (Fig. 8Ci, bands 1 and 3). A very
faint band corresponding to the molecular weight of PDI could
also be observed in BiP co-IP lanes but not in non-immunized
rabbit serum controls (Fig. 8Ci, bands 2 and 4). In-gel tryptic
digestion unambiguously identified this protein as Conus PDI
(Fig. 8E). A number of additional gel bands were observed in
BiP co-IP lanes. However, these proteins could not be identified
by in-gel tryptic digest. The identity of the PDI protein band
was further confirmed by immunopositive staining of co-IP
samples using the anti-PDI antibody (Fig. 8Cii, black arrow).
Immunostaining of this bandwas also observed inwhole lysates
but not in the serum control (Fig. 8Cii). Both anti-PDI and
anti-BiP were raised in rabbits, resulting in high background
staining. To rule out the possibility that PDI staining resulted
from the secondary anti-rabbit antibody, membranes were
stripped and reblotted using secondary antibody only. PDI-as-
sociated staining could not be observed in BiP co-IP lanes.
Together, in-gel tryptic digest and immunoblotting of BiP co-IP
samples confirmed the association between PDI and BiP in the
venom glandular cells of C. victoriae.
In Vitro Interaction between Conus PDI and Conotoxin -GI—
Several studies have proposed PDI-assisted folding of conotox-
ins (18, 27, 35–37). However, a direct interaction between PDI
and conotoxins has never been demonstrated. To determine
whether PDI directly interacts with a conotoxin in vitro, the
biotin-labeled propeptide of -GI was incubated with whole
venomgland lysates ofC. geographus and subsequently affinity-
purified using streptavidin beads. Affinity-purified proteins
were analyzed by SDS-PAGE under reducing conditions (Fig.
8Di). A number of proteins specifically associated with pro-GI
but not with the random YARF control peptide (Fig. 8Di).
Bands were excised and subjected to in-gel tryptic digest and
mass spectrometric analysis. Due to a lack of Conus protein
sequences represented in public databases, only a limited num-
ber of proteins could be identified. One of these proteins was
Conus PDI (Fig. 8, Di (white arrow) and E). PDI was associated
with pro-GI but not YARF (Fig. 8Di). Immunoblotting using
anti-PDI antibody further confirmed that PDI was successfully
affinity-purified with biotin-pro-GI but not biotin-YARF (Fig.
8Cii, white arrow).
DISCUSSION
The Conus venom gland can be regarded as one of the most
sophisticated organs of disulfide-rich peptide biosynthesis. At
any given time, hundreds of biologically diverse and structur-
ally complex peptides are expressed, translated, folded, and
secreted in the epithelial cells of this highly specialized organ. It
is now well understood that the folding and assembly of larger
polypeptides is guided by the action of a number of different
foldases and chaperones. Enzymes known to cooperate in the
folding of protein substrates include various members of the
PDI family; heat shock proteins, such as Hsp90 and BiP; PPI-
like enzymes; and lectins, such as calreticulin and calnexin (38).
Although our understanding of these events is steadily improv-
ing, comparably little is known about the contribution of these
enzymes to the assembly of small peptides, especially those
comprising multiple disulfide bonds. Given the diversity of
peptides generated by cone snails, we believe that conotoxins
can serve as model peptides for understanding general mecha-
nisms of peptide folding. In this study, we investigated the con-
tribution of a number of enzymes to the folding of the two
-conotoxins GI and ImI. Our findings suggest that, similar to
the assembly of larger polypeptide substrates, the proper fold-
ing of conotoxins is a multienzyme-assisted process.
FIGURE6.A andB, analysis of PDI andBiP-assisted foldingof-GI (A) and-ImI
(B) in the presence of rat livermicrosomal proteins. Foldingwas carried out in
the presence of 40 g of microsomal proteins, 0.1 mM GSH, 0.1 mM GSSG, 1
mMMgCl2, 10 mM ATP, and 20 M linear peptide with and without Conus PDI
and/or BiP. Folding reactionswere acid-quenched at 8 and 4min for-GI and
-ImI, respectively, and analyzed by reversed-phase chromatography. Plot-
ted values are averages from three independent experiments (mean  S.D.
(error bars)). Statistical analysis was performed using two-tailed Student’s t
testswith unequal variance (*, p 0.05; **, p 0.001).C, microsomal proteins
were analyzed by SDS-PAGE. A total of 20 g was separated on a 12% Tris-
glycine gel under reducing conditions.
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Three enzymes were selected based on their well established
roles in the folding of protein substrates and their high expres-
sion levels in the venom gland of Conus. We showed that all
three enzymes, PDI, PPI B, and BiP, efficiently assist in the
oxidative folding of -GI and -ImI. PDI represents one of the
most abundant soluble proteins in the venom gland of several
cone snail species (16, 37) and has previously been shown to
improve in vitro folding rates of conotoxin substrates (18). We
confirm this finding and further demonstrate the ability of PDI
to efficiently unfold disulfide bonds in conotoxins under reduc-
ing conditions. The role of this enzyme in oxidative protein
folding is well established. In contrast, in vivo PDI-mediated
protein unfolding has only been demonstrated for cholera
toxin. PDI catalyzes the reduction of the A subunit of this pro-
tein, which enables its retrograde transport into the cytosol
(39). Whether the PDI-assisted unfolding of conotoxins
observed in vitro here also plays a role in vivo remains to be
determined.
PDI has been repeatedly implicated in the oxidative folding
of conotoxins (18, 36), but a direct interaction has never been
demonstrated. Here, we provide evidence for the direct inter-
action between PDI and the -conotoxin GI by affinity purifi-
cation, ultimately establishing the role of this enzyme in the
folding of conotoxins. Furthermore, by investigating different
folding isomers of-ImI, we reveal a substrate selectivity of PDI
for the ribbon isomer, which was previously believed to be
absent from the venom (28, 32). Similar observations were
made for the folding of the ribbon isomer in the presence of
ConusPPI B. Both enzymes significantly accelerated the folding
of ribbon -ImI, a peptide isomer with otherwise slow cysteine
oxidation rates. These observations suggest that both disulfide
bond formation and isomerization of the peptide bond to pro-
FIGURE 7. Analysis of -ImI isomers in the venom of C. imperialis. A, overlay of reversed-phase chromatograms of crude C. imperialis venom (green; 4 mg)
with the ribbon and globular isomer of ImI (orange; 2 nmol each) and crude venom spiked with 6 nmol of each ImI isomer (blue). Samples were separated on
a semipreparativeC18column (5-mparticle size, 10250mm,Vydac-Grace) usinga lineargradient from5 to100%buffer B (90%ACN, 0.1%TFA)over 80min.
B, enlargement of reversed-phase chromatogram depicted in A. Venom fractions co-eluting with ribbon (C) and globular ImI (D) were collected and subjected
toMALDI-MS. Synthetic isomers were analyzed for comparison. MALDI-MS analysis shows the presence of peptides with the samemass/charge ratio as ImI in
venom fractions that co-eluted with the ribbon (C) and globular (D) peptide (m/z 1351.5).
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line are rate-limiting steps in the folding of this isomer. The
three-dimensional structure of the ribbon isomer is unknown.
However, PPI-assisted folding of ribbon-ImI suggests that the
Asp5–Pro6 bond has a cis orientation or transiently adopts this
conformation during folding. For the globular form, the Asp5–
Pro6 bond adopts a trans orientation (33) that most likely does
not undergo transient trans-cis isomerization during folding.
Previous studies have predominantly focused on the pharma-
cological properties of globular, so-called native conotoxin iso-
mers. The few published studies on receptor selectivity of dif-
ferent -conotoxin isomers all demonstrated a shift in target
affinity upon disulfide rearrangement (40–42). For example,
the ribbon isomer of -Vc1.1 is a weaker antagonist of the
bovine nicotinic receptor than the globular peptide (42). In
contrast, the ribbon form of AuIB has significantly higher
potency at rat nicotinic receptors than the globular peptide
(40). These observations together with our findings of ribbon
-ImI in the venom of C. imperialis suggest that cone snails
synthesize a variety of different disulfide isomers in order to
extend their repertoire of biologically active neuropeptides.We
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show that whereas the globular isomer of -ImI rapidly folds
under oxidizing conditions, the in vitro folding of the ribbon
form is guided by ER-resident foldases.
Folding studies on -GI and -ImI carried out in the pres-
ence of both enzymes showed an additive rather than a syner-
gistic effect, suggesting that these two enzymes act independ-
ently in the folding of the two peptides. Consequently, PPI B is
unlikely to present conotoxins containing the correct proline
isomer to PDI as previously suggested for ribonuclease T1 (7).
Investigations on the concerted folding by PDI and BiP resulted
in similar observations. An additive rather than a synergistic
effect was observed when PDI and BiP were simultaneously
present in folding reactions supplemented with microsomal
extracts. BiP does not directly contribute to disulfide-exchange
reactions (38). Instead, it may have promoted faster folding by
preventing aggregation and/or increasing the solubility of the
toxins and/or of PDI (9, 38). The BiP-mediated increase in fold-
ing rates was abolished when microsomal proteins were omit-
ted, strongly suggesting that this enzyme requires one or more
ER-resident co-factors. Free thiols present inmicrosomal prep-
arations are unlikely to have contributed to faster folding rates
because their concentration was very low. Macromolecular
crowding is another factor that is known to contribute to alter-
ations in rates and equilibria of protein interactions. However,
the total protein concentrations used in this study were too low
to have caused crowding (43). It is now well understood that
members of the Hsp70 family interact with a variety of Hsp40
co-chaperones. Themajor function of Hsp40 is to stimulate the
otherwise weak ATPase activity of BiP by increasing the rate of
hydrolysis of boundATP (44).Microsomal extracts are likely to
have contained ER-resident Hsp40 co-chaperones that could
have contributed to BiP-assisted folding of conotoxins. Because
endogenous ATP was not depleted from microsomal prepara-
tions, no conclusions can be drawn on the ATP dependence of
this reaction.
Although PDI- and BiP-assisted folding did not appear to be
synergistic for -GI and -ImI, this could be the case for cono-
toxins that contain very hydrophobic regions and more than
two disulfide bonds. We acknowledge that more studies utiliz-
ing a wider range of conotoxin substrates are needed to eluci-
date this possibility in the future.
However, our findings on the additive effect of ER-resident
enzymes on the folding of -conotoxins led us to investigate
whether these events may occur in close spatial and/or tempo-
ral proximity. This would probably be corroborated by the
existence of multienzyme complexes. Immunoprecipitation
studies alongsidewith BN-PAGEexperiments clearly identified
a complex between PDI and BiP in the venom glandular cells of
Conus. Because folding intermediates are highly susceptible to
degradation, this multienzyme complex may decrease the time
needed to generate conotoxins in their final three-dimensional
structure. BN-PAGE followed by second dimension SDS-
PAGE revealed that the PDI-BiP complex contained additional
proteins, including those migrating at the same molecular
weight as PPI B and Hsp40. Attempts to identify these proteins
by mass spectrometry and immunoblotting failed due to low
concentrations and/or lack of homologywith published protein
sequences. Future studies utilizing Conus-specific antibodies
will determine whether proteins such as PPI B and Hsp40 form
part of the BiP-PDI complex. A recent investigation into the
existence of multiprotein complexes in mammalian cells iden-
tified a complex comprising, among other proteins, PDI, PPI B,
BiP, and the Hsp40 protein ERdj3 (13). The authors suggested
that a large fraction of ER-resident chaperones forms a network
that can bind to unfolded protein substrates rather than exist-
ing as free proteins that assemble onto nascent polypeptide
chains (13). Based on the contribution of PDI, PPI B, and BiP to
conotoxin folding and the existence of a PDI-BiP complex in
venom glandular cells, it may be hypothesized that this pro-
posed ER network has been utilized by cone snails for toxin
assembly formore than 55million years and has remained con-
served throughout evolution. Notably, high expression levels of
PDI, BiP, and PPIwere also found in the venomglands of snakes
and wasps, animals that secrete disulfide-rich peptides as part
of their venoms (45–47). The existence ofmultienzyme folding
complexes in the venom glands of these and other venomous
animals has not been investigated. However, studies on the oxi-
dative folding of the scorpion toxin maurotoxin revealed most
efficient folding in the presence of PDI and the cytosolic pepti-
dyl-prolyl isomerase FKBP-12 (8). PDI has also been shown to
accelerate the folding rates of insulin, an archetypal peptide
hormone that contains multiple disulfide bonds (48). Interest-
ingly, recent studies also implicated BiP in the folding and
secretion of insulin (49). Based on these observations and our
findings on themultienzyme-assisted folding of conotoxins, we
hypothesize that small, disulfide-rich peptides abide by similar
rules and experience folding environments comparable with
those of larger polypeptide chains.
FIGURE 8. Investigations of protein-protein interactions in the venom gland of Conus. A, blue native polyacrylamide gel electrophoresis (BN-PAGE) of
soluble and membrane-associated protein complexes isolated from the venom gland of C. victoriae. Gels were immunoblotted using anti-PDI- and anti-BiP-
specific antibodies (AB). A band with immunopositive staining for PDI and BiP was identified in both preparations (black arrows). Corresponding bands were
excised from BN-polyacrylamide gels and further analyzed by immunoblotting and second dimension SDS-PAGE under denaturing conditions (Bi and Bii)
followedby in-gel tryptic digestion (see E for results). Both techniques confirmed thepresenceof PDI andBiP aspart of theprotein complex.Ci, co-IP of proteins
in the venom gland of C. victoriae using an anti-BiP antibody. Immunoprecipitated proteins were separated by SDS-PAGE and analyzed by in-gel tryptic
digestion (bands 1, 2, 3, and 4; see E for results) and immunoblotting using an anti-PDI-specific antibody. In-gel tryptic digestion identified BiP and PDI in BiP
co-IP samples but not in rabbit serum controls. Immunoblotting further revealed the presence of PDI in BiP Co-IP samples (black arrow), confirming the
association between BiP and PDI.Ciii, to rule out the possibility that PDI-positive stainingwas derived from the secondary antibody,membraneswere stripped
and reblotted using secondary antibody alone. No staining of the PDI band was observed for reblotted membranes. Di, affinity purification of PDI using the
biotin-labeled propeptide of -GI. Biotin-labeled pro-GI was incubated with venom gland protein lysates of C. geographus. Proteins interacting with pro-GI
were pulled down using streptavidin beads and analyzed by SDS-PAGE, in-gel tryptic digestion (see E for results), and immunoblotting using an anti-PDI-
specific antibody. In-gel tryptic digestion demonstrated that PDI was successfully affinity-purified using biotin-labeled pro-GI but not using a random biotin-
labeled control peptide (YARF).Dii, immunoblotting using an anti-PDI antibody further confirmed the identity of the PDI band (white arrow). E, results of in-gel
tryptic digestions. Tryptic peptides were analyzed by ESI-MS/MS on the QStar Elite Hybrid Q-TOF mass spectrometer (AB SCIEX). MS/MS data were searched
against an in-house molluscan protein database using Protein Pilot software (version 3.0, AB SCIEX). Peptides with a confidence of99 and a false discovery
rate of5 were accepted for protein identifications.
Multienzyme-assisted Folding of Conotoxins
OCTOBER 5, 2012•VOLUME 287•NUMBER 41 JOURNAL OF BIOLOGICAL CHEMISTRY 34301
 at UNIV O
F UTAH on O










In conclusion, this study is the first to investigate the con-
certed contribution of a number of highly expressed, ER-resi-
dent Conus enzymes to the folding of conotoxins. All enzymes
were shown to accelerate oxidative folding rates of two-cono-
toxins in vitro, with the most efficient rates in the presence of
PDI and PPI B or PDI, BiP, and microsomes. We were able to
demonstrate multienzyme-assisted folding of the thermody-
namically less favored ribbon isomer of -ImI and reveal its
presence in the venom of C. imperialis. We further provide the
first evidence for the direct interaction between PDI and a nas-
cent conotoxin, unequivocally establishing the role of this
enzyme in the folding of cone snail peptides. Our subsequent
investigations into the presence of multienzyme complexes led
to the discovery of a novel Conus ER protein complex, strongly
suggesting that conotoxins interact with a variety of enzymes to
acquire their correct three-dimensional conformation. In
effect, these enzymes form amolecular machine to process and
fold these disulfide-rich toxins. Future studies addressing the
full composition of this ER complex are likely to extend our
understanding of the mechanisms underlying disulfide-rich
peptide synthesis.
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ature uses disulﬁdes in the construction of stable
structural motifs in peptides that are secreted by the
cell. Peptides containing multiple disulﬁde bonds
are better protected from stress and unfolding con-
ditions found in extracellular environments.1–6 One
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Dissecting a Role of Evolutionary-Conserved but Noncritical Disulﬁde
Bridges in Cysteine-Rich Peptides Using x-Conotoxin GVIA and Its
Selenocysteine Analogs
ABSTRACT:
Conotoxins comprise a large group of peptidic
neurotoxins that use diverse disulﬁde-rich scaffolds. Each
scaffold is determined by an evolutionarily conserved
pattern of cysteine residues. Although many structure–
activity relationship studies conﬁrm the functional and
structural importance of disulﬁde crosslinks, there is
growing evidence that not all disulﬁde bridges are critical
in maintaining activities of conotoxins. To answer the
fundamental biological question of what the role of
noncritical disulﬁde bridges is, we investigated function
and folding of disulﬁde-depleted analogs of x-conotoxin
GVIA (GVIA) that belongs to an inhibitory cystine knot
motif family and blocks N-type calcium channels.
Removal of a noncritical Cys1–Cys16 disulﬁde bridge in
GVIA or its selenopeptide analog had, as predicted,
rather minimal effects on the inhibitory activity on
calcium channels, as well as on in vivo activity following
intracranial administration. However, the disulﬁde-
depleted GVIA exhibited signiﬁcantly lower folding yields
for forming the remaining two native disulﬁde bridges.
The disulﬁde-depleted selenoconotoxin GVIA analog also
folded with signiﬁcantly lower yields, suggesting that the
functionally noncritical disulﬁde pair plays an important
cooperative role in forming the native disulﬁde scaffold.
Taken together, our results suggest that distinct disulﬁde
bridges may be evolutionarily preserved by the oxidative
folding or/and stabilization of the bioactive conformation
of a disulﬁde-rich scaffold. # 2012 Wiley Periodicals, Inc.
Biopolymers (Pept Sci) 98: 212–223, 2012.
Keywords: disulﬁde bridges; conotoxins, structure–func-
tion; oxidative folding; calcium channels
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such class of disulﬁde-rich natural peptides having well-
deﬁned structures are conotoxins, neuroactive modulators
derived from marine cone snails.7–10 Conotoxins are short
peptides of varying length from 6 to 50 residues and contain-
ing 1–5 disulﬁde bonds that provide characteristic scaffolds
to the peptides and stabilize the biologically active conforma-
tion.10 Although multiple disulﬁde bonds generally contrib-
ute to the stability of native conotoxin fold, the removal of
one of the native disulﬁde bond was found to not affect their
structure or function in conkunitzin-S1,11 l-conotoxin
KIIIA,12 x-conotoxin MVIIA,13 a-conotoxin ImI,14 and a-
conotoxin GI.15 These ﬁndings indicate that disulﬁdes are
differentially associated with structure and function of disul-
ﬁde rich conopeptides (a disulﬁde can be critical for struc-
ture or function or both), which could be dissected by study-
ing the corresponding disulﬁde-depleted peptides. The best
example of one such study is x-conotoxin MVIIA, an N-type
Ca2+ channel blocker isolated from the marine snail Conus
magus having the inhibitory cystine knot (ICK) motif.13,16
The fundamental question of why nature conserves function-
ally noncritical disulﬁde bridges still remains unanswered.
ICK motif is a common structural motif found in peptides
of diverse origin including toxins from plants, antimicrobial
peptides from insects, and in venoms of scorpions, spiders
and cone snails.17–21 They share a unique knotted topology
consisting of three disulﬁde bridges, with one disulﬁde cross-
ing a loop formed by the two other disulﬁdes and intercon-
necting peptide backbone. The ICK motif containing cono-
toxins with the cysteine pattern CCCCCC are
widely characterized from Conus venom; x-conotoxin (in-
hibitor of Ca2+ channel),22 j-conotoxin (modulator of K+
channel),23 d-conotoxin (delay inactivation of Na+ chan-
nel),24 and lO-conotoxin (inhibitor of Na+ channel activa-
tion).25,26 x-Conotoxins are the best characterized ICK motif
containing conopeptides (Figure 1a), including x-conotoxin
MVIIA, which is an Food and Drug Administration-
approved drug for the treatment of intractable pain (zicono-
tide, Prialt).27–30 The role of disulﬁde bonds in structure–ac-
tivity relationships of x-conotoxins were investigated by
Sabo et al.,31 Norton and coworkers32 and the Goldenberg
group.13 As summarized in Table I, the ﬁrst disulﬁde bond
has a minimal contribution to the activity, whereas removal
of either the second or third disulﬁde bond drastically
affected the activity of peptide.
x-Conotoxin GVIA (Figure 1b) is a standard pharmaco-
logical tool for inhibiting synaptic transmission.29,30 Previous
studies by the Sabo group and the Norton group showed that
the disulﬁde bond between Cys1 and Cys16 in GVIA had
minimal contribution to the activity.31,32 Based on these
ﬁndings, we selected GVIA to ask a more general fundamen-
tal question: what is the role of a functionally noncritical di-
sulﬁde bridge? Keeping in mind that the functional role was
assessed based on in vitro assays, one possibility was that the
disulﬁde bridge might be important for in vivo activity
(when injected into an animal). We also hypothesized a
potential role of a functionally noncritical disulﬁde in oxida-
tive folding, which affects efﬁcient biosynthesis of a disul-
ﬁde-rich scaffold, rather than in stabilizing the ‘‘end-point’’
bioactive conformation. To address the above questions, we
reassessed the role of the functionally noncritical disulﬁde in
folding and activity of x-conotoxin GVIA using disulﬁde-
depleted analogs, namely dd-GVIA and dd-Sec-GVIA (Figure
2). Replacing disulﬁde bridges with diselenide bridges was
previously shown to be an effective strategy to simplify the
oxidative folding of cysteine-rich peptides, without affecting
their native conformation or biological activity.33–43 Our
ﬁndings indicate that the ﬁrst disulﬁde bridge (Cys1–Cys16)
in x-conotoxin GVIA is important for directing the correct
formation of the other two native disulﬁdes. The results are
discussed in the evolutionary context of conserving the func-




Peptides were synthesized using solid phase peptide synthesis meth-
odology, with Fmoc chemistry and activated OPfp esters of pro-
tected amino acids.
Natively Folded dd-GVIA. Side chains of one pair of natively
connected cysteines were protected with trityl (Trt) group, and the
other pair of natively connected cysteines was protected with the
acetamidomethyl group. Peptide cleaved from the resin and side
chains were deprotected using reagent K (triﬂuoroacetic acid
[TFA]/thianisol/phenol/water/ethanedithiol [82.5:5:5:5:2.5]), pre-
cipitated with MTBE, and washed several times with MTBE. The
peptide was puriﬁed using C18 RP-HPLC over linear gradient of 10–
40% buffer B (90% acetonitrile containing 0.1% TFA) for 40 min.
The puriﬁed peptide contains two acetamidomethyl-protected cys-
teines and two free thiols. Disulﬁde bond formation between the
free thiols was achieved by incubating 20 lM peptide in a folding
buffer containing 100 mM Tris-HCl (pH 7.5), 1 mM oxidized gluta-
thione (GSSG), and 2 mM reduced glutathione (GSH). A 20-lM
single disulﬁde containing peptide was incubated with 10 mM io-
dine dissolved in 50% of acetonitrile containing 1% TFA for simul-
taneous deprotection of acetamidomethyl groups and formation of
disulﬁde bond between corresponding cysteines. The reaction pro-
ceeded at room temperature for 5 min by gentle shaking in a glass
vial and subsequently quenched by drop wise addition of 1 M ascor-
bic acid. The natively folded peptide was puriﬁed by RP-HPLC and
characterized using mass spectrometry {[M + H]+oxi ¼ 2974.2 Da
(calculated), 2974.3 Da (observed)}.
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Natively Folded dd-Sec-GVIA. The side chains of selenocys-
teines were protected with a p-methoxybenzyl (Mob) group and
cysteines were protected with trityl (Trt) groups. Peptides were
removed from resin, and side chains were deprotected using
enriched reagent K (TFA/thianisol/phenol/water [90:2.5:7.5:5] and
1.3 equiv of DTNP [2,20-dithiobis(5-nitropyridine)]) and precipi-
tated using MTBE. Crude peptide was treated with 50 mM dithio-
threitol (DTT) in 100 mM Tris-HCl (pH 7.5) and subsequently
puriﬁed using preparative RP-HPLC with a C18 column over a lin-
ear gradient of 10–40% buffer B (90% acetonitrile containing 0.1%
TFA) for 40 min. Observed mass of the peptide was 2 Da less than
the predicted mass, conﬁrming the presence of a preformed disele-
nide in the linear peptide {[M + H]+red.¼ 3074.2 Da (calculated),
3072.4 Da (observed)}. This was further supported by an alkylation
reaction using iodoacetamide; the resulting species was shown by
mass spectrometry to contain a diselenide bridge.38,39 A 20-lM of
diselenide containing peptide was treated with 10 mM iodine dis-
solved in 50% of acetonitrile containing 1% TFA for formation of
disulﬁde bond between free thiols. The reaction proceeded at room
temperature for 5 min by gentle shaking in a glass vial and subse-
FIGURE 1 x-Conotoxins derived from the marine cone snails. a: Multiple sequence align-
ment of diverse x-conotoxins. Absolutely conserved residues were shaded and they include Cys
residues. Observed modes of disulﬁde connectivity in x-conotoxins were also highlighted.
Sequences were retrieved from conoserver, alignments were achieved using ClustalW software
and observed posttranslational modiﬁcations were manually incorporated (Note: Number sign
[#] indicates C-terminal amidation). b: The orientation in three-dimensional space of the con-
served Cys residues of x-conotoxins, depicted using x-conotoxin GVIA as an example. The
structure of GVIA (PDBID: 2CCO) was modeled using PyMOL software.
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quently quenched by drop wise addition of 1 M ascorbic acid. The
natively folded peptide was puriﬁed by RP-HPLC and characterized
using mass spectrometry {[M + H]+oxi.¼ 3070.2 Da (calculated),
3070.3 Da (observed)}.
Oxidative Folding
Free thiol containing linear peptide dd-GVIA was obtained by incu-
bating natively folded dd-GVIA in 10 mM DTT containing 10 mM
Tris-Hcl (pH 7.5) at 378C, puriﬁed by RP-HPLC and characterized
using mass spectrometry. Note that the linear peptide dd-Sec-GVIA
contains a preformed diselenide bridge. The folding reaction (or)
stability assay was initiated by resuspending 5 nmol of linear peptide
or natively folded peptide into 200 lL of folding buffer containing
100 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM GSSG, and 2 mM
GSH. The reaction was quenched after 2 h by acidiﬁcation with for-
mic acid (10% ﬁnal concentration). Samples were analyzed using
C18 analytical HPLC over a linear gradient of 10–40% buffer B
(90% acetonitrile containing 0.1% TFA) in 40 min. Accumulation
of natively folded peptide at the steady state was calculated by inte-
grating the HPLC chromatogram.
Proteolytic Digestion and Mass Spectrometry
The disulﬁde/selenosulﬁde connectivity in non-natively folded dd-
GVIA and dd-Sec-GVIA were studied by coupling tryptic digestion
with mass spectrometry. Five nanomoles of non-natively folded dd-
GVIA (or) dd-Sec-GVIA were dissolved in 100 mM Tris-Hcl (pH
7.5), 5 lL of trypsin (25ng/lL) was added and reaction mixture was
incubated at 378C for 4–8 h. The resulting peptide fragments were
separated using analytical RP-HPLC over a linear gradient of 10–
80% buffer B (90% acetonitrile containing 0.1% TFA) in 60 min
and the fractions were subsequently analyzed using mass spectrome-
try. The MALDI-mass spectra were acquired at the Mass Spectrome-
try and Proteomic Core facility of the University of Utah.
Measurement of N-Type Calcium Currents (CaV2.2)
HEK Cell Transfection. HEK293 cells were maintained in
DMEM/Glutamax medium containing 10% fetal bovine serum and
1% antibiotic-antimycotic (Invitrogen, Carlsbad, CA), at 378C in
5% CO2 incubator. The cells were transfected using Lipofectamine
2000 (Invitrogen) following the manufacturer’s instructions. The
complementary DNA plasmids were 1.93 lg a1B-CFP, 1.55 lg a2d,
and 0.97 lg b2a subunits. N-channel expressing cells were visualized
by CFP, which was attached to the N-terminus of a1B (a1B-CFP; from
Dr. Blaise Peterson, Penn State College of Medicine). Transfected
cells were split into 35 mm dishes that also served as the recording
chamber.
N-Current Measurement and Analysis. HEK cells were volt-
age-clamped as described previously44,45 in an external solution
containing (in mM): 145 N-methyl-D-glucamine (NMG) Cl, 10
NMG HEPES, 5 BaCl2. The internal (pipette) solution contained
(in mM): 104 NMG Cl, 14 creatine  PO4, 6 MgCl2, 10
NMG HEPES, 10 NMG2  EGTA, 5 Tris ATP, and 0.3 Tris GTP.
The osmolarity of the external solution was 300 mOsm, while that
of the internal solution was 280 mOsm. Both the internal and exter-
nal solutions were adjusted to pH 7.4 using NMG base. Leak current
was subtracted online using a -P/4 protocol for ionic currents. All
recordings were carried out at room temperature and the holding
potential was 120 mV. Ionic currents were digitized at 50 kHz after
analog ﬁltering at 5–10 kHz. Solutions were applied using a gravity-
fed perfusion system with an exchange time of 1–2 s. All toxin con-
centrations were 1 lM. Data were analyzed using IgorPro (Wave-
Metrics, Lake Oswego, OR) as described previously.38
Behavioral Assay
The natively folded GVIA, Sec-GVIA, dd-GVIA, and dd-Sec-GVIA
and the misfolded dd-GVIA and dd-Sec-GVIA were injected intra-
cranially to 21- to 23-day-old Swiss Webster mice using a syringe
with a 29-gauge needle. 1 nmol of each peptide was dissolved sepa-
rately in 15 lL of saline and subsequently injected in mice; an equal
volume of normal saline was used as a control. After injection, mice
were placed in a cage for observation. All of the native peptides
exhibited the shaking syndrome, which is characterized by a persis-
tent body tremor, and this behavior was maintained for a long time
in GVIA and Sec-GVIA, as compared to dd-GVIA and dd-Sec-
GVIA. Mice injected with misfolded dd-GVIA and dd-Sec-GVIA
did not exhibit the shaking syndrome; rather, the injected mice were
quite passive, occasionally shaking their bodies.
RESULTS
Design of dd-GVIA and dd-Sec-GVIA
To investigate the role of the functionally noncritical disulﬁde
in the folding and activity of x-conotoxin GVIA, dd-GVIA,
and dd-Sec-GVIA were designed and synthesized. Table I







GVIA 1-16; 8-19; 15-26 63a 31
[C1A,C16A] GVIA ND 933a 31
[C8A,C19A] GVIA ND NAa 31
[C15A,C26A] GVIA ND NAa 31
GVIA 1-16; 8-19; 15-26 10 nMb 32
[C1S,C16S] GVIA 8-15; 19-26 > 1 lMb 32
[C8S,C19S] GVIA ND > 1 lMb 32
[C15S,C26S] GVIA 1-16; 8-19 > 10 lMb 32
x-MVIIA-Gly 1-16; 8-20; 15-25 2.5 nMc 13
[8-20, 15-25]1,16 Ala 8-20; 15-25 170 nM
c 13
[1-16, 15-25]8,20 Ala 1-16; 15-25 517 nM
c 13
[1-16, 8-20]15,25 Ala 1-16; 8-20 13000 nM
c 13
RCM x-MVIIA-Gly Linear peptide 37000 nMc 13
ND, not determined; NA, not active (LD50 > 6000 lg/kg).
a Biological activity of the peptide was determined by their LD50 (lg/kg)
in the gold ﬁsh assay.
b Activity of the peptides was accessed using the twitch responses of the
rat vas deferens to sympathetic nerve stimulation.
c Functions of the peptides was established by competitive binding assay
using 125I-labeled x-GVIA on chick brain synaptosomes.
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summarizes the effect of removal of a disulﬁde bond on the
activity of x-conotoxins. It is apparent from Table I that re-
moval of the ﬁrst disulﬁde bridge in x-conotoxins resulted
in decreased activity by 15- to 70-fold. The loss of activity
observed by removal of any other native disulﬁdes is 200–
5000 fold. Hence, the removal of ﬁrst disulﬁde bridge in x-
conotoxin GVIA results in peptide that retains the ability to
modulate N-type calcium currents. It is worth mentioning
that the previous studies on the role of removing the ﬁrst di-
sulﬁde in x-conotoxin GVIA are not conclusive because the
disulﬁde connectivity of the peptides used in these studies
were unknown31 or misfolded.32,46
The removal of the ﬁrst disulﬁde bridge in x-conotoxin
GVIA resulted in two-disulﬁde containing dd-GVIA. The re-
moval of ﬁrst disulﬁde bridge in x-conotoxin GVIA reduces
the possible number of disulﬁde isomers from 15 to 3. Figure
2 shows a schematic representation of the design of disulﬁde-
depleted-seleno-x-conotoxin GVIA (dd-Sec-GVIA). The
design of dd-Sec-GVIA involves incorporation of selenocys-
teine into dd-GVIA. Systematic replacement of native disul-
ﬁde bridges with a diselenide bridge in x-conotoxin GVIA
has resulted in increased yield of natively folded peptide in
all Sec-GVIA analogs. The most prominent effect was
observed when the second native disulﬁde bridge was
replaced with a diselenide bridge (net yield enhancement of
natively folded peptide is 19%).38 Thus, removal of the func-
tionally noncritical ﬁrst disulﬁde bridge and incorporation of
a diselenide bridge in the second native disulﬁde position in
x-conotoxin GVIA resulted in biologically active dd-Sec-
GVIA. The incorporation of a diselenide bridge in dd-GVIA
has further simpliﬁed the folding problem and eliminated
the need for disulﬁde mapping in the folded peptide (dd-
Sec-GVIA needs to form only one disulﬁde bond to achieve
the natively folded state).
Synthesis of Natively Folded dd-GVIA
and dd-Sec-GVIA
The natively folded dd-GVIA was accessed using an orthogo-
nal protection scheme; one pair of natively connected
FIGURE 2 Design of disulﬁde-depleted seleno-x-conotoxin GVIA was accomplished using
redox favored selenocysteine and removing the functionally noncritical disulﬁde. Systematic di-
sulﬁde-to-diselenide scanning in x-conotoxin GVIA suggested that the second disulﬁde bridge
is ideal for replacement with selenocysteines.38 Structure/function studies on the role of disulﬁde
bridges in x-conotoxin GVIA suggested that the removal of ﬁrst disulﬁde bridge had relatively
small effects on the functional properties of x-conotoxin GVIA.31,32 Combination of disulﬁde
deletion and incorporation of a diselenide in x-conotoxin GVIA resulted in dd-Sec-GVIA,
which requires the formation of only one disulﬁde, thus removing the need for disulﬁde map-
ping of the folded peptides (Note: Number sign [#] indicates C-terminal amidation).
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cysteines were protected with the trityl (Trt) group (Cys8
and Cys19) and the other pair of natively connected cysteines
were protected with the acetamidomethyl (Acm) group
(Cys15 and Cys26). Figure 3a shows the regioselective folding
of dd-GVIA. Upon cleavage from the resin, TFA-labile trityl
groups yielded free thiols, and TFA-resistant acetamido-
methyl groups retain protected thiols, as described in Materi-
als and Methods section. The disulﬁde bond formation
between free thiols was achieved using a GSSG/GSH buffer,
resulting in formation of one native disulﬁde bridge. The
deprotection of the Acm group and simultaneous disulﬁde
bond formation between corresponding thiols was achieved
using molecular iodine, yielding natively folded dd-GVIA.
The identity of natively folded dd-GVIA was conﬁrmed by
mass spectrometric studies following the two successive fold-
ing steps, each of which resulted in a single major peak. Syn-
thesis of natively folded dd-Sec-GVIA was achieved as
described in Materials and Methods section, Sec residues
were incorporated into the sequence using p-methoxybenzyl-
protected selenocysteine and side chain deprotection was
achieved using DTNP. Figure 3b shows the regioselective
folding of dd-Sec-GVIA. The crude peptide obtained follow-
ing cleavage from the resin contains two DTNP-selenocys-
teine adducts, which were subsequently removed by thiolysis
using 50 mM DTT. The spontaneous oxidation of the sele-
nols to a diselenide yields a linear dd-Sec-GVIA containing a
preformed diselenide bridge, which was actually detected.37–41
Observed mass of linear dd-Sec-GVIA analogue was 2 Da less
than the predicted mass and had two alkylation sites
(iodoacetamide was used as alkylating agent), conﬁrming the
presence of a preformed diselenide bridge. The formation of
a disulﬁde bond between free thiols was achieved using mo-
lecular iodine, which leads to rapid and irreversible disulﬁde
bond formation yielding natively folded dd-Sec-GVIA.
FIGURE 3 Comparison of regioselective folding of dd-GVIA and dd-Sec-GVIA. a: Two-step
oxidative folding of dd-GVIA. The ﬁrst disulﬁde bond formation was mediated by redox buffer
(GSH/GSSG) and second disulﬁde bond formation was achieved using iodine. b: One-step oxi-
dative folding of dd-Sec-GVIA. Crude peptide was treated with DTT to remove the DTNP
adduct, which is followed by spontaneous diselenide bond formation. The diselenide-directed
folding requires only one folding step (disulﬁde bond formation using iodine) to achieve the
natively folded peptide. (Note: Asterisk [*] indicates the desired product).
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Similar to dd-GVIA, the elution proﬁles of the folding path-
way of dd-Sec-GVIA yielded a single major peak correspond-
ing to folded peptides. Mass spectrometric studies conﬁrmed
the identity of natively folded dd-Sec-GVIA. It is evident
from Figure 3 that the regioselective folding of dd-GVIA con-
sists of two folding steps and that of dd-Sec-GVIA consists of
only one folding step, demonstrating that the incorporation
of selenocystine simpliﬁes the oxidative folding.
Oxidative Folding Studies of dd-GVIA
and dd-Sec-GVIA
Incubation of the native forms of disulﬁde-rich peptides in
redox buffers, such as a mixture of GSSG/GSH, can be used
as a measure of the stability of the corresponding disulﬁde
isomer at the given redox potential.36 The glutathione medi-
ated folding of disulﬁde rich peptides involves thiol-disulﬁde
exchange reactions and a steady-state folding mixture reﬂects
the thermodynamic stability of the resulting disulﬁde iso-
mers of cysteine-rich peptides. To investigate the stability of
natively folded GVIA analogs, natively folded dd-GVIA and
dd-Sec-GVIA were incubated in redox-buffer containing
GSSG (1 mM GSSG) and GSH (2 mM GSH); these experi-
mental conditions were shown previously to promote efﬁ-
cient folding of GVIA.47,48
Figure 4a shows elution proﬁles of steady-state folding mix-
tures of dd-GVIA, dd-Sec-GVIA and the corresponding pep-
tide GVIA and Sec-GVIA. Similar elution proﬁles were
obtained by incubating corresponding linear peptides in the
folding buffer under identical experimental conditions. The
elution proﬁle of dd-GVIA at the steady state, in the presence
of the glutathione mixture retains about 15% of natively
folded peptide and that of GVIA retains about 60% of natively
folded peptide. The major peak accumulated at the steady
state in dd-GVIA corresponds to the non-natively folded spe-
cies (observed mass is 2974 Da). The tryptic digest of non-
natively folded dd-GVIA yielded fragments of mass 1745 Da
and 1247/1265Da, which could be ascribed to peptide frag-
ment AKSOGSSCSOTSYNCAR and SCNOYTKRCY# (Note:
O denotes hydroxyproline, # denotes an amidated C-terminus
and cysteines are disulﬁde bonded), respectively. The disulﬁde
connectivity in non-natively folded dd-GVIA is Cys8–Cys15
and Cys19–Cys26. These results were further supported by the
folding studies of [C1S, C16S]GVIA by Flinn et al.,32 where
the major folded fraction corresponds to the Cys8–Cys15 and
Cys19–Cys26 connectivity.
The elution proﬁle of dd-Sec-GVIA at the steady state, in
the presence of the glutathione mixture, retains about 45%
of natively folded peptide and that of Sec-GVIA retains about
78% of natively folded peptide. The major satellite peak
accumulated at the steady state in dd-Sec-GVIA has the mass
3070 Da, indicating the formation of non-natively folded
and seleno-sulﬁde containing dd-Sec-GVIA. The satellite
peak was attributed to the isomer Sec8–Cys15 and Sec19–
Cys26, since its retention time and shift in retention time (as
compared to that of natively folded peptide) was similar to
non-natively folded dd-GVIA having the Cys8–Cys15 and
Cys19–Cys26 connectivity. To further conﬁrm the presence
of seleno-sulﬁde bonds in the satellite peak, the peptide was
subjected to tryptic digestion and the resulting fragments
were analyzed using mass spectrometry. Incubation of the
satellite peak of dd-Sec-GVIA with trypsin yielded fragments
FIGURE 4 The role of the biologically noncritical disulﬁde in the oxidative folding of x-con-
otoxin GVIA and Sec-GVIA. a: RP-HPLC elution proﬁles of steady state folding mixtures of
GVIA, Sec-GVIA, and the corresponding disulﬁde-depleted analogues. Incubation of linear (or)
natively folded peptides in the folding mixture containing GSH/GSSG (2:1) at steady-state
yielded an identical elution proﬁle (Note: Asterisk [*] indicates the biologically active and
natively folded peptides). b: Steady state accumulation of biologically active and natively folded
peptide during oxidative folding (at room temperature). Error bars represent the standard error
of the mean, derived from four independent experiments.
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of mass 1793 Da & 1295/1313 Da, which corresponds to the
fragment AKSOGSSUSOTSYNCAR and SUNOYTKRCY#
(Note: cysteine and selenocysteine are bonded), further con-
ﬁrming the presence of Sec8–Cys15 and Sec19–Cys26 con-
nectivity in non-natively folded dd-Sec-GVIA. Note also that
the natively folded and non-natively folded dd-Sec-GVIA
were sensitive to dissolved oxygen species, and tended to
redistribute among all three the possible disulﬁde/selenosul-
ﬁde isomers of dd-Sec-GVIA over time.
Figure 4b shows accumulation of the natively folded and
biologically active conformer of GVIA, dd-GVIA, Sec-GVIA,
and dd-Sec-GVIA at steady state in the presence of a
GSH/GSSG mixture. It is evident from Figure 4b that incorpo-
ration of selenocystine at native disulﬁde connectivity in GVIA
(Sec-GVIA) and dd-GVIA (dd-Sec-GVIA) has a profound
inﬂuence on improving the yield of natively folded peptide.
The net increase in yield of natively folded peptide by incorpo-
ration of selenocystine in GVIA is 20%, and that of dd-GVIA
is 29%. The greater redox stability and more rapid formation
of diselenide bonds, as compared to disulﬁde bonds, signiﬁ-
cantly improves folding yields, and preferential formation of
diselenides over selenosulﬁdes further simpliﬁes disulﬁde map-
ping in the folded peptide. Impairment in folding pattern of
GVIA and Sec-GVIA upon removing the functionally noncriti-
cal disulﬁde conﬁrms the role that the Cys1–Cys16 disulﬁde
bond plays in the folding of x-conotoxin GVIA.
Biological Activities of dd-GVIA and dd-Sec-GVIA
We previously demonstrated that GVIA and Sec-GVIA pro-
duced an equivalent block of N-type calcium currents follow-
ing a 16 minute application.38 The disulﬁde deﬁcient pep-
tides, dd-GVIA and dd-Sec-GVIA, also block N-type calcium
currents expressed in HEK293 cells, but with a slower time
course (Figure 5a). The blocking time course for each peptide
was well described by a single exponential function to yield
the time constant, s. The s values for dd-GVIA and dd-Sec-
GVIA were signiﬁcantly different from that of GVIA and
Sec-GVIA (Figure 5b). As we had previously suggested,38 the
substitution of Cys8 and Cys19 by selenocysteine had no sig-
niﬁcant effect on the kinetics of N-current block since s of
GVIA and Sec-GVIA were not statistically different. The sele-
nocysteine change also did not impact the block by the di-
sulﬁde deﬁcient peptide, since the block s was statistically
equivalent between dd-GVIA and dd-Sec-GVIA. We con-
clude that the removal of the ﬁrst disulﬁde pair does not
prevent block of N-type channels, but does slow that block
by roughly 50%.
FIGURE 5 The blocking effect of GVIA, Sec-GVIA, and their corresponding disulﬁde-
depleted analogues on the N-type calcium channel. a: The blocking time courses from three N-
type calcium channel-expressing HEK cells exposed to 1 lM of either GVIA (closed circles), dd-
GVIA (open squares), or dd-Sec-GVIA (closed squares). The smooth gray lines are single expo-
nential ﬁts that begin with the toxin onset. b: Peptide blocking time constant (block s) measured
from N-type calcium channels expressed in HEK293 cells. The bar graph shows mean 6 stand-
ard deviation for data from 4 to 7 cells (indicated within each bar). The lower case letters indi-
cate signiﬁcant differences (P < 0.05, analysis of variance with Tukey HSD post hoc analysis).
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To investigate the role of removal of the functionally non-
critical disulﬁde in the in vivo activity of x-conotoxin GVIA,
dd-GVIA, Sec-GVIA, dd-Sec-GVIA and the non-natively
folded dd-GVIA and dd-Sec-GVIA were injected intracrani-
ally into mice. GVIA and Sec-GVIA were previously shown
to induce shaking syndrome in mice upon intracranial injec-
tion, which is characterized by a persistent body tremor, and
this behavior was maintained for a long time in a dose-de-
pendent manner.22,38 Both dd-GVIA and dd-Sec-GVIA also
exhibit shaking syndrome in mice, conﬁrming that the re-
moval of the functionally noncritical disulﬁde did not affect
the biological activity of x-conotoxin GVIA. However, the
shaking syndrome induced by dd-GVIA and dd-Sec-GVIA in
mice was not as long-lasting as either GVIA or Sec-GVIA.
The non-natively folded dd-GVIA and dd-Sec-GVIA did not
exhibit shaking syndrome; rather, the injected mice were pas-
sive, occasionally shaking their bodies. The distinct behav-
ioral symptoms elicited by natively folded and non-natively
folded disulﬁde-depleted peptide analogues demonstrate that
the topology of disulﬁde connectivity is critical to the biolog-
ical activity. Similar behavioral symptoms were elicited by
natively folded GVIA and dd-GVIA and their corresponding
selenocysteine analogues, conﬁrming that the removal of the
disulﬁde between Cys1 and Cys16 did not substantially affect
the biologically active conformation of x-conotoxin GVIA.
DISCUSSION
Although cone snails have a very efﬁcient mechanism to in-
capacitate their prey, they are not as mobile as other species,
FIGURE 6 Biochemical synthesis of cysteine rich conotoxins and disulﬁde scaffolds found
among conotoxins. a: The precursor prepropeptide with highlighted conserved and variable
regions. b: Two disulﬁde scaffolds found in conotoxins (i) shows the disulﬁde scaffold for x, j,
d, and lO pharmacological families and (ii) shows the disulﬁde scaffold for the l and C phar-
macological families. The scaffold shown in (i) can act as a calcium channel blocker, potassium
channel blocker, delayer of sodium channel inactivation, or a sodium channel blocker. Con-
versely, the scaffold shown in (ii) can act as a sodium channel blocker or a noncompetitive in-
hibitor of nicotinic acetylcholine receptors. c: Conkunitizin scaffold with a naturally deleted di-
sulﬁde bridge marked by a dashed line. Conserved Cys–Cys motifs in Kunitz domain were
replaced by Gly-Gln motif in conkunitizin.
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and therefore rely on high-efﬁciency hunting mechanisms.
Consequently, the implications of a failed envenomation
event are dramatically larger for snails than they are for other
venomous animals that are more able to pursue their prey as
it attempts to escape. Therefore, it is likely that the evolution-
ary pressures on cone snails are stronger than those on other
venomous animals. For example, if an injection of venom
takes 2 min to paralyze the prey, the cone snail would remain
hungry, where a snake or scorpion would likely not. This is
probably the explanation for the atypically high evolutionary
rate of venom peptides in Conus.49 However, as discussed
below, conotoxins offer a unique opportunity to study evolu-
tionary and molecular mechanisms by which genetic infor-
mation is translated into folding and activity of disulﬁde-rich
polypeptides.
As illustrated in Figure 6a, the high rate of evolution of
Conus venom toxins is in striking contrast with discrete con-
servation of various portions of a toxin precursor gene.49
From a mechanistic point of view, even more puzzling is the
fact that the cysteine scaffold remains highly conserved at the
level of Cys codon usage (TGC or TGT), while adjacent co-
dons belong to hypervariable sequences of intercysteine
loops.50–52 Despite this extreme conservation of the cysteine
scaffold, this does not imply a conservation of pharmacologi-
cal properties.10 For example, Figure 6b shows two common
disulﬁde scaffolds found in conotoxins blocking sodium
channels,53,54 but one scaffold (i) also blocks calcium chan-
nels and potassium channels (x- and j-conotoxins, respec-
tively), as well as delaying the inactivation of sodium chan-
nels (d-conotoxins), whereas the other scaffold (ii) is also ca-
pable of functioning as a noncompetitive inhibitor of
nicotinic acetylcholine receptors.55 Noteworthy, despite an
evolutionary conservation of Cys positions and codons, both
the scaffolds provide examples of conotoxins containing
functionally noncritical disulﬁde bridges.
However, despite the highly conserved disulﬁde scaffolds in
Conus, there are several instances of evolutionary divergence
of disulﬁde scaffolds in these marine snails. Although it is of-
ten difﬁcult to reliably determine which is the ‘‘ancestral’’ fold,
the conservation of cysteine codons and propeptide region
strongly suggests evolutionary linkage between the a-conotox-
ins (bearing two disulﬁde bridges) and the aA-conotoxins
(bearing three disulﬁde bridges).50 Additionally, the examples
of Kunitz domains in conotoxins indicate that the evolution of
disulﬁde bridges does not bear an inherent directionality
(gain/loss of bridges). The Kunitz domain is a very ancient
fold, being present in both plants56 and animals,57 with bovine
pancreatic trypsin inhibitor (BPTI) being the prototypical
example. From this ancient fold/cysteine scaffold, cone snails
have developed a class of conotoxins, referred to as conkunit-
zins. The conkunitzin family has sequences that show a dele-
tion of a disulﬁde bridge (illustrated in Figure 6c) that is
highly conserved in non-Conus Kunitz domains,58 as well as
in other conkunitzins that contain two Kunitz domains in tan-
dem, with addition of a fourth disulﬁde bridge on the N-ter-
minal Kunitz scaffold.59
One outstanding question that remains is that the mech-
anism by which the cysteine scaffold is so highly conserved
remains unknown. The extent of conservation decreases
from the signal peptide to the mature toxin region (Figure
6a). However, the placement of cysteine, and even the cyste-
ine codons within the mature toxin region are much more
highly conserved than the remainder of the toxin region.
Although it has been proposed that this is due to a poly-
merase that preferentially preserves cysteine codons,60 a
DNA polymerase capable of recognizing frame shifts has yet
to be discovered. Consequently, it is possible that the cyste-
ine scaffold is preserved by another mechanism, likely rely-
ing on evolutionary pressures. A given disulﬁde bond may
be either critical to oxidative folding or to biological activity
(or both), or may even be expendable. Thus, the extent to
which the sequence encodes folding information to direct
the folding to the native disulﬁde connectivity is critical to
the ability to add and/or remove disulﬁde bridges to an
existing scaffold. Herein, we explore the ability to delete a
native disulﬁde bridge from x-conotoxin GVIA, and con-
sider the evolutionary pressures present to preserve a given
disulﬁde scaffold.
The potential to dissect the roles of individual disulﬁde
bridges in a short, disulﬁde-rich peptide allows for a much
more thorough analysis of the evolutionary pressures present
to maintain each bridge. In Figure 4, it is evident that the ﬁrst
disulﬁde bridge is critical to the efﬁcient folding of GVIA, while
Figure 5 shows that the same disulﬁde has a minimal effect on
the biological activity of GVIA. Other work on deleting the sec-
ond and third disulﬁde bridges demonstrated signiﬁcant loss
of the activity.32 Using x-conotoxin GVIA as a model for ICK
peptides, it is evident that each of the disulﬁdes serves a critical
purpose in generating the ﬁnal, biologically active compound.
Consequently, the evolutionary pressure to efﬁciently produce
active peptide has caused the retention of the disulﬁde bridges
in almost all ICK peptides, with the only potential exception
being U1-liotoxin-Lw1a, from the scorpion, Liocheles waigien-
sis,61 which may also be a precursor that never acquired a third
disulﬁde bridge.
The authors thank Drs. Robert Schackmann and Scott Endicott
from the DNA/Peptide Synthesis Core Facility at the University of
Utah for the synthesis of peptides as well as Pranav Mathur for criti-
cal reading of the manuscript and his helpful suggestions.




1. Ryan, C. A. Hand Book of Biologically Active Peptides; Aca-
demic Press, Elsevier Inc.: CA, 2006.
2. Lehrer, R. I.; Lichtenstein, A. K.; Ganz, T. Annu Rev Immunol
1993, 11, 105–128.
3. Rodrı´guez de la Vega, R. C.; Schwartz, E. F.; Possani, L. D. Toxi-
con 2010, 56, 1155–1161.
4. Escoubas, P.; Sollod, B. L.; King, G. F. Toxicon 2006, 47,
650–663.
5. Gray, W. R.; Olivera, B. M.; Cruz, L. J. Annu Rev Biochem 1988,
57, 665–700.
6. Mouhat, S.; Jouirou, B.; Mosbah, A.; De Waard, M.; Sabatier, J.
M. Biochem J 2004, 378, 717–726.
7. Olivera, B. M.; Rivier, J.; Clark, C.; Ramilo, C. A.; Corpuz, G. P.;
Abogadie, F. C.; Mena, E. E.; Woodward, S. R.; Hillyard, D. R.;
Cruz, L. J. Science 1990, 249, 257-263.
8. Olivera, B. M. Mol Biol Cell 1997, 8, 2101–2109.
9. Olivera, B. M.; Teichert, R. W. Mol Interv 2007, 7, 251–260.
10. Terlau, H.; Olivera, B. M. Physiol Rev 2004, 84, 41–68.
11. Bayrhuber, M.; Vijayan, V.; Ferber, M.; Graf, R.; Korukottu,
J.; Imperial, J.; Garrett, J. E.; Olivera, B. M.; Terlau, H.;
Zweckstetter, M.; Becker, S. J Biol Chem 2005, 280,
23766–23770.
12. Han, T. S.; Zhang, M. M.; Walewska, A.; Gruszczynski, P.; Rob-
ertson, C. R.; Cheatham, T. E., 3rd.; Yoshikami, D.; Olivera, B.
M.; Bulaj, G. ChemMedChem 2009, 4, 406–414.
13. Price-Carter, M.; Hull, M. S.; Goldenberg, D. P. Biochemistry
1998, 37, 9851–9861.
14. Lamthanh, H.; Jegou-Matheron, C.; Servent, D.; Me´nez, A.;
Lancelin J. M. FEBS Lett 1999, 454, 293–298.
15. Kaerner, A.; Rabenstein, D. L. Biochemistry 1999, 38,
5459–5470.
16. Price-Carter, M.; Bulaj, G.; Goldenberg, D. P. Biochemistry
2002, 41, 3507–3519.
17. Rees, D. C.; Lipscomb, W. N. J Mol Biol 1982, 160, 475–498.
18. Pallaghy, P. K.; Nielsen, K. J.; Craik, D. J.; Norton, R. S. Protein
Sci 1994, 3, 1833–1839.
19. Gelly, J. C.; Gracy, J.; Kaas, Q.; Le-Nguyen, D.; Heitz, A.; Chiche,
L. Nucleic Acids Res 2004, 32, 156–159.
20. Gracy, J.; Le-Nguyen, D.; Gelly, J. C.; Kaas, Q.; Heitz, A.; Chiche,
L. Nucleic Acids Res 2008, 36, 314–319.
21. Norton, R. S.; Pallaghy, P. K. Toxicon 1998, 36, 1573–1583.
22. Olivera, B. M.; McIntosh, J. M.; Cruz, L. J.; Luque, F. A.; Gray,
W. R. Biochemistry 1984, 23, 5087–5090.
23. Shon, K. J.; Stocker, M.; Terlau, H.; Stu¨hmer, W.; Jacobsen, R.;
Walker, C.; Grilley, M.; Watkins, M.; Hillyard, D. R.; Gray, W.
R.; Olivera, B. M. J Biol Chem 1998, 273, 33–38.
24. Shon, K. J.; Hasson, A.; Spira, M. E.; Cruz, L. J.; Gray, W. R.;
Olivera, B. M. Biochemistry 1994, 33, 11420–11425.
25. McIntosh, J. M.; Hasson, A.; Spira, M. E.; Gray, W. R.; Li, W.;
Marsh, M.; Hillyard, D. R.; Olivera, B. M. J Biol Chem 1995,
270, 16796–16802.
26. Fainzilber, M.; van der Schors, R.; Lodder, J. C.; Li, K. W.; Ger-
aerts, W. P.; Kits, K. S. Biochemistry 1995, 34, 5364–5371
27. Olivera, B. M. In Drugs from the Sea; Fusetani N., Ed. Karger:
Basel, Switzerland, 2000.
28. Miljanich, G. P. Curr Med Chem 2004, 11, 3029–3040.
29. Horne, A. L.; Kemp, J. A. Br J Pharmacol 1991, 103, 1733–1739.
30. Takahashi, T.; Momiyama, A. Nature 1993, 366, 156–158.
31. Sabo, T.; Gilon, C.; Shafferman, A.; Elhanaty, E. In 12th
American Peptide Symposium; Smith J.A., Ed.; 1992,
1559–1560.
32. Flinn, J. P.; Pallaghy, P. K.; Lew, M. J.; Murphy, R.; Angus, J. A.;
Norton, R. S. Biochim Biophys Acta 1999, 1434, 177–190.
33. Fiori, S.; Pegoraro, S.; Rudolph-Bo¨hner, S.; Cramer, J.; Moroder,
L. Biopolymers 2000, 53, 550–564.
34. Pegoraro, S.; Fiori, S.; Cramer, J.; Rudolph-Bo¨hner, S.; Moroder,
L. Protein Sci 1999, 8, 1605–1613.
35. Pegoraro, S.; Fiori, S.; Rudolph-Bo¨hner, S.; Watanabe, T. X.;
Moroder, L. J Mol Biol 1998, 284, 779–792.
36. Armishaw, C. J.; Daly, N. L.; Nevin, S. T.; Adams, D. J.; Craik, D.
J.; Alewood, P. F. J Biol Chem 2006, 281, 14136–14143.
37. Walewska, A.; Zhang, M. M.; Skalicky, J. J.; Yoshikami, D.; Oli-
vera, B. M.; Bulaj, G. Angew Chem Int Ed Engl 2009, 48, 2221–
2224.
38. Gowd, K. H.; Yarotskyy, V.; Elmslie, K. S.; Skalicky, J. J.; Olivera,
B. M.; Bulaj G. Biochemistry 2010, 49, 2741–2752.
39. Han, T. S.; Zhang, M. M.; Gowd, K. H.; Walewska, A.; Yoshi-
kami, D.; Olivera, B. M.; Bulaj, G. ACS Med Chem Letter 2010,
4, 140–144.
40. Steiner, A. M.; Bulaj, G. J Pept Sci 2011, 17, 1–7.
41. Walewska, A.; Jaskiewicz, A.; Bulaj, G.; Rolka K. Chem Biol
Drug Des 2011, 77, 93–97.
42. Muttenthaler, M.; Nevin, S. T.; Grishin, A. A.; Ngo, S. T.; Choy,
P. T.; Daly, N. L.; Hu, S. H.; Armishaw, C. J.; Wang, C. I.; Lewis,
R. J.; Martin, J. L.; Noakes, P. G.; Craik, D. J.; Adams, D. J.; Ale-
wood, P. F. J Am Chem Soc 2010, 132, 3514–3522.
43. de Araujo, A. D.; Callaghan, B.; Nevin, S. T.; Daly, N. L.;
Craik, D. J.; Moretta, M.; Hopping, G.; Christie, M. J.;
Adams, D. J.; Alewood, P. F. Angew Chem Int Ed Engl 2011,
50, 6527–6529.
44. Yarotskyy, V.; Elmslie, K. S. J Neurophysiol 2009, 101, 332–
340.
45. Yarotskyy, V.; Elmslie, K. S. Br J Pharmacol 2007, 152, 386–395.
46. Flinn, J. P.; Pallaghy, P. K.; Lew, M. J.; Murphy, R.; Angus, J. A.;
Norton, R. S. Eur J Biochem 1999, 262, 447–455.
47. Price-Carter, M.; Gray, W. R.; Goldenberg, D. P. Biochemistry
1996, 35, 15537–15546.
48. Price-Carter, M.; Gray, W. R.; Goldenberg, D. P. Biochemistry
1996, 35, 15547–15557.
49. Duda, T. F.; Palumbi, S. R. Proc Natl Acad Sci USA 1999, 96,
6820–6823.
50. Santos, A. D.; McIntosh, J. M.; Hillyard, D. R.; Cruz, L. J.; Oli-
vera, B. M. J Biol Chem 2004, 279, 17596–17606.
51. Wang, Q.; Jiang, H.; Han, Y. H.; Yuan, D. D.; Chi, C. W. Toxicon
2008, 51, 813–822.
52. Zhangsun, D.; Luo, S.; Wu, Y.; Zhu, X.; Hu, Y.; Xie, L. Chem
Biol Drug Des 2006, 68, 256–265.
53. Eckberg, J.; Jayamanne, A.; Vaughan, C. W.; Aslan, S.; Thomas,
L.; Mould, J.; Drinkwater, R.; Baker, M. D.; Abrahamsen, B.;
Wood, J. N.; Adams, D. J.; Christie, M. J.; Lewis, R. J. Proc Natl
Acad Sci USA 2006, 103, 17030–17035.
54. Zhang, M. M.; Green, B. R.; Catlin, P.; Fiedler, B.; Azam, L.;
Chadwick, A.; Terlau, H.; McArthur, J. R.; French, R. J.; Gulyas,
J.; Rivier, J. E.; Smith, B. J.; Norton, R. S.; Olivera, B. M.; Yoshi-
kami, D.; Bulaj, G. J Biol Chem 2007, 282, 30699–30706.
55. Olivera, B. M.; Cruz, L. J. Toxicon 2001, 39, 7–14.
222 Gowd et al.
Biopolymers (Peptide Science)
153
56. Troncoso, M. F.; Biron, V. A.; Longhi, S. A.; Retegui, L. A.; Wolf-
enstein-Todel, C. Int Immunopharmacol 2007, 7, 625–636.
57. Ascenzi, P.; Bocedi, A.; Bolognesi, M.; Spallarossa, A.; Coletta,
M.; De Cristofaro, R.; Menegatti, E. Curr Protein Pept Sci 2003,
4, 231–251.
58. Dy, C. Y.; Buczek, P.; Imperial, J. S.; Bulaj, G.; Horvath, M. P.
Acta Crystallogr D Biol Crystallogr 2006, 62, 980–990.
59. Olivera, B.; Bulaj, G.; Garrett, J.; Terlau, H.; Imperial, J. Editora
UFMG 2009, 25–48.
60. Conticello, S. G.; Gilad, Y.; Avidan, N.; Ben-Asher, E.; Levy, Z.;
Fainzilber, M. Mol Biol Evol 2001, 18, 120–131.
61. Smith, J. J.; Hill, J. M.; Little, M. J.; Nicholson, G. M.; King, G.
F.; Alewood, P. F. Proc Natl Acad Sci USA 2011, 108, 10478–
10483.
Role of Disulﬁde Bridges in Conotoxins 223
Biopolymers (Peptide Science)
154
